Tranter contributes to fossil fuels reduction in steel production.

Tranter’s plate and frame heat exchangers will be used in the process to capture and separate the carbon dioxide coming from the energy intense steel production process. The order is for four large plate and frame heat exchangers in stainless steel with extra hard EPDM gaskets that will be used for heat recovery in the removal process of CO\2\ from a gas stream, carried out by absorption in a continuous process with regenerable solvents. The plant is a direct reduced iron (DRI) plant and can reduce the carbon footprint significantly compared to traditional steel plants by utilizing green hydrogen as energy and post combustion carbon capture technology, hence an important step in reaching the NetZero goals by 2030. “The subject of effective heat exchangers is getting more and more attention in the industry. The fact that our products are key components for the world to reach their NetZero goals by 2030 is both encouraging for our own workers and makes us feel proud about our company and our products.” says Thomas Cassirer – Director Global Energy Segment Tranter’s heat exchangers will operate as lean/rich solvent interchanges and the lean solvent heat exchanger is part of the amine preparation before and after the carbon dioxide absorption. Efficient heat transfer is crucial for effective carbon dioxide absorption and for amine regeneration. Tranter’s ThermoFit plates (GT-series) with the Omniflex plate pattern is a perfect fit for post-combustion carbon capture applications, as they are specifically designed for heat recovery duties capable of handling high NTUs without sacrificing too much pressure drop. Both are essential in the absorption process, the solvent absorbs carbon dioxide but is also an aggressive contaminant. This makes the material selection a key parameter for the operational economy of the plant. Tranter’s references from similar applications and proven expertise in the carbon capture application helped the customer to find suitable material without sacrificing too much on the capital expenditure of plant. “Tranter’s vast experience in amine applications and references on what special materials work well in the process was a key factor to gain the customer’s trust. Tranter’s local presence with our factory in Sweden and our service center in Germany was considered an added value for the end-user, making Tranter the first-choice provider for plate heat exchangers in this important project.” declares Fredrik Nyström – Sales Manager EPC Europe. The heat exchangers were ordered by an Italian EPC contractor in the metal and mining industry and will be manufactured in Tranter’s factory in Vänersborg, Sweden. 

BiBB receives patent approval for EndoDrill in India

The approved Indian patent 532933 originates from the patent application IN202127017788 from patent family 1 and protects the EndoDrill[®] product series, the world's first market-cleared electric-driven biopsy instrument for endoscopy. BiBB has two additional international patent families for EndoDrill[®] that have entered the national/regional phase. In 2023, BiBB received approval of two patents in Europe, and in February 2024, the Japanese Patent Office decided to approve the first patent for EndoDrill[®]. "The first approved patent in India strengthens our global IP portfolio and increases the possibility of a successful future global launch with a partner," says Fredrik Lindblad, CEO of BiBB. About EndoDrill® EndoDrill[®] biopsy instruments work with precision to take high-quality tissue samples to improve diagnostics for several types of cancer, such as stomach, pancreatic, liver, lung, and bladder cancer. The innovative product technology redefines the growing area of endoscopic ultrasound-guided tissue acquisition for cancer diagnostics. The motorized high-speed rotational EndoDrill[®] needle enables high-quality core biopsies, overcoming the limitations of today’s standard manual needles. In 2023, EndoDrill[®] GI, BiBB’s lead product, received market clearance from the US FDA as the first electric-driven biopsy instrument for endoscopy in the USA. At the beginning of 2024, CE certification according to MDR was obtained in Europe for the entire EndoDrill[®] product family. The EndoDrill[®] system has been designed to be easy to use consisting of a sterile disposable biopsy instrument with an associated drive system. This is a translation of the Swedish press release. If there should be any discrepancies, the Swedish language version prevails. For more information about BiBB, please contact:Fredrik Lindblad, CEOE-mail: fredrik.lindblad@bibbinstruments.comPhone: +46 70 899 94 86www.bibbinstruments.comThis disclosure contains information that BiBBInstruments AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, on April 18, 2024. About BiBB The cancer diagnostics company BiBBInstruments AB develops and manufactures EndoDrill[®], a patented product line of electric-driven endoscopic biopsy instruments. The EndoDrill[®] instruments take high-quality tissue samples with high precision with the goal of improving the diagnosis of several serious cancers, such as stomach, pancreas, liver, lung, and bladder. The product portfolio is aimed at the global market for ultrasound-guided endoscopic (EUS/EBUS) biopsy instruments, which constitute the most advanced and fast-growing area of endoscopy. BiBB received 510(k) clearance from the US FDA for the lead product EndoDrill[®] GI in 2023. At the beginning of 2024, CE marking according to MDR was also obtained for all three product variants: EndoDrill[®] GI, EndoDrill[®] EBUS and EndoDrill[®] URO. Thus EndoDrill[®] is the first cleared electric endoscopic biopsy system in both the US and Europe. The EndoDrill[®] system includes sterile disposable biopsy instruments with associated drive system. The company was founded in 2013 by Dr. Charles Walther, cancer researcher at Lund University and senior consultant in clinical pathology at Skåne University Hospital in Lund. BiBBInstruments is based at Medicon Village in Lund and the BiBBInstruments share (ticker: BIBB) is listed on Spotlight Stock Market.

Scania Super Green Truck 2024

“Scania participates in many press tests in Europe, but the Green Truck Award really focuses on what is an absolute core requirement in our industry – offering customers the best possible transport efficiency,” says Stefan Dorski, Senior Vice President and Head of Scania Trucks. “Our Super-based powertrain was introduced in 2021 and brought a new performance level to the market, with its 8% fuel-savings that our customers now benefit from in their daily operations.”  The annual “Green Truck” test is organised by the magazines Trucker and VerkehrsRundschau. It began in 2011 and has been held 14 times. So far, Scania has scored nine (!) wins in total, four second places and one 5th place (in the very first year). Needless to say, no other brand is even close to Scania’s track record.  “Ah, the fifth place – that happened long before my tenure started,” says a smiling Dorski. “Seriously though, we at Scania are very proud and happy at having regained the title as the most efficient long-haul truck in the world. Consuming less fuel means that our trucks contribute a lot for curbing CO2 emissions, since so much of the world’s transports is still dependent on combustion engines.”  The best truck in the test is identified by applying a clever formula that covers all the relevant aspects of being transport-efficient and sustainable: fuel consumption, average speed, used AdBlue volume and the weight of the truck (the lighter the better).  And when one takes a closer look at the actual data that are used in the Green Truck formula, Scania’s results stand out: over 100km distance, the average difference compared to the runner-up is 0.41 litres of fuel. Taking into perspective the fact that  a long-haul truck travels something like 150,000 km each year, this makes Scania’s more than 600 litre per year better off than the nearest competitor. At 7,040 kg, the Scania truck was also the lightest vehicle, and achieved the highest average speed, at 79.70 km/h. Scania also introduced an updated version of its CCAP system (Cruise Control with Active Prediction) in May 2023, something that is believed to have given an edge in the test.  The actual testing takes place on various types of roads (though mainly motorways) in the Munich area. Everything is closely monitored by the organisers and by staff from the participating manufacturers. A reference truck is always used to compensate for changing conditions such as head winds, rain and temperature.  Watch the winning truck in action here. 

Elkem ASA - Minutes from the annual general meeting 2024

Oslo, 18 April 2024 The annual general meeting of Elkem ASA was held on 18 April 2024 in Oslo. All proposals on the agenda were adopted, cf. the notice of the annual general meeting that was sent to the Oslo Stock Exchange on 22 March 2024. The minutes of the annual general meeting is attached and available on www.elkem.com. This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act. For further information, please contact:Odd-Geir LyngstadVP Finance & Investor RelationsTel: +47 976 72 806Email: odd-geir.lyngstad@elkem.com About Elkem:Elkem is one of the world’s leading providers of advanced silicon-based materials shaping a better and more sustainable future. The company develops silicones, silicon products and carbon solutions by combining natural raw materials, renewable energy and human ingenuity. Elkem helps its customers create and improve essential innovations like electric mobility, digital communications, health and personal care as well as smarter and more sustainable cities. With a strong track record since 1904, its global team of more than 7,400 people has a joint commitment to stakeholders: Delivering your potential. In 2023, Elkem achieved an operating income of NOK 35.5 billion and CDP ratings of A on Forests, and A- on Climate Change and Water Security. Elkem is listed on the Oslo Stock Exchange (ticker: ELK), where the company is also included in the ESG Index. www.elkem.com

Norse Atlantic Airways Introduces New Route Between London Gatwick and Cape Town

Norse Atlantic Airways proudly announces the launch of its newest route connecting London Gatwick and Cape Town, set to commence on October 28th, 2024. With flights operating three times a week on Monday, Wednesday, and Saturday, travellers can now experience the vibrant culture and breathtaking landscapes of Cape Town with ease. With fares starting from just £499 return in Economy and £1199 return in Norse Premium class, Norse Atlantic Airways is committed to delivering exceptional value without compromising on quality. Moreover, this historic route launch signifies a shift in consumer choice, as Norse Atlantic Airways breaks the existing duopoly on the London to Cape Town route. By injecting much-needed competition into the market, Norse Atlantic Airways aims to empower consumers with greater choice, flexibility, and affordability. “We are thrilled to introduce our new route between London and Cape Town. By breaking the duopoly on this route, we are not only expanding travel options for consumers but also driving down costs and putting the customer back in the pilot’s seat. At Norse Atlantic Airways, we believe that everyone deserves the opportunity to experience the wonders of the world and our new route to Cape Town will allow many more people to visit this amazing destination,” said Bjorn Tore Larsen, CEO and Founder of Norse Atlantic Airways. Stephanie Wear, VP Aviation Development, London Gatwick said: “We are proud to welcome another new route from Norse Atlantic, connecting passengers across London and the South East with Cape Town from October. “Norse has continued to grow at London Gatwick and provide excellent connectivity to a number of key markets across the USA. This new route to South Africa is great news not only for those looking for a fantastic holiday destination, but also for trade and inbound tourism.” Cape Town boasts a myriad of attractions, from the iconic Table Mountain to the stunning coastline and world-renowned vineyards of the Cape Winelands. Travelers can immerse themselves in the rich history of Robben Island, explore the bustling Victoria & Alfred Waterfront, or indulge in delectable cuisine at the city’s top restaurants. Outbound flights depart London Gatwick at 20.00 and land in Cape Town at 0930 the following morning. Inbound flights depart Cape Town at 11.45 and arrive at London Gatwick at 21.35 the same day. Norse Atlantic exclusively operates modern Boeing 787 Dreamliner aircraft. The cabin offers passengers a relaxed and comfortable travel experience with each seat including a personal, state-of-the-art entertainment experience. Our Norse Premium cabin offers an industry leading 43” seat pitch and 12” recline, allowing passengers to arrive at their destination feeling refreshed and ready to explore their destination. Norse Atlantic offers two cabin choices: Economy and Norse Premium. Passengers can choose from a simple range of fares, Light, Classic and Flextra, that reflect the way that they want to travel, and which options are important to them. Light fares represent Norse’s value option, while Flextra fares include the maximum baggage allowance, two meal services and increased ticket flexibility. For more information or to book visit www.flynorse.com

Everfuel A/S – Annual General Meeting 2024

Herning, Denmark, 18 April 2024 – The Annual General Meeting 2024 was held today. All the proposed resolutions were approved by the AGM. This includes the re-election of Søren Eriksen, Jørn Rosenlund, Christina Aabo and Anne Kathrine Steenbjerge to the Board of Directors and approval of the resolution to appoint Yasuhiro Miyata a seat in the Board of Directors. The Minutes of Meeting is attached and will be available from the company’s website: www.everfuel.com/investor/ For additional information, please contact Jesper Ejlersen, CFO, Everfuel, jej@everfuel.com Mads T. Mortensen, Director of investor relations and communication, Everfuel, mm@everfuel.com, +45 7730 4727 About Everfuel | www.everfuel.com Everfuel is making green hydrogen for zero emission industry and mobility commercially available across Europe, offering competitive all-inclusive hydrogen supply and fuelling solutions. We own and operate green hydrogen infrastructure and partner with industry and vehicle OEMs to connect the entire hydrogen value chain and seamlessly provide hydrogen fuel to enterprise customers under long-term contracts. Green hydrogen is a 100% clean energy carrier made from renewable solar and wind power and key to decarbonising industry and transportation in Europe. We are an ambitious, rapidly growing company, headquartered in Herning, Denmark, and with activities in Norway, Denmark, Sweden, The Netherlands and Germany, and a plan to grow across Europe. Everfuel is listed on Euronext Growth in Oslo under EFUEL. This information is subject to the disclosure requirements pursuant to Section 5-12 of the Norwegian Securities Trading Act.

Calliditas Therapeutics Presents Additional Data Analyses from the Phase 3 NeflgArd trial of Nefecon in Primary IgA Nephropathy at the ISN World Congress of Nephrology 2024

“We were pleased to share additional analyses from the 2-year Phase 3 NeflgArd trial of Nefecon in IgAN at this year’s World Congress of Nephrology,” said Richard Philipson, Chief Medical Officer of Calliditas. “These additional data further reinforce the impact of Nefecon across the entire study population, irrespective of baseline UPCR levels or patient’s racial and ethnic backgrounds.” Poster presentation details are below and will be available on the Presentations and Publications page  on the Calliditas’ corporate website following the meeting. Poster Presentation Analyses: Poster Title: “Nefecon treatment provides kidney benefits for patients with IgAN that extend to those with low levels of UPCR: A sub-analysis of the phase III NefIgArd trial” An extended analysis of patients with baseline UPCR levels above and below 0.8 g/g was performed to further explore the potential benefits of Nefecon. In the full analysis involving 364 patients regardless of baseline UPCR, Nefecon treatment consistently improved the estimated glomerular filtrate rate (eGFR) over the 2-year study period compared to placebo. 72 patients with a baseline UPCR <0.8 g/g experienced sustained eGFR improvement (p=0.0026), which persisted for up to 18 months after treatment initiation, even after the treatment cessation at month 9.  Those patients also achieved an eGFR slope of –0.25 mL/min/1.73 m[2] per year, indicating that Nefecon treatment may support them in reaching the RaDaR treatment target of an eGFR decline of <1 mL/min/1.73 m2 per year. This objective is pivotal in mitigating the risk of kidney failure in their lifetime. Poster Title: “eGFR decline in patients with IgAN treated with Nefecon or placebo: Results from the 2-year NefIgArd Phase 3 trial” During the 9-month treatment period, Nefecon showed a 30% reduction in UPCR compared to the placebo, sustained for 2 years. The percentage of patients with a confirmed 30% reduction in eGFR or kidney failure was lower in the Nefecon arm compared to placebo, and the time to such events was significantly delayed with Nefecon (hazard ratio [HR] 0.45; 95% confidence interval 0.26, 0.75]; p=0.0014 [1-sided]). Supplementary analysis with rescue medication yielded similar results, irrespective of the handling of rescue medication: Rescue medication counted as an event: HR 0.51 (95% CI 0.33, 0.79), Regardless of rescue medication: HR 0.44 (95% CI 0.27, 0.71). The treatment effect of Nefecon on the risk of kidney function decline was consistent regardless of baseline UPCR. These findings strongly suggest preserved kidney function and provide support for Nefecon as a disease-modifying therapy in patients with IgAN. Poster Title: Nefecon effect on quality of life in patients with IgAN: SF-36 results from the Phase 3 NefIgArd trial” The 2-year results of quality of life (QoL) analyses based on 36-Item Short Form Survey (SF-36) assessments at 9 and 24 months revealed no meaningful differences in any QoL domain between Nefecon and placebo groups after 9 months of treatment. These SF-36 scores remained consistent after 15 months of off-drug observational follow-up further supporting the benefit/risk profile of Nefecon. Poster Title: “Nefecon treatment response in Asian and White patient populations with immunoglobulin A nephropathy: A 2-year analysis of the Phase 3 NefIgArd trial” The responses to Nefecon treatment from the full 2-year NefIgArd trial were assessed in patients identifying as Asian (n=83) or White (n=275). Regardless of race and ethnicity, Nefecon showed a favorable change in eGFR compared to placebo of 5.5 mL/min/1.73 m[2] in Asian patients and 4.8 mL/min/1.73 m[2] in White patients. Nefecon also demonstrated greater reductions in UPCR at 9 and 24 months with notable delays in kidney function decline events. These effects were consistent across races and ethnicities. Additionally, Nefecon significantly reduced the rate of microhematuria in both Asian and White patients. Overall, these findings highlight Nefecon’s efficacy and tolerability across different racial and ethnic groups. Indication TARPEYO is indicated to reduce the loss of kidney function in adults with primary immunoglobulin A nephropathy (IgAN) who are at risk for disease progression. Important Safety Information Contraindications: TARPEYO is contraindicated in patients with hypersensitivity to budesonide or any of the ingredients of TARPEYO. Serious hypersensitivity reactions, including anaphylaxis, have occurred with other budesonide formulations. Warnings and Precautions Hypercorticism and adrenal axis suppression: When corticosteroids are used chronically, systemic effects such as hypercorticism and adrenal suppression may occur. Corticosteroids can reduce the response of the hypothalamus-pituitary-adrenal (HPA) axis to stress. In situations where patients are subject to surgery or other stress situations, supplementation with a systemic corticosteroid is recommended. When discontinuing therapy or switching between corticosteroids, monitor for signs of adrenal axis suppression.  Patients with moderate to severe hepatic impairment (Child-Pugh Class B and C respectively) could be at an increased risk of hypercorticism and adrenal axis suppression due to an increased systemic exposure to oral budesonide. Avoid use in patients with severe hepatic impairment (Child-Pugh Class C). Monitor for increased signs and/or symptoms of hypercorticism in patients with moderate hepatic impairment (Child-Pugh Class B). Risks of immunosuppression: Patients who are on drugs that suppress the immune system are more susceptible to infection than healthy individuals. Chickenpox and measles, for example, can have a more serious or even fatal course in susceptible patients or patients on immunosuppressive doses of corticosteroids. Avoid corticosteroid therapy in patients with active or quiescent tuberculosis infection; untreated fungal, bacterial, systemic viral, or parasitic infections, or ocular herpes simplex. Avoid exposure to active, easily transmitted infections (e.g., chicken pox, measles). Corticosteroid therapy may decrease the immune response to some vaccines.  Other corticosteroid effects: TARPEYO is a systemically available corticosteroid and is expected to cause related adverse reactions. Monitor patients with hypertension, prediabetes, diabetes mellitus, osteoporosis, peptic ulcer, glaucoma or cataracts, or with a family history of diabetes or glaucoma, or with any other condition where corticosteroids may have unwanted effects. Adverse reactions: In clinical studies, the most common adverse reactions with TARPEYO (occurring in ≥5% of TARPEYO treated patients, and ≥2% higher than placebo) were peripheral edema (17%), hypertension (12%), muscle spasms (12%), acne (11%), headache (10%), upper respiratory tract infection (8%), face edema (8%), weight increased (7%), dyspepsia (7%), dermatitis (6%), arthralgia (6%), and white blood cell count increased (6%). Drug interactions: Budesonide is a substrate for CYP3A4. Avoid use with potent CYP3A4 inhibitors, such as ketoconazole, itraconazole, ritonavir, indinavir, saquinavir, erythromycin, and cyclosporine. Avoid ingestion of grapefruit juice with TARPEYO. Intake of grapefruit juice, which inhibits CYP3A4 activity, can increase the systemic exposure to budesonide. Use in specific populations Pregnancy: The available data from published case series, epidemiological studies, and reviews with oral budesonide use in pregnant women have not identified a drug-associated risk of major birth defects, miscarriage, or other adverse maternal or fetal outcomes. There are risks to the mother and fetus associated with IgAN. Infants exposed to in-utero corticosteroids, including budesonide, are at risk for hypoadrenalism.  Please see Full Prescribing Information . About TARPEYO TARPEYO is an oral 4mg delayed release formulation of budesonide, designed to remain intact until it reaches the ileum. Each capsule contains coated beads of budesonide that target mucosal B-cells present in the ileum, including the Peyer’s patches, which are responsible for the production of galactose-deficient IgA1 antibodies (Gd-Ag1) causing IgA nephropathy. About the NeflgArd Study NefIgArd was a global, Phase 3, randomized, double-blind, placebo-controlled, multicenter study to evaluate the efficacy and safety of TARPEYO 16 mg once daily vs placebo in adult patients with primary IgAN (N=364) as an addition to optimized RASi therapy. Patients were randomized 1:1 to receive 16 mg/day oral capsules of TARPEYO or matching placebo for 9 months, followed by a 15-month observational follow-up period without the study drug. The primary efficacy endpoint was time-weighted average of eGFR over 2 years. The time-weighted average of eGFR over 2 years showed a statistically significant treatment benefit with TARPEYO versus placebo (difference 5·05 mL/min per 1·73 m² [95% CI 3·24 to 7·38], p<0·0001). The favorable effect of TARPEYO on eGFR was seen by Month 3 (the earliest assessment) and did not appear to increase in magnitude over two years.  At the end of Year 2, there was a 5.9 mL/min/1.73 m2 difference in the mean change from baseline in eGFR between TARPEYO and placebo (95% CI: 3.3 to 8.5 mL/min/1.73 m2; p<0.0001). The effect on kidney function seen during the 9-month treatment period persisted following completion of treatment through the end of the study but the overall effect on the long-term rate of decline has not been established. The most common adverse reactions with TARPEYO (occurring in ≥5% of TARPEYO treated patients and ≥2% higher than placebo) were peripheral edema (17%), hypertension (12%), muscle spasms (12%), acne (11%), headache (10%), upper respiratory tract infection (8%), face edema (8%), weight increase (7%), dyspepsia (7%), dermatitis (6%), arthralgia (6%), and white blood cell count increase (6%). About Primary Immunoglobulin A Nephropathy Primary immunoglobulin A nephropathy (IgA nephropathy or IgAN or Berger’s Disease) is a rare, progressive, chronic autoimmune disease that attacks the kidneys and occurs when galactose-deficient IgA1 is recognized by autoantibodies, creating IgA1 immune complexes that become deposited in the glomerular mesangium of the kidney.This deposition in the kidney can lead to progressive kidney damage and potentially a clinical course resulting in end- stage renal disease. IgAN most often develops between late teens and late 30s.

HKScan to change its name - the company’s new name will be HKFoods

The parallel company names of the new name are HKFoods Plc (in English) and HKFoods Abp (in Swedish). “The name HKFoods will continue the company’s traditions and reflects one of the company's core consumer brands, as well as the company's industry and strategic reference. We continue our strategic journey to become a versatile food company. HKFoods is strongly Finnish at its core, but an internationally operating company," says CEO Juha Ruohola. The company name change has no impact on the company’s iconic consumer brands, HK[®], Kariniemen[® ]and Via[®] in Finland and Rose[®] in Denmark. The company’s new name, logo, website and email address, etc. will be introduced in stages from May 2024 after the name has been registered with the Trade Register. Other contact details of the company and its personnel (phone numbers, addresses) will remain unchanged. The company will publish a separate stock exchange release once the name change has been registered with the Trade Register. Further information: Juha Ruohola, CEO, HKScan Corporation, tel. +358 400 647 160HKScan Media Service Desk, tel. +358 10 570 5700 or by email: communications@hkscan.com With 110 years of experience, we at HKScan make life tastier – today and tomorrow. Our strategic target is to grow into a versatile food company. Our home markets are Finland and Denmark, where around 3,600 of our professionals make responsible and locally produced food for consumers’ varied food moments. Our well-known brands include HK[®], Kariniemen[®], Via[®] and Rose[®.] We are developing a more climate-friendly way of producing food. HKScan is a publicly listed company, and in 2023, our net sales from continuing operations totalled nearly EUR 1.2 billion. www.hkscan.com

Arjo’s interim report January-March 2024

”We start the year with growth and improved profitability. Rental and service develop well globally and the positive trend in the US continues, with a gradual improvement of the market situation. Overall, a solid start to the year and I look forward to continue the work together with the team to strengthen Arjo’s positions in 2024,” says Joacim Lindoff, President and CEO of Arjo. January-March 2024 in brief · Net sales increased to SEK 2,759 M (2,638).Net sales grew organically by 4.3%. · Adjusted EBITDA increased 5.7% to SEK 502 M (475). · Adjusted operating profit increased 13.2% to SEK 248 M (219). · Profit after financial items increased to SEK 175 M (150). · Earnings per share rose to SEK 0.48 (0.42). · Cash flow from operations rose to SEK 256 M (250), corresponding to a cash conversion of 54.2% (54.5). · Arjo’s climate targets were approved by the Science Based Targets initiative during the quarter. Telephone conference Fund managers, analysts and media are invited to participate in a conference call and presentation of the report on April 18 at 15:00 CEST via the following link: https://ir.financialhearings.com/arjo-q1-report-2024 Those who wish to ask questions verbally during the teleconference will need to register via the link below. A phone number and a conference ID will be provided after registration in order to access the conference. Link to registration: https://conference.financialhearings.com/teleconference/?id=50048573 Alternatively, use the following link to download the presentation:https://www.arjo.com/int/about-us/investors/reports--presentations/2024/ A recorded version of the conference is accessible for three years via the following link:https://ir.financialhearings.com/arjo-q1-report-2024 For more information, please contact: Maria Nilsson, EVP Communications & Public Relations Tel: +46 734 244 515 Email: maria.nilsson@arjo.com   Sara Ehinger, VP Investor Relations & Corporate Communications Tel: +46 723 597 794 Email: sara.ehinger@arjo.com This information is information that Arjo AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 14:00 CEST on April 18, 2024. About Arjo At Arjo, we believe that empowering movement within healthcare environments is essential to quality care. Our products and solutions are designed to promote a safe and dignified experience through patient handling, medical beds, personal hygiene, disinfection, diagnostics, and the prevention of pressure injuries and venous thromboembolism. With more than 6,500 people worldwide and over 65 years caring for patients and healthcare professionals, we are committed to driving healthier outcomes for people facing mobility challenges. www.arjo.com

JACK & JONES and SPINNOVA takes next step in their joint development collaboration and release 2nd product made with SPINNOVA® fibre

The new t-shirt is the first consumer product that is made from SPINNOVA® fibre produced at Spinnova and Suzano’s jointly-owned Woodspin facility, which began operating in 2023. The fibre produced at the facility is made from certified wood pulp from Scandinavia using Spinnova's pioneering technology. The t-shirt has the largest production volume of a commercially available SPINNOVA® product to date. The t-shirt is sold in selected JACK & JONES stores, through wholesalers and online on jackjones.com. “We're delighted to continue our close collaboration with Bestseller and do our part to help them bring to life their strong sustainability strategy. We couldn’t be more excited to see them launch a new product made from SPINNOVA® – let alone one that has an accessible price point and availability.” says Spinnova’s CEO Tuomas Oijala. Spinnova and Bestseller began their joint development partnership in 2020 and in 2022, JACK & JONES became the first BESTSELLER brand to use SPINNOVA® in a consumer product. The initial product from the collaboration was a pair of cream-coloured men’s trousers, made from cotton and SPINNOVA® fibre. JACK & JONES is now the first major global brand to launch a new consumer product made with SPINNOVA® fibre for the second time. “At JACK & JONES we strive for a better way of making clothes. We push ourselves to innovate and explore processes and materials with a lower impact on the environment. In SPINNOVA® we’ve found a strong partner to take part in that journey. We are very excited to now launch the second JACK & JONES product made with SPINNOVA® fibre.” says Allan Jung Thorbøll, International Buying Manager, JACK & JONES. JACK & JONES t-shirts made with SPINNOVA® are available in selected stores and online at www.jackjones.com from April 2024. See the t-shirt and more information here: https://www.jackjones.com/da-dk/indhold/abetter-world/spinnova

Wirtek signs non-binding acquisition agreement

Company announcement no. 6/202418 April 2024 This announcement contains inside information Wirtek has entered into a comprehensive non-binding agreement (Letter of Intent) to acquire a profitable IT services company in Portugal that provides services complementing Wirtek’s existing service offerings in the Clean Energy sector. The expected acquisition is closely aligned with Wirtek’s Accelerate25XL strategy. Wirtek achieves the strategic goal of having a sourcing location outside of Romania by 2025 while strengthening its competencies in the Clean Energy domain. Wirtek also gains access to new international clients as well as approx. 20 IT specialists. The acquisition, when and if completed, will have a positive effect on both revenue and EBITDA for Wirtek during the financial year 2024. The final closing of the acquisition is planned for end of May 2024 and is conditional upon a satisfactory due-diligence result. Payment for the acquisition will be given partly in cash and partly in Wirtek shares. Part of the payment will be directly linked to the financial results of the acquired software company over the next years. The pricing of the shares used in all the agreements has been calculated based on the current pricing of Wirtek shares on the Nasdaq First North Growth Market. Further details about the acquisition will be published after the final closing. Further information · Kent Mousten Sørensen, Chairman, Wirtek A/S, Phone: +45 2125 9001 · Michael Aaen, CEO, Wirtek A/S, Phone: +45 2529 7575, E-mail: ir@wirtek.comNiels Jernes Vej 10, 9220 Aalborg, Denmark, www.wirtek.com · Grant Thornton, Certified Advisor, Phone: +45 3311 0220 About Wirtek Wirtek A/S is a Danish IT consultancy company that provides software development, testing, and consultancy services to help clients worldwide. Wirtek specializes in Digitalization, Energy, Workforce & Facility Management, Wireless Communication & Automation, and Trade & E-commerce. At Wirtek, we prioritize building long-term client relationships, with some lasting over a decade. We believe that quality partnerships are just as important as software quality in achieving our client's goals. Established in 2001, we have offices in Denmark and Romania and have been listed on Nasdaq First North Copenhagen since 2006. Ticker Code: WIRTEK (DK0060040913) 

MapsPeople A/S announces a directed issue and sale of own shares

MapsPeople A/S | Inside Information Company Announcement No. 6 - 2024 Aalborg, April 18, 2024 Commencement of private placement and sale of own shares The Board of Directors of MapsPeople A/S ("MapsPeople") has today decided to strengthen the company's capital structure by launching an issuance of new shares in a private placement (the "Private Placement") expected to result in approximately DKK 4.2 million in gross proceeds. In connection herein, MapsPeople has also decided to sell 550,000 own shares at a price of DKK 2.10 per share, corresponding to the subscription price of the new shares issued in the Private Placement. These shares relate to the clawback of 50% of the purchase price of the acquisition of the Point Inside business equaling 1,570,101 shares as informed in Company announcement 1-2024 of 27 February 2024. The Private Placement of new shares (the "New Shares") is directed to one new shareholder. The Private Placement is expected to be subscribed for today. MapsPeople will inform the market of the result of the subscription of the Private Placement immediately thereafter. The Private Placement will be carried out at a subscription price of DKK 2.10 equaling the average closing price of the share in the period from April 12 2024 to April 17 2024 (DKK 2,04) plus DKK 0,06. The Private Placement is made pursuant to and in compliance with the applicable exemptions from the obligation to publish a prospectus, and the New Shares will be issued in accordance with the Board of Directors' authorization to increase MapsPeople's share capital without pre-emptive rights for the existing shareholders. The Private Placement is expected to be completed on 23 April 2024 and the New Shares are expected to be admitted to trading on Nasdaq First North Growth Market Denmark on 25 April 2024. Background for the Private Placement and sale of own shares In Company Announcement number 36-2023 MapsPeople informed that the financial plan for 2024 was fully financed, and the company continues to perform according to that plan. After announcing the 2023 Annual Report in Company Announcement 3-2024 that also provided guidance for growth in 2024, there has been increased inbound interest to invest in MapsPeople. To further strengthen the capital structure the board has decided to proceed with this process.  Gaining additional financial headroom provides more flexibility to MapsPeoples continuous efforts to improve the operational efficiencies through 2024, as well as improved flexibility delivering the guided growth through signing up and onboarding additional smart building partners. There are no changes to the existing guidance for 2024.   Admission to trading The New Shares will be listed on Nasdaq First North Growth Market Denmark in reliance on the exemption in the EU Prospectus Regulation and not on the basis of a prospectus. The New Shares will be issued in the systems of VP Securities A/S ("Euronext Securities Copenhagen") and delivered to the investors in the temporary ISIN code DK0062843884. The temporary ISIN code will not be admitted to trading on Nasdaq First North Growth Market Denmark but will only be registered with Euronext Securities Copenhagen for use in connection with the investors' subscription of the New Shares. The temporary ISIN code in Euronext Securities Copenhagen will be merged with the permanent ISIN code for the existing shares, DK0061549052, as soon as possible following registration of the share capital increase with the Danish Business Authority, expectedly on 26 April 2024. The New Shares are expected to be admitted to trading on Nasdaq First North Growth Market Denmark on or around 25 April 2024 in the permanent ISIN code for MapsPeople's existing shares. Expected timetable for the Private Placement The completion of the Private Placement, including admission to trading of the New Shares, is subject to the Private Placement not being withdrawn prior to the settlement thereof. 18 The company commences the Private Placement with subscriptionApril expectedly completed no later than on 19 April 2024 before the market2024 opens19 Trading day for the New SharesApril202423 Settlement and payment against delivery of the New Shares. The NewApril Shares will be delivered in the temporary ISIN code202423 Registration of the New Shares with the Danish Business AuthorityApril202425 Admittance to trading of the New SharesApril202426 Merger of the temporary ISIN code with the permanent ISIN codeApril2024 The New Shares The New Shares will rank pari passu in all respects with existing shares in MapsPeople. The New Shares will be negotiable instruments, and no restrictions will apply to their transferability. No shares, including the New Shares, carry or will carry any special rights. Rights conferred by the New Shares, including voting rights and dividend rights, will apply from the time when the capital increase is registered with the Danish Business Authority. The New Shares must be registered in the name of the holder in MapsPeople’s register of shareholders. Personal data For information about how the Company collects, processes, and protects personal data, please refer to the Company's website , where the Company's policy on processing of personal data and information about personal data protection are available. CONTACT INFORMATION MapsPeople A/S Morten Brøgger, CEO Mobile (+45) 31 23 48 72 Email mobr@mapspeople.com Stigsborgvej 60, 9400 Nørresundby Denmark Certified Advisor Grant Thornton Jesper Skaarup Vestergaard Mobile (+45) 31 79 90 00 Stockholmsgade 45 2100 Copenhagen Ø Denmark IMPORTANT INFORMATION This announcement is not an offer to sell or a solicitation of any offer to buy any securities issued by MapsPeople in any jurisdiction where such offer or sale would be unlawful and the announcement and the information contained herein are not for distribution or release, directly or indirectly, in or into such jurisdictions, including but not limited to, the United States, Australia, Canada or Japan. This announcement does not constitute an offering circular, company description or other offer document and nothing herein contains an offering of securities. No one should purchase or subscribe for any securities in MapsPeople except as described in this company announcement. Neither the existing shares of MapsPeople (the "Existing Shares") nor the New Shares have been, or will be, registered under the United States Securities Act of 1933, as amended ("Securities Act"). Neither the Existing Shares nor the New Shares may be offered or sold, directly or indirectly, in or into the United States or to persons residing there. Moreover, the Private Placement is not made to persons resident in Australia, Hong Kong, Japan, Canada, New Zealand, South Africa, Switzerland, or Singapore or to persons whose participation would require the publication up of a prospectus, registration or other measures. Certain statements in this announcement constitute forward-looking statements. Forward-looking statements are statements (other than statements of historical fact) relating to future events and the Company's anticipated or planned financial and operational performance. The words "targets", "believes", "expects", "aims", "intends", "plans", "seeks", "will", "may", "might", "anticipates", "would", "could", "should", "continues", "estimates" or similar expressions or the negative forms thereof, identify certain of these forward-looking statements. Other forward-looking statements can be identified in the context in which the statements are made. MapsPeople has based these forward-looking statements on its current views with respect to future events and financial performance. By their nature, forward-looking statements are based on certain assumptions and projections on future events and financial performance, which involve a number of risks and uncertainties that could cause actual results or events to differ materially from those expressed or implied by the forward-looking statements. These risks, uncertainties and assumptions could adversely affect the outcome and financial consequences of the plans and events described herein. Actual results are likely to differ from those set forth in the forward-looking statements. Any forward-looking statements speak only as at the date of this document and neither the Company nor any of its respective affiliates, directors, officers, employees, advisors, or any other person is under any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. You should not and may not rely on these forward-looking statements.

Annual General Meeting of JM AB

The AGM approved the Income Statement, the Balance Sheet, the Consolidated Income Statement and the Consolidated Balance Sheet. The AGM resolved to pay a dividend of SEK 3 per share. The record date for payment has been set on Monday, April 22, 2024. Euroclear Sweden AB is expected to send the dividend on Thursday, April 25, 2024. The AGM resolved to discharge the Board members and the CEO from liability.Board Members and remunerationThe Annual General Meeting resolved that the Board will have seven Members. The AGM resolved to re-elect Fredrik Persson as Chair of the Board of Directors and Members Kerstin Gillsbro, Stefan Björkman, Jenny Larsson, Olav Line, and Thomas Thuresson, and to elect new Member Liia Nõu. Remuneration to the Chair for work on the Board will be raised to SEK 1,000,000, and remuneration to Members will be raised to SEK 395,000. Fees for work on committees will be raised as follows: Chair of the Audit Committee: SEK 185,000. Members of the Audit Committee: SEK 110,000. Chair of the Compensation Committee: SEK 70,000.Members of the Compensation Committee: SEK 70,000.Chair of the Investment Committee: SEK 110,000. Members of the Investment Committee: SEK 85,000. The total proposed fee for the seven paid Members amounts to SEK 4,265,000, including remuneration for committee work. Election of auditorsThe AGM resolved to re-elect PricewaterhouseCoopers AB as auditing company. In accordance with Swedish law, the term of service extends until the end of the 2025 Annual General Meeting.Remuneration – report and guidelinesThe AGM resolved to approve the remuneration report presented by the Board.  The AGM approved the proposed guidelines for remuneration to senior executives.

Audientes A/S: Outcome of Annual General Meeting

Company announcement no. 15-2024 April 18, 2024 On April 18, 2024, the annual general meeting was held in Audientes A/S (CVR-no. 36 04 76 31) at the Company’s address, Teknikerbyen 5, 2830 Virum. The Company’s chairman Hossein Sandfeld Jelveh opened the meeting and informed that according to the articles of association section 5.6, the board of directors had appointed him as chairman of the meeting. Having accepted the nomination, the chairman noted that with the accession of the annual general meeting that the meeting was regularly constituted and convened and a quorum in every respect. The chairman pointed out that notice of the annual general meeting had been posted via Spotlight Stock Market on April 3, 2024, by separate company announcement and the same day posted on the Company’s webpage. At the meeting, all representatives of the Management of the Company as well as half of the board of directors were present (Hossein Jelveh, Steen Thygesen). The share capital of the Company is DKK6,938,432 divided into 69,384,322 shares of DKK 0.10 each. Each share of nominally DKK 0.10 carries one vote. Of the Company’s total share capital of DKK 6,938,432, shareholders representing 23.17% (16,076,197 votes) participated. Five shareholders representing 19.13% (13,270,751 votes) were present. Votes cast in the meeting amounted to 15.35% (10,650,751) and proxy or postal votes amounted to 7.82% (5,425,446) incl. votes of some shareholders’ also present in the meeting. The agenda for the general meeting is in accordance with section 5 of the articles of association, as follows: 1. Election of chairman of the meeting 2. Adoption of the Annual Report 3. Appropriation of profit or loss as recorded in the adopted Annual Report 4. Remuneration of the board of directors 5. Appointments to the board of directors 6. Election of auditors 7. Proposal to reduce the nominal value per share 8. Authorization to inform the Danish Business Authority of decisions takenat the annual general meeting 9. Any other business Re item 1: Election of chairman of the meeting Hossein Sandfeld Jelveh was elected as chairman of the meeting. The chairman concluded that notice of the general meeting was sent to the shareholders in accordance with the company’s articles of association. The votes of 23.17% of the share capital was represented in the meeting and the general meeting was able to conduct business in accordance with the agenda. Re item 2: Adoption of annual report The Management presented the Annual Report for 2023. Shareholders were given opportunity to ask questions. The accounts showed a result of TDKK minus 13,405. Status balanced with TDKK 14,394 and showed equity of TDKK 4,020. The general meeting approved the result and status. Re item 3: Appropriation of profits or losses as recorded in the adopted Annual Report The Management proposed the result of TDKK minus 13,405 transferred to next year, which was approved by the general meeting. Re item 4: Remuneration of the Board of Directors The Management proposed for the remuneration of the external members of the board of directors to amount to remain at DKK 50,000 per year for individual external board members, and DKK 100,000 for the chairman of the board, which was unanimously approved by the general meeting. The general meeting suggested for the Company to allow the individual board members to receive their board fee as shares as an incentive for their involvement and means of reducing the cost base further. Re item 5: Appointments to the Board of Directors All current members were re-elected, as the board constituted itself with Hossein Jelveh as chairman: The members of the Board of Directors at Audientes A/S are: · Hossein Jelveh (chairman) · Steen Thygesen · Hiroshi Maeda · Wendi Ma Re item 6: Election of auditors The company’s existing auditors Christensen Kjærulff, Statsautoriseret revisionsaktieselskab, were re-elected. Re item 7: Proposal to reduce the nominal value per share from DKK 0.1 to DKK 0.01 The general meeting voted against the proposal as it decided to defer the decision to reduce the nominal value per share from nominal DKK 0.1 to DKK 0.01 to the upcoming extraordinary general meeting on April 29, 2024, where this also is on the agenda, together with a proposed reduction of the share capital and a new authorization for the Company’s board of directors to issue new shares. Re item 8: Authorization to inform the Danish Business Authority of decisions taken at the annual general meeting The general meeting authorized Audientes’ CEO Steen Thygesen to inform the Danish Business Authority of any decisions taken at the annual general meeting and in this connection to make any changes and addendums to the decisions and the Company’s articles of association that the Danish Business Authority may require to register the decisions or approving the resolutions passed by the general meeting. Re item 9: Any other business There was nothing under this item. The general meeting was adjourned by the chairman of the meeting, Hossein Sandfeld Jelveh. For further information, please contact: Steen Thygesen,CEO, Audientes A/S Phone: ‭+45 77 34 16 80‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬ Email:st@audientes.com About Audientes A/S Audientes A/S is a Danish hearing health company specializing in smart, self-fitting and affordable hearing aids and advanced hearables. Audientes’ unique hearing aid solution, Ven™ by Audientes, is available for purchase in the Indian and Nepalese markets and will be introduced in other markets in the coming years. Companion by Audientes is an advanced hearable, a consumer electronics product, that is commercially available in Europe and later in 2024 in Japan, China, and other markets. Audientes’ mission is to make high-quality hearing aids and hearables for hearing improvement or hearing enhancement accessible to everyone who needs them globally. Audientes is listed on Spotlight Stock Market Denmark (AUDNTS) and headquartered in Copenhagen, Denmark with subsidiaries in Hyderabad, India and in Tokyo, Japan. For additional information please refer to the company’s websites, www.audientes.com, www.audientes.eu, or www.audientes.in.

WindowMaster International A/S: Annual General Meeting 2024

The Company’s Annual General Meeting was held today, 18 April 2024, at Skelstedet 13, 2950 Vedbæk. The Chairman of the Board of Directors, Lars Fournais, welcomed the shareholders to the Annual General Meeting and announced that in accordance with Article 9.2 of the company's Articles of Association that the Board of Directors had appointed attorney-at-law Peter Mollerup as Chairperson of the Meeting. The Chairperson thanked for the appointment and stated the following: · The general meeting was convened in time on 25 March 2024, cf. Article 7.4 of the Articles of Association. · The Company’s share capital of nominally DKK 14,512,903 is divided into 14,512,903 shares of DKK 1. Each share amount of DKK 1 gives one vote corresponding to a total of 14,512,903 votes. · Shareholders representing nominally DKK 9,559,784 of the Company's share capital equal to 9,559,784 votes, corresponding to 65.87% of the capital, were represented at the general meeting including representation by proxy. · All proposals on the agenda requires simple majority. · The Annual General Meeting was lawful and able to decide on the items on the agenda. Agenda item 1. Board of Directors’ report on the Company’s activities in thepast financial year The Chairman of the Board of Directors reported on the Company’s activitiesincluding that WindowMaster International A/S generated revenue in 2023 of238.0 mDKK and EBITDA of 19mDKK. The Chairperson of the Meeting concluded thatthe Annual General Meeting had taken account of the report.Agenda item 2. Presentation and approval of the audited Annual Report 2023 Key numbers from the Annual Report was highligthed. One question related to warrant program was raised – and it was referred tothe overview in the Annual Accounts. The Chairperson of the Meeting concluded that the Annual Report was adoptedand that the Board of Directors and Executive Board were granted discharge bythe Annual General Meeting.Agenda item 3. Approval of the remuneration of the Board of Directors for thecurrent financial year The shareholders approved the following remuneration for the Board ofDirectors for the current financial year: Chairman - DKK 375,000. ViceChairman - DKK 200,000. Board Member - DKK 125,000.The Chairperson of theMeeting concluded that the proposal for remuneration for the Board ofDirectors for the current financial year was adopted by the Annual GeneralMeeting.Agenda item 4. Decision on the use of profit or the covering of loss accordingto the approved annual report The Chairperson of the Meeting concluded that the proposal by the Board ofDirectors to cover the loss according to the approved annual report wasadopted by the Annual General Meeting.Agenda item 5. Election of members to the Board of DirectorsRe-election of Lars FournaisRe-election of Erik Koch BoyterRe-election of Mette Søs LassesenRe-election of Leif JensenNew election of Nina Ringen The Chairperson of the Meeting concluded that all the members of the Board ofDirectors were re-elected and elected by the Annual General Meeting.Agenda item 6. Election of auditor – the Board of Directors propose to re-elect the auditor from PwC. The Chaiperson of the meeting concluded that PwC was re-elected as theCompany’s auditor.Agenda item 7. Any proposals from the Board of Directors or shareholders. There was no proposal presented.Agenda item 8. Other issues The Board of Directos proposed to authorize the Chairperson of the Meeting toregister any decision with the Danish Business Authority and to makecorrections in the documents drawn up based on the decisions. The Chairpersonof the Meeting concluded that the proposal by the Board of Directors wasadopted by the Annual General Meeting.There were no further questions orcomments from the shareholders. As nobody else wished to speak, the Chairperson of the Meeting declared that the agenda had been exhausted. Chairperson of the Board Lars Fournais thanked the shareholders for attending and gave the floor to the CEO Erik Boyter for final remarks. The Annual General Meeting was then adjourned. April 18, 2024 ___________________________                       ____________________________ Peter Mollerup                                                                                       Lars Fournais Chairperson of the Meeting                                                  Chairperson of the Board of Directors

Resolutions made at the AGM 2024 in AQ Group AB

Today, AQ Group AB (publ) held its Annual General Meeting (AGM) which, inter alia, elected the Board, adopted the 2023 annual accounts, granted the Board and the CEO discharge from liability, and resolved on authorization for the Board to decide on a new issue of shares, a warrant-based incentive program, amendment of the articles of association, and on a share split. The AGM also resolved that dividends shall be paid and that the Board’s remuneration report for 2023 is approved. At the meeting, 60,97percent of the total amount of shares and votes in the company were represented. Income statements and balance sheets The AGM resolved to adopt the presented income statements and balance sheets for the company and the group for the 2023 financial year. Appropriation of the result The AGM resolved on a dividend with a cash amount of SEK 6,66 per share. The record day for the dividend was set at 22 April 2024. The payment for the dividend is expected to take place through Euroclear Sweden AB’s care on 25 April 2024. Discharge from liability The AGM granted the board members and CEO discharge from liability for the preceding financial year. The Board The AGM resolved, in accordance with the Nomination Committee’s proposal, that the following fees shall be paid: SEK 475 000 to the Chairman of the Board and SEK 235 000 to each of the other board members, SEK 120000 to the Chairman of the audit committee and SEK 60 000 to each of the other members of the audit committee and that no fees shall be paid for work in the remuneration committee. The AGM resolved, in accordance with the Nomination Committee’s proposal, that the number of board members shall be six, and re-elected the board members Per Olof Andersson,Ulf Gundemark, Gunilla Spongh, Claes Mellgren, Lars Wrebo and Kristina Willgård. Claes Mellgren was re-elected as Chairman of the Board. Auditor The AGM resolved to re-elect the chartered auditing firm Ernst & Young AB as auditor during the period until end of the 2025 AGM. Ernst & Young AB has informed that Jennifer Rock-Baley will be the auditor in charge. The auditor’s fee shall be paid in accordance with an approved account. Remuneration report 2023 The AGM resolved to approve the Board’s report regarding remuneration to senior executives for 2023. Authorisation The AGM resolved, in accordance with the Board’s proposal, to authorize the Board to, on one or more occasions until the next AGM, with or without deviation from the shareholders' preferential rights subscribed for in cash, by in kind or with the right of set-off, decide to increase the company's share capital through the new issue corresponding to a maximum of ten (10) percent of the total number of shares issued by the company at the time when the authorisation is utilized. Implementation of a warrant-based incentive program 2024-2027 and directed issue of warrants The AGM resolved to approve the Board of Directors' proposal to establish a long-term incentive program for ca 50 key employees including a directed new issue of warrants, of a maximum of 155,000 warrants, including an increase in the share capital upon full exercise of a maximum of SEK 310,000.  All warrants shall be issued at market price to the Participants. The price per warrant shall correspond to the market value of the warrant calculated using the customary valuation model (the so-called Black & Scholes formula). The warrant program is three years and each warrant entitles to subscription of one (1) new share in the company after 12 May 2027. The subscription price shall be set at an amount corresponding to 125 percent of the volume-weighted average price paid for the company's share on Nasdaq Stockholm during the period from and including 19 April 2024 up to and including 2 May 2024. Amendment of the articles of association and share split The AGM resolved, in accordance with the Board’s proposal, that the number of shares in the company is increased by division of each existing share into five shares (share split 5:1), and to authorize the Board to determine the record day for the share split. Following the share split, the number of shares in the Company will increase from 18,294,058 to 91,470,290 and the quota value of the share will change from SEK 2 to SEK 0.40. In order to enable the share split, the AGM resolved to amend § 4 of the articles of association by changing the limits for the permitted number of shares to a minimum of 50 million shares and a maximum of 150 million shares. Furthermore, the AGM resolved on the introduction of a new § 11 in the articles of association to enable the Board to collect proxies and to allow postal voting prior to the general meeting. Complete proposals and decisions The AGM approved all proposals submitted by the Board and the Nomination Committee. The proposals are fully set out in the previously published notice to the AGM, and the resolutions will be set out in the Minutes of the AGM, which will be published on the company's website, www.aqgroup.com This is a translation of the Swedish original wording. In case of discrepancies, the Swedish version shall prevail. For further information, please contact: Claes Mellgren, Chairman of the Board, telephone +46 70 592 83 38 The information was submitted for publication at 08:00 p.m. CEST on 18 April 2024. AQ in brief AQ is a global manufacturer of components and systems to demanding industrial customers and is listed on Nasdaq Stockholm’s main market. The Group consists mainly of operating companies each of which develop their special skills and in cooperation with other companies, striving to provide cost effective solutions in close cooperation with the customer. The Group headquarter is in Västerås, Sweden. AQ has 8,000 employees in Bulgaria, Poland, Lithuania, Sweden, China, Estonia, Hungary, Mexico, Finland, India, Canada, USA, Germany, Italy, and Brazil. In 2023 AQ had net sales of SEK 9 billion, and the Group has since its start in 1994 shown profit every quarter. www.aqgroup.com 

Elisa’s Interim Report Q1 2024

First quarter 2024 financial highlights · Revenue decreased by EUR 5m to EUR 535m, mainly due to business disposals. · Mobile service revenue increased by 5.8 per cent to EUR 249m. · Comparable EBITDA grew by EUR 7m to EUR 190m. · Comparable EBIT increased by EUR 5m to EUR 122m. · Comparable cash flow increased by EUR 15m to EUR 86m, mainly due to a change in net working capital. · In Finland, mobile post-paid ARPU increased to EUR 22.8 (22.4 in the previous quarter), and mobile post-paid churn decreased to 15.0 per cent (15.4). · During the quarter, post-paid mobile subscriptions increased by 18,200. M2M and IoT subscriptions grew by 36,100. · Due to seasonality, prepaid subscriptions decreased by 14,800 during the quarter. · The number of fixed broadband subscriptions increased by 3,300 during the quarter. Key indicators [][][][][][][]EUR million 1Q24 1Q23 Δ % 2023Revenue 534.5 540 -1.0 % 2,180EBITDA 179.7 183 -2.0 % 756Comparable EBITDA [(1] 190.0 183 3.6 % 756EBIT 112 117 -4.5 % 482Comparable EBIT [(1-2] 121.9 117 4.3 % 487Profit before tax 104 112 -7.5 % 458Comparable profit before tax [(1-2] 114 112 1.6 % 464EPS, EUR 0.52 0.57 -9.5 % 2.34Comparable EPS, EUR [(1-2] 0.57 0.57 -0.5 % 2.37Capital expenditure 68 66 4.2 % 321Net debt 1,260 1,217 3.5 % 1,304Net debt / EBITDA [(3] 1.7 1.6 1.7Gearing ratio, % 92.0 % 91.0 % 100.8 %Equity ratio, % 43.8 % 42.6 % 41.6 %Cash flow [(4] 62 71 -13.7 % 347Comparable cash flow [(5] 86 71 20.6 % 361 [1)][ ]1Q2024 excluding EUR 10m in restructuring costs. [2)] 2023 excluding a EUR 6m impairment. [3)] (Interest-bearing debt – financial assets) / (four previous quarters’ comparable EBITDA). [4)] Cash flow before financing activities. [5)] 1Q2024 excluding EUR 24m in share investments. 2023 excluding EUR 14m in share and business investments and sales. Additional key performance indicators are available at elisa.com/investors (Elisa Operational Data.xlsx). CEO Topi Manner: A good start to the year despite a challenging environment In the first quarter, Elisa continued its good performance despite geopolitical and macroeconomic headwinds. Revenue decreased by EUR 5 million to EUR 535 million due to business disposals and a decrease in equipment sales and interconnection revenue. However, comparable EBITDA improved by 4 per cent to EUR 190 million, driven by mobile service revenue and efficiency improvements. Comparable earnings per share was EUR 0.57. On 12 April 2024, for the tenth consecutive year, Elisa’s AGM approved a growing dividend, of EUR 2.25 per share. During the first quarter, we continued to expand the coverage of our high-speed connections. Elisa was the first operator in Finland to launch standalone 5G subscriptions, including standalone 5G fixed wireless access (FWA) connections for consumers. We continued to expand our fibre network, and we made G.fast technology available to residential properties, allowing the speed of a building’s indoor copper network to be accelerated to the speed of fibre. As a sign of Elisa’s innovativeness, the Finnish Transport and Communications Agency (Traficom) recognised Elisa with the 2024 Information Security Trailblazer award for its pioneering work in preventing scam calls and messages in Finland. The country now has a nationwide call blocking solution based on the scam call blocking solution that Elisa developed and patented. Elisa has also become the first telecom operator in Finland to register its own SMS Sender ID with Traficom, preventing scammers from sending text messages claiming to be from Elisa. We continued to grow with bolt-on acquisitions in accordance with our strategy. In Finland, Elisa’s corporate business strengthened its position as a provider of mobile value-added services by acquiring a majority stake in Moontalk Oy. The acquisition of Romaric, a provider of manufacturing automation and optimisation software solutions, strengthens Elisa IndustrIQ’s software portfolio and its foothold in the US market. The acquisition of Leanware Oy, which was announced in April, will accelerate the growth of Elisa IndustrIQ’s industrial software business by adding warehouse management software to the offering. It also strengthens Elisa IndustrIQ’s foothold in the Finnish manufacturing customer base. Elisa’s Distributed Energy Storage (DES) solution is gaining international interest. In February, DNA Tower Finland, part of Telenor Group, announced their roll-out of Elisa’s DES solution in their equipment spaces, supporting the energy transition. Elisa is rated as one of the most sustainable companies in the world. CDP, a global environmental disclosure system, recognised Elisa’s leadership in corporate transparency and performance on climate change by including Elisa on its highest “A List”. As Elisa’s new CEO, I’m impressed by the culture of excellence in the company and the commitment and capabilities of our people. Our competitiveness is based on continuous improvement of productivity and quality, the innovativeness of our people in creating customer value, and clear priorities in making investments. Together with the entire Elisa team, I will stay focused on the long-term execution of our strategy, and I see further potential for generating profitable growth in our home markets in Finland and Estonia, as well as through digital services internationally. Outlook and guidance for 2024 The development in the general economy includes many uncertainties. Growth in the Finnish economy is expected to stall. In particular, there is continuing uncertainty in e.g. inflation and energy prices relating to Russia’s war in Ukraine and other conflicts. Challenges in global supply chains may also result in uncertainties in volumes and prices. Competition in the Finnish telecommunications market remains keen. Full-year revenue is estimated to be at the same level or slightly higher than in 2023. Mobile data and digital services are expected to increase revenue. Full-year comparable EBITDA is anticipated to be at the same level or slightly higher than in 2023. Capital expenditure is expected to be 12–13 per cent of revenue. Elisa continues to improve productivity, for example by increasing automation and data analytics in different processes, such as customer interaction, network operations and delivery. Additionally, Elisa’s continuous quality improvement measures will increase customer satisfaction and efficiency, and reduce costs. Elisa’s transformation into a provider of exciting, new and relevant services for its customers is continuing. Long-term revenue growth and profitability improvement will derive from growth in the mobile data market, as well as domestic and international digital services. ELISA CORPORATION Additional information: Mr Topi Manner, CEO, tel. +358 10 265 1200Mr Jari Kinnunen, CFO, tel. +358 10 262 9510Mr Vesa Sahivirta, IR Director, tel. +358 50 520 5555 Distribution: Nasdaq HelsinkiPrincipal mediaelisa.com

Flexion and Kabam Team Up to Bring Marvel Contest of Champions to the Alternative App Stores

LONDON, 19 April 2024. Flexion (Nasdaq: FLEXM), the games marketing company, and Kabam, one of the world’s leading game developers, today announce a new partnership to bring Marvel Contest of Champions to alternative app stores. Flexion will distribute the game on the Amazon Appstore, Aptoide, ONE store, Samsung Galaxy Store, and Digital Turbine Hubs in 2024.  “We are excited to partner with Flexion to bring Marvel Contest of Champions to even more players,” says SeungWon Lee, CEO of Kabam. “Flexion’s expertise, experience and technology make them the ideal partner for us. This collaboration will help us reach new audiences by making Marvel Contest of Champions available on even more app stores. This is especially exciting ahead of the game’s upcoming 10-year anniversary.”  “We are delighted to partner with Kabam, one of the world’s leading game developers, to bring their hit game to more players around the globe,” says Jens Lauritzson, CEO of Flexion. “This partnership is a win for Kabam and the app stores, which we will connect to drive audience engagement.” Marvel Contest of Champions is an epic fighting RPG with over 260 iconic Marvel Super Heroes and Super Villains in the ultimate cosmic showdown! Players can collect and build a competitive team of Champions, compete against the world’s top Summoners, battle through an epic and deep Marvel story, and team up with powerful Summoners in alliances to become the Ultimate Marvel Champion. “We’re delighted to add such a well-known and successful game like Marvel Contest of Champions to our portfolio,” continues Jens. “I am very positive about the growth potential of these alternative stores in 2024. There is no better time to expand to more audiences.” Marvel Contest of Champions will be available on the Amazon Appstore, Samsung Galaxy Store, Aptoide, and ONEstore Korea starting on April 29, 2024, with Samsung Gaming Hub, OneStore Global, and DT Games Hub following in the near future. For more information Scott Johnston, Email: scott.johnston@flexionmobile.com About Flexion Mobile Plc: Flexion grows revenue and audiences for games. Our mission is to become the leading games marketing company. We offer unique game distribution and influencer marketing services to top grossing developers around the world.  Flexion boosts game revenue and audiences for games by maxisimising their performance in new alternative app stores, including the Amazon, Samsung, Huawei, Xiaomi and ONE Store. In 2022, the company acquired Audiencly GmbH, a leading game influencer marketing agency. Flexion Mobile Plc is listed on Nasdaq First North Growth Market, Shortname: FLEXM. Certified Adviser is FNCA Sweden AB, +46(0)8-528 00 399, info@fnca.se ABOUT KABAM Kabam  is a world leader in developing entertaining, immersive, and highly social multiplayer games, bringing high-quality graphics, next-generation technology, and revolutionary gameplay to players around the world. Kabam’s games, Marvel Contest of Champions , King Arthur: Legends Rise , Shop Titans , and Disney Mirrorverse  have generated hundreds of millions of downloads and have received multiple awards, including Apple’s Editor’s Choice and Google Play’s Best Game of the Year. Founded in 2006, Kabam has studios and offices in North America, including Vancouver and Montreal in Canada, and Los Angeles and San Francisco in the United States, and Seoul, Korea.

Clinical Laserthermia Systems announces timetable and additional information for the upcoming reverse share split

Reverse share split On April 12, 2024, the extraordinary general meeting of CLS resolved to carry out a reverse share split, whereby two hundred (200) existing shares (regardless of share class) are consolidated into one (1) new share (regardless of share class). The board of directors has now, in accordance with the general meeting's authorization, set the record date for the reverse share split to April 26, 2024. The last day of trading in the Company's shares before the reverse share split is April 24, 2024 and the first day of trading in the Company's shares after the reverse share split is April 25, 2024. Shareholders whose holdings on the record date are not evenly dividable by two hundred (200) will receive, free of charge, as many shares (regardless of share class) as required for the shareholder's holding to be evenly dividable by two hundred (200). Thus, a shareholder who currently holds 200 shares in CLS will own 1 share after the reverse split. The receipt of shares according to the above and the reverse share split will take place through Euroclear Sweden AB without any action being required by the Company's shareholders. The shareholders' percentage of the total number of shares in the Company and the value of the individual shareholding remains unchanged. The effect of the reverse split will be reflected in shareholders' deposits from April 25, 2024 as an increase in the price per share, as the total market value of the Company will be divided over a lower number of shares. As a result of the reverse split, the shares in CLS will change ISIN-code. As of April 25, 2024, the B-share in the Company will be traded with the new ISIN-code SE0022049920 (previous ISIN-code SE0002756130). The A-share will have the new ISIN-code SE0022049912 (previous ISIN-code SE0002802215). The reverse share split is carried out primarily to reduce the volatility of the share pricing and to streamline the administration of share trading. Number of shares and share capital After the reverse share split, the total number of shares in CLS will amount to 7,851,707, of which 3,000 A-shares and 7,848,707 B-shares, each share with a quota value of approximately SEK 2.31. The share capital will amount to approximately SEK 18,134,146.88. For more information about CLS, please contact: Dan J Mogren, CEO, Clinical Laserthermia Systems AB (publ) Phone: +46 (0) 70-590 11 40 E-mail: dan.mogren@clinicallaser.com Website: www.clinicallaser.se This press release has been translated from Swedish. The Swedish text shall govern for all purposes and prevail in case of any discrepancy with the English version. About CLS Clinical Laserthermia Systems AB (publ) develops and sells the TRANBERG[®]|Thermal Therapy Systems, including Thermoguide Workstation and sterile disposables, for minimally invasive treatment of cancer tumors and drug-resistant epilepsy, according to regulatory approvals in the EU and the US. The products are marketed for image-guided laser ablation and used in studies for treatment with imILT[®], the Company's interstitial laser thermotherapy for immunostimulating ablation with potential abscopal effects. CLS is headquartered in Lund and has subsidiaries in Germany, the US and Singapore. CLS is listed on the Nasdaq First North Growth Market under the symbol CLS B. The Certified Advisor (CA) is FNCA Sweden AB. For more information about CLS, please visit the Company's website: www.clinicallaser.se

Notification according to chapter 9, section 5 and 6 of the Securities Market Act: BlackRock Inc.’s holding in Metso

Metso Corporation has received a notification, pursuant to Chapter 9, Section 5 and 6 of the Finnish Securities Markets Act, about a change in the shareholding of BlackRock, Inc. On April 17, 2024, BlackRock's holding in Metso’s shares fell below the 5 percent threshold and amounted to 41,027,512 shares or 4.94 percent of total shares and votes. BlackRock's holding through financial instruments in Metso amounted to 1,155,295 shares, which corresponds to 0.13 percent of the total amount of Metso’s shares. On April 17, 2024, BlackRock's total position amounted to 42,182,807 or 5.08 percent of Metso’s shares and votes. Metso’s total number of shares and voting rights is 828,972,440.BlackRock, Inc.’s holdings according to the notification: % of % of shares and voting rights Total of both shares through financial instruments in % (7.A + and (total of 7.B) 7.B) voting rights (total of 7.A)Resulting 4.94% 0.13% 5.08%situation on thedate onwhich thresholdwas crossed orreachedPosition of 5.02% 0.13% 5.16%previousnotification A: Shares and votingrightsClass/type of Number of % ofshares shares and shares and voting voting rights rightsISIN code Direct(SMA Indirect(SMA Direct(SMA Indirect(SMA 9:5) 9:6 and 9:7) 9:5) 9:6 and 9:7)FI0009014575 41,027,512 4.94%SUBTOTAL A 41,027,512 4.94%B: FinancialInstruments accordingto SMA 9:6aType of financial Expiration Exercise/ Physical or Number of % of sharesinstrument date Conversion cash shares and voting Period settlement and rights voting rightsAmerican Depositary N/A N/A Physical 8,969 0.00%Receipt(US5926721094)Securities Lent N/A N/A Physical 1,146,326 0.13% SUBTOTAL B 1,155,295 0.13% Metso Corporation  Distribution:  Nasdaq Helsinki Ltd Main media www.metso.com Metso is a frontrunner in sustainable technologies, end-to-end solutions and services for the aggregates, minerals processing and metals refining industries globally. We improve our customers’ energy and water efficiency, increase their productivity, and reduce environmental risks with our product and service expertise. We are the partner for positive change.  Headquartered in Espoo, Finland, Metso employs over 17,000 people in close to 50 countries and sales for 2023 were about EUR 5.4 billion. The company is listed on the Nasdaq Helsinki. metso.com, x.com/metsoofficial

Donkey Republic records revenue of DKK 20.6M in Q1-2024, showing a solid revenue growth of 19%, positive EBITDA trends and reaffirmation of 2024 guidance

Company Announcement No. 8 - 2024 RevenueRider revenue growth in Q1-2024 aligns with expectations and guidance. This growth is fueled by both a larger fleet and higher revenue per bike, and is further bolstered by an expanding portfolio of city contracts compared to Q1-2023. EBITDAEBITDA in Q1-2024 outperformed Q1-2023 by DKK 0.7M if a one-time benefit in Q1-2023 is excluded, this effect is from a lower-than-expected penalty resolution on delayed bike deliveries in Q1-2023. The improvement is due to strong revenue growth that has more than offset any fixed cost increases over the last year. GuidancePositive Q1-2024 results support our previously issued 2024 guidance: Revenue of DKK 135M to 160M EBITDA of DKK 15M to 30MEBIT of DKK 0 to 5M Events after the period Donkey republic completed an oversubscribed private placement of DKK 22.4M in April 2024This private placement was supported by existing investors including EIFO and Bankinvest. The successful private placement is testament to the existing investors’ continued commitment to the company’s strategy to achieve growth at sustainable margins. The private placement is carried out after a successful 2023 with the pursuit of positive EBIT of DKK 0M-5M in 2024. Completing a capital raise aligns with the company’s strategic goals outlined in the 2023 annual report, where it signaled intentions to explore capital-raising opportunities to bolster B2G growth initiatives through long-term contracts with cities beyond 2024. The newly secured funds are intended to strengthen the company’s balance sheet, positioning it to capitalize swiftly on market opportunities that are expected to drive growth in 2025 and beyond through healthy long term contracts with cities. KEY PERFORMANCE INDICATORS Q1-2024 (01 January 2024 - 31 March 2024) Metric Total for Q1-2024 Compared to Q1-2023Total Revenue  DKK 20.6M +19%EBITDA DKK -6.6M N/AMonthly revenue per bike 335 +10%Riders 127k +52%Trips 1M +32%Fleet size (active bikes) 22k +13%CO2 savings 81 tons +24%

MapsPeople A/S announces result of private placement and sale of own shares

MapsPeople A/S | Inside Information Company Announcement No. 7- 2024 Aalborg, April 19, 2024 Result of private placement and sale of own shares With reference to company announcement no. 2024-6, MapsPeople A/S ("MapsPeople") hereby announces that the private placement has now been successfully subscribed. The private placement has been executed in accordance with applicable exemptions from the obligation to publish a prospectus at market price without pre-emption rights for existing shareholders. Furthermore, MapsPeople announces that they have successfully sold 550,000 own shares at a price of DKK 2.10 per share, corresponding to the subscription price of the Private Placement. Following this, MapsPeople holds 857,950 own shares. The subscription of the private placement totals a nominal amount of DKK 40,000 divided into 2,000,000 new shares of a nominal amount of DKK 0.02 each, subscribed for at a market price of DKK 2.10 per share calculated as the average closing price of the share in the period from April 12 2024 to April 17 2024 (DKK 2,04) plus DKK 0,06. The total gross proceeds from the private placement amounts to DKK 4.2 million assuming payment of the subscription amount, and the total gross proceeds, including the sale of own shares, amounts to approximately DKK 5.3 million. The new shares will have the same rights in all respects with existing shares in MapsPeople and will be admitted to trading in the existing ISIN code DK0061549052 on Nasdaq First North Growth Market, expectedly on 25 April 2024, when payment of the subscription amounts and registration with the Danish Business Authority has taken place, expectedly on 23 April 2024. MapsPeople will inform the market when the registration with the Danish Business Authority has taken place. After the private placement has been registered with the Danish Business Authority, the total share capital in MapsPeople will amount to a nominal value of DKK 1,621,133.08 divided into 81,056,654 shares with a nominal value of DKK 0.02 each, corresponding to a total of 81,056,654 voting rights. For additional information, please contact MapsPeople A/S Morten Brøgger, CEO Mobile (+45) 31 23 48 72 Email mobr@mapspeople.com Stigsborgvej 60, 9400 Nørresundby Denmark Certified Advisor Grant Thornton Jesper Skaarup Vestergaard Mobile (+45) 31 79 90 00 Stockholmsgade 45 2100 Copenhagen Ø Denmark IMPORTANT INFORMATION This announcement is not an offer to sell or a solicitation of any offer to buy any securities issued by MapsPeople in any jurisdiction where such offer or sale would be unlawful and the announcement and the information contained herein are not for distribution or release, directly or indirectly, in or into such jurisdictions, including but not limited to, the United States, Australia, Canada or Japan. This announcement does not constitute an offering circular, company description or other offer document and nothing herein contains an offering of securities. No one should purchase or subscribe for any securities in MapsPeople except as described in this company announcement. Neither the existing shares of MapsPeople (the "Existing Shares") nor the New Shares have been, or will be, registered under the United States Securities Act of 1933, as amended ("Securities Act"). Neither the Existing Shares nor the New Shares may be offered or sold, directly or indirectly, in or into the United States or to persons residing there. Moreover, the Private Placement is not made to persons resident in Australia, Hong Kong, Japan, Canada, New Zealand, South Africa, Switzerland, or Singapore or to persons whose participation would require the publication up of a prospectus, registration or other measures. Certain statements in this announcement constitute forward-looking statements. Forward-looking statements are statements (other than statements of historical fact) relating to future events and the Company's anticipated or planned financial and operational performance. The words "targets", "believes", "expects", "aims", "intends", "plans", "seeks", "will", "may", "might", "anticipates", "would", "could", "should", "continues", "estimates" or similar expressions or the negative forms thereof, identify certain of these forward-looking statements. Other forward-looking statements can be identified in the context in which the statements are made. MapsPeople has based these forward-looking statements on its current views with respect to future events and financial performance. By their nature, forward-looking statements are based on certain assumptions and projections on future events and financial performance, which involve a number of risks and uncertainties that could cause actual results or events to differ materially from those expressed or implied by the forward-looking statements. These risks, uncertainties and assumptions could adversely affect the outcome and financial consequences of the plans and events described herein. Actual results are likely to differ from those set forth in the forward-looking statements. Any forward-looking statements speak only as at the date of this document and neither the Company nor any of its respective affiliates, directors, officers, employees, advisors, or any other person is under any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. You should not and may not rely on these forward-looking statements.

Altaal and Nordic Credit Partners form investment company

Founded in 2020 by Erik Penser among others, Altaal has pursued a value-driven agenda with an operational focus, investing in real estate and infrastructure. Nordic Credit Partners, established in 2013, has consistently concentrated on investments in sustainable, Nordic corporate credits.The investment activities are led by founders Jakob Eliasson, Stefan Gattberg and Henrik Schmidt. The board, investment committee, and councils for industry and sustainability, consisting of around 40 senior advisors, play a key role in the company's systematic and well-proven investment process. The founders have worked together for many years, united in their view of value creation and active entrepreneurship."Since its inception, Altaal has operated in a turbulent market but has grown by an impressive 70% per year without compromising on quality and risk management. There are likely to be many interesting business opportunities ahead, and Altaal is well-prepared for this" says Erik Penser, co-founder of Altaal."We were pioneers when we started investing in Nordic corporate bonds in an institutional and systematic manner. As an integral part of the Altaal group, we gain the capacity to analyse investment opportunities regardless of their position in the capital structure, once again breaking new ground" says Jakob Eliasson, founder of NCP.NCP's Luxembourg-based credit funds will continue to be managed by the same team as today, but within the framework of Altaal, the names Nordic Credit Partners and Nordic Credit Opportunities will be retained."We are in a unique position where we can now act on business situations in the real estate industry that arise in the wake of interest rate increases and financial stress" says Henrik Schmidt, co-founder of Altaal."The green transition currently happening across Nordic infrastructure and transportation requires capital, and it is very stimulating to be able to contribute to this transformation" says Stefan Gattberg, co-founder of Altaal.

NOVOS FiBER brings affordable high-speed broadband to Texas communities

Launched in the Dallas-Fort Worth area in 2023, NOVOS FiBER aims to bring high-speed fiber internet to families and small businesses across Texas and beyond. Reaching communities regardless of size and offering affordable prices are a high priority. The first major fiber deployment is in the vicinity of Arlington, Texas. Smartoptics open line systems, 400G optics and muxponders were selected as the most cost-efficient way to light up new dark fiber. “Despite much funding earmarked for high-speed broadband in the US, we see that many communities are still underserved. NOVOS FiBER is on a mission to change that, which means not just building fiber networks the same old way. We must be innovative and always find the most effective and cost-efficient ways of delivering connectivity. Smartoptics shares these values, so we teamed up, leveraging open and flexible solutions to maximize fiber utilization. Arlington is just the first stop on our journey to bridge the digital divide,” says Rob Johnson, CTO, NOVOS FiBER. The Arlington deployment utilizes a fully redundant architecture and spans distances over 100 km. NOVOS FiBER will also benefit from the flexibility to add alien wavelengths at no additional cost with open line systems and run multiple low-cost 100G links on a single dark fiber pair with the DCP-404 muxponder. “Our flexible solutions are increasingly popular in rural, metro and regional deployments across the US, and NOVOS FiBER is an excellent addition to these community-focused ISPs. NOVOS FiBER embodies a true customer-first approach, with a commitment to what’s best for local communities and a refreshing customer experience. This is similar to our own philosophy and our challenger DNA at Smartoptics, and we look forward to future collaboration,” says Kevin Robinson, Vice President of Sales, Americas, Smartoptics. For more information please contact:Magnus GrenfeldtCEOSmartoptics+46 73-366 88 77E-mail: magnus.grenfeldt@smartoptics.com   About SmartopticsSmartoptics provides innovative optical networking solutions and devices for the new era of open networking. Our customer base includes thousands of enterprises, governments, cloud providers, Internet exchanges as well as cable and telecom operators. We have an open networking approach in everything we do which allows our customers to break unwanted vendor lock-in, remain flexible and minimize costs. Our solutions are used in metro and regional network applications that increasingly rely on data center services and specifications. Smartoptics is a Scandinavian company founded in 2006. We partner with leading technology and network solution providers such as Brocade, Cisco and Dell and have a global reach through more than 100 business partners. For additional information about Smartoptics, please visit https://smartoptics.com/ About NOVOS FiBERNOVOS FiBER is a fiber-to-the-home (FTTH) provider focused on providing affordable, reliable high-speed fiber internet to customers, especially those in previously lacking internet regions. NOVOS FiBER is the customer-centric brand of Flying Bull Internet, founded by Andrew Snead and Melker Sandberg in 2022 and funded by InLight Capital, a Sugar Land based private investment firm.

Katalysen Ventures Co-Founder in Japanese SKB.vc

Derived from the Japanese word "shokubai" meaning "catalyst", SKB.vc successfully completed an extensive one-year preliminary study phase in early 2024. The venture is currently in the final stages of assembling its team and has received significant support from strategic partners, including prominent Japanese science cities, prefectural governments, and the Japan External Trade Organization's Invest Japan program. An operational partner has joined and an advisory board of Japanese innovation experts, research directors and former government officials has been established. SKB.vc aims to bridge the gap between Japanese innovation and international investment, providing local founders with critical support in navigating global markets. Explaining the venture's mission, Tobias Mathiasen says, "Our focus is to provide Japanese entrepreneurs with the resources, expertise and networks necessary to secure international investment. By fostering a global perspective from the seed stage, we aim to elevate Japanese startups to international prominence and valuation levels." Underscoring the strategic importance of Japan's Osaka-Kobe-Kyoto innovation triangle, SKB.vc intends to establish its headquarters in this thriving hub. Tobias Mathiasen says, "The Kansai region, strategically located at the intersection of Western and Central Japan, embodies a spirit of innovation and free-thinking that is conducive to early-stage ventures. Having established strategic partnerships with key research and innovation centers, SKB.vc is poised to capitalize on the region's rich entrepreneurial landscape. The World Expo 2025 in Osaka adds further value to our timing." “The European venture capital market is still recovering, and Katalysen’s financial resources are yet reserved for our home market. Despite this, Katalysen and SKB.vc have proven that it’s possible to achieve remarkable results if you have the right determination, passion and know-how. As co-founder, Katalysen’s contribution to SKB.vc is focused on our deep early-stage experience, expertise, and our global, world-class network,” comments Katalysen CEO Peter Almberg. He continues, "Today, Tobias has a dual role as COO of Katalysen Ventures and co-founder of SKB.vc. This setup has proven to work exceptionally well, and we have already seen a stream of new opportunities for Katalysen’s portfolio emerge out of this setup. Several portfolio companies are currently in discussions with Japanese investors who recognize the quality of Nordic innovation and appreciate the relative cultural proximity between the Nordics and Japan." Tobias continues, "The Kansai region has a remarkable innovation track record, with Kyoto University alone boasting 8 Nobel Laureates, underscoring the region's reputation as a hotbed of paradigm-shifting innovation. In addition, its proximity to the Chūbu region and Aichi Prefecture, home of Toyota, Toyota's extensive network of suppliers, and the new Station Ai incubator, unlocks additional opportunities. In essence, Western and Central Japan offers a wealth of innovation prospects for investors with the time, energy and skills to identify and develop early-stage startups." After a 12-month preliminary study phase in 2023, during which Tobias Mathiasen held hundreds of meetings in Japan with founders, investors and ecosystem stakeholders, Katalysen Ventures received a formal invitation from the Japan External Trade Organization to visit Kansai in January 2024. In February 2024, the project moved into Phase 2, which focused on assembling a Japan-based team, strategic partners, and advisors. As Phase 2 nears completion, Phase 3 will begin, focusing on securing soft commitments from investors for SKB.vc while finalizing administrative requirements such as incorporation and necessary licenses. Phase 4, planned for this fall, will mark the start of the formal fundraising period, with a first close planned for the end of this year. "To be honest, the Nordic innovation ecosystem is already very well developed," concludes Tobias Mathiasen. "I see this as an opportunity to use my own experience in venture development and venture investing in a high-impact context, where more solutions to global challenges can be developed for global success. We welcome anyone interested in the intersection of early-stage innovation and Japan to reach out, connect and explore how we can join forces in this important mission.”

Giant BidCo completes the recommended public cash offer to the shareholders of Byggfakta and becomes the owner of 99.0 per cent of the shares in the company

THIS PRESS RELEASE IS NOT AN OFFER, WHETHER DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND OR SOUTH AFRICA OR IN ANY OTHER JURISDICTION WHERE SUCH OFFER PURSUANT TO LEGISLATION AND REGULATIONS IN SUCH RELEVANT JURISDICTION WOULD BE PROHIBITED. SHAREHOLDERS NOT RESIDENT IN SWEDEN WHO WISH TO ACCEPT THE OFFER (AS DEFINED BELOW) MUST MAKE INQUIRIES CONCERNING APPLICABLE LEGISLATION AND POSSIBLE TAX CONSEQUENCES. SHAREHOLDERS SHOULD REFER TO THE OFFER RESTRICTIONS INCLUDED IN THE SECTION TITLED “IMPORTANT INFORMATION” AT THE END OF THIS PRESS RELEASE AND IN THE OFFER DOCUMENT. SHAREHOLDERS IN THE UNITED STATES SHOULD ALSO REFER TO THE SECTION TITLED “SPECIAL NOTICE TO SHAREHOLDERS IN THE UNITED STATES” AT THE END OF THIS PRESS RELEASE. On 5 January 2024, Stirling Square[1], TA[2] and Macquarie Capital[3] (together, the “Consortium”), through Giant BidCo[4], announced a public offer (the “Offer”) to the shareholders of Byggfakta Group Nordic HoldCo AB (publ) (“Byggfakta”). On 2 April 2024, Giant BidCo increased the offer price to SEK 52 in cash per share and extended the acceptance period until 18 April 2024. At the end of the acceptance period, the Offer had been accepted by shareholders holding 31.6 per cent of the shares in Byggfakta. Giant BidCo has decided to complete the Offer and acquire the shares tendered in the Offer. This means that Giant BidCo controls 99.0 per cent of the shares in Byggfakta.[5] Settlement in respect of the shares tendered on 18 April 2024 is expected to commence on or around 2 May 2024. To allow shareholders that have not yet accepted the Offer an additional opportunity to do so, Giant BidCo has decided to extend the acceptance period until 3 May 2024. Henrik Lif, Partner, Stirling Square, and spokesperson for Giant BidCo, comments: “Stirling Square, TA and Macquarie Capital are pleased that the Offer is supported to such an extent that the Consortium can continue to develop the company in a private environment. Byggfakta will be provided with access to important additional growth capital and operational resources in order to accelerate the long-term delivery of its stated strategy, including additional international M&A. Stirling Square, TA, and Macquarie Capital are very much looking forward to work together with the Byggfakta team to facilitate this journey.” Shares tendered in the Offer The Offer has been accepted by shareholders holding 68,017,711 shares, corresponding to 31.6 per cent of the total number of shares and votes in Byggfakta. This means that Giant BidCo, together with the 145,343,615 shares already owned by Stirling Square and TA prior to the announcement of the Offer that now will be contributed to Giant BidCo, controls 213,361,326 shares, corresponding to 99.0 per cent of the total number of shares and votes in Byggfakta.[6] Apart from the above, neither Giant BidCo or the members of the Consortium nor any closely related parties to them owned any shares or other financial instruments that give a financial exposure equivalent to a shareholding in Byggfakta at the time of the announcement of the Offer, and they have not acquired, or agreed to acquire, any such shares or financial instruments outside of the Offer. Completion of the Offer All conditions for completion of the Offer have been fulfilled. Giant BidCo has therefore decided to complete the Offer and acquire the shares tendered in the Offer. Giant BidCo expects to commence settlement in respect of the shares tendered in the Offer by 17:00 CEST on 18 April 2024 on or around 2 May 2024. Extension of the acceptance period To allow shareholders that have not yet accepted the Offer an additional opportunity to do so, Giant BidCo has decided to extend the acceptance period until 17:00 CEST on 3 May 2024. Giant BidCo expects to commence settlement in respect of the shares tendered in the Offer during this extended acceptance period on or around 16 May 2024. Since the Offer is now unconditional, shareholders who have accepted the Offer, or who accept the Offer during the extended acceptance period, are not entitled to withdraw their acceptances. Giant BidCo intends to initiate a compulsory buy-out procedure in accordance with the Swedish Companies Act to acquire the shares not tendered in the Offer. Giant BidCo also intends to promote a delisting of the shares in Byggfakta from Nasdaq Stockholm. The information was submitted for publication on 19 April 2024 at 12:30 (CEST). For enquiries, please contact: Adam Makkonen, Giant BidCoPhone: +46 70 316 63 75Email: giant@fogelpartners.se Information about the Offer is available at: www.giant-bidco.com. For administrative questions regarding the Offer, please contact your bank or nominee where you have your shares registered. Important information The Offer is not being made to (and acceptance forms will not be accepted from or on behalf of) persons domiciled in Australia, Canada, Hong Kong, Japan, New Zealand, South Africa, or whose participation in the Offer requires that additional offer documents are prepared or registrations effected or that any other measures are taken in addition to those required under Swedish law (including Nasdaq Stockholm’s Takeover Rules), unless an exemption applies. This press release, the offer document, the supplements to the offer document (the “Supplements”) and any other documentation related to the Offer (including copies of such documentation) must not be mailed or otherwise distributed, forwarded or sent in or into any jurisdiction (including, without limitation, Australia, Canada, Hong Kong, Japan, New Zealand or South Africa) in which the distribution of this press release, the offer document, the Supplements or the Offer would require any additional measures to be taken or would be in conflict with any law or regulation in any such jurisdiction. Persons who receive this press release, the offer document or the Supplements (including, without limitation, banks, brokers, dealers, nominees, trustees and custodians) and are subject to the laws or regulations of any such jurisdiction will need to inform themselves about, and observe, any applicable restrictions and requirements. Any failure to do so may constitute a violation of the securities laws or regulations of any such jurisdiction. To the extent permitted by applicable law, Giant BidCo, Stirling Square, TA and Macquarie Capital disclaim any responsibility or liability for any violations of any such restrictions, and Giant BidCo reserves the right to disregard any acceptance forms whose submission constitutes a direct or indirect violation of any of these restrictions. The Offer, the information and documents contained in this press release are not being made and have not been approved by an authorised person for the purposes of section 21 of the UK Financial Services and Markets Act 2000 (the “FSMA”). Accordingly, the information and documents contained in this press release are not being distributed to, and must not be passed on to, the general public in the United Kingdom, unless an exemption applies. The communication of the information and documents contained in this press release is exempt from the restriction on financial promotions under section 21 of the FSMA on the basis that it is a communication by or on behalf of a body corporate which relates to a transaction to acquire day to day control of the affairs of a body corporate; or to acquire 50 per cent or more of the voting shares in a body corporate, within article 62 of the UK Financial Service and Markets Act 2000 (Financial Promotion) Order 2005. Forward-looking statements Statements in this press release relating to any future status or circumstances, including statements regarding future performance, growth and other trend projections and other effects of the Offer, are forward-looking statements. These statements may generally, but not always, be identified by the use of words such as “anticipate”, “believe”, “expect”, “intend”, “plan”, “seek”, “will”, “would” or similar expressions. By their nature, forward-looking statements involve risk and uncertainty because they relate to events and depend on circumstances that could occur in the future. There can be no assurance that actual results will not differ materially from those expressed or implied by these forward-looking statements due to several factors, many of which are outside Giant BidCo’s, Stirling Square’s, TA’s and Macquarie Capital’s control. Any forward-looking statements in this press release speak only as of the date on which the statements are made and none of Giant BidCo, Stirling Square, TA or Macquarie Capital have any obligation (and undertake no obligation) to update or revise any of them, whether as a result of new information, future events or otherwise, except as required by applicable laws and regulations. Special notice to shareholders in the United States The Offer described in this press release is made for the issued and outstanding shares of Byggfakta, a company incorporated under Swedish law, and is subject to Swedish disclosure and procedural requirements, which may be different from those of the United States. The Offer is made in the United States pursuant to Section 14(e) of the U.S. Securities Exchange Act of 1934, as amended (the “U.S. Exchange Act”) and Regulation 14E thereunder, subject to the exemption provided by Rule 14d-1(c) under the Exchange Act for a Tier I tender offer (the “Tier I Exemption”), and otherwise in compliance with the disclosure and procedural requirements of Swedish law, including with respect to withdrawal rights, the Offer timetable, notices of extensions, announcements of results, settlement procedures (including with respect to the time when payment of the consideration is rendered) and waivers of conditions, which may be different from requirements or customary practices in relation to U.S. domestic tender offers. Holders of the shares of Byggfakta domiciled in the United States (the “U.S. Holders”) are encouraged to consult with their own advisors regarding the Offer. Byggfakta’s financial statements and all financial information included herein, or any other documents relating to the Offer, have been or will be prepared in accordance with Swedish generally accepted accounting principles and may not be comparable to the financial statements or financial information of companies in the United States or other companies whose financial statements are prepared in accordance with U.S. generally accepted accounting principles. The Offer is made to the U.S. Holders on the same terms and conditions as those made to all other shareholders of Byggfakta to whom an offer is made. Any information documents, including the offer document and the Supplements, are being disseminated to U.S. Holders on a basis comparable to the method pursuant to which such documents are provided to Byggfakta’s other shareholders. The Offer, which is subject to Swedish law, is being made to the U.S. Holders in accordance with the applicable U.S. securities laws, and applicable exemptions thereunder, in particular the Tier I exemption. To the extent the Offer is subject to U.S. securities laws, those laws only apply to U.S. Holders and thus will not give rise to claims on the part of any other person. The U.S. Holders should consider that the Offer Price will be paid in SEK and that no adjustment will be made based on any changes in the exchange rate. It may be difficult for Byggfakta’s shareholders to enforce their rights and any claims they may have arising under the U.S. federal or state securities laws in connection with the Offer, since Byggfakta and Giant BidCo are located in countries other than the United States, and some or all of their officers and directors may be residents of countries other than the United States. Byggfakta’s shareholders may not be able to sue Byggfakta or Giant BidCo or their respective officers or directors in a non-U.S. court for violations of U.S. securities laws. Further, it may be difficult to compel Byggfakta or Giant BidCo and/or their respective affiliates to subject themselves to the jurisdiction or judgment of a U.S. court. To the extent permissible under applicable law or regulations, Giant BidCo and its affiliates or its brokers and its brokers’ affiliates (acting as agents for Giant BidCo or its affiliates, as applicable) may from time to time and during the pendency of the Offer, and other than pursuant to the Offer, directly or indirectly purchase or arrange to purchase shares of Byggfakta outside the United States, or any securities that are convertible into, exchangeable for or exercisable for such shares. These purchases may occur either in the open market at prevailing prices or in private transactions at negotiated prices, and information about such purchases will be disclosed by means of a press release or other means reasonably calculated to inform U.S. Holders of such information. In addition, the financial advisors to Giant BidCo may also engage in ordinary course trading activities in securities of Byggfakta, which may include purchases or arrangements to purchase such securities as long as such purchases or arrangements are in compliance with the applicable law. Any information about such purchases will be announced in Swedish and in a non-binding English translation available to the U.S. Holders through relevant electronic media if, and to the extent, such announcement is required under applicable Swedish or U.S. law, rules or regulations. The receipt of cash pursuant to the Offer by a U.S. Holder may be a taxable transaction for U.S. federal income tax purposes and under applicable U.S. state and local, as well as foreign and other, tax laws. Each shareholder is urged to consult an independent professional adviser regarding the tax consequences of accepting the Offer. Neither Giant BidCo nor any of its affiliates and their respective directors, officers, employees or agents or any other person acting on their behalf in connection with the Offer shall be responsible for any tax effects or liabilities resulting from acceptance of this Offer. NEITHER THE U.S. SECURITIES AND EXCHANGE COMMISSION NOR ANY U.S. STATE SECURITIES COMMISSION HAS APPROVED OR DISAPPROVED THE OFFER, PASSED ANY COMMENTS UPON THE MERITS OR FAIRNESS OF THE OFFER, PASSED ANY COMMENT UPON THE ADEQUACY OR COMPLETENESS OF THIS PRESS RELEASE OR PASSED ANY COMMENT ON WHETHER THE CONTENT IN THIS PRESS RELEASE IS CORRECT OR COMPLETE. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENCE IN THE UNITED STATES. [1] “Stirling Square” refers to SSCP Byggest S.à r.l (where applicable, together with its affiliates and their respective funds under management). [2] “TA” refers to Bock Capital EU Luxembourg Tricycle II S.à r.l (where applicable, together with its affiliates and their respective funds under management). [3] “Macquarie Capital” refers to Macquarie European Investment Holdings Limited (acting as a wholly owned subsidiary of Macquarie Group Limited). [4] “Giant BidCo” refers to Giant Sweden Bidco AB, company registration number 559462-7118, a newly established Swedish private limited liability company that currently is owned by Stirling Square and TA, and will, at completion of the Offer, become co-owned by all members of the Consortium. [5] The ownership percentages set out in this paragraph are calculated based on 215,536,667 outstanding shares in Byggfakta (i.e. 218,666,667 issued shares less 3,130,000 shares held in treasury by Byggfakta). [6] The ownership percentages set out in this paragraph are calculated based on 215,536,667 outstanding shares in Byggfakta (i.e. 218,666,667 issued shares less 3,130,000 shares held in treasury by Byggfakta).

Ahlstrom launches consultation process to divest or close its Bousbecque plant and centralize its parchment production activities at Saint-Séverin plant in France

AHLSTROM OYJ PRESS RELEASE APRIL 19, 2024 AT 15:20 EET Ahlstrom has launched today a consultation process with employee representatives at its Bousbecque plant in France about the possibility to divest or close the plant and to centralize parchment paper production to its Saint-Séverin plant in France to ensure the long-term future and competitiveness of the specialty materials business. The Bousbecque plant in the north of France focuses on producing parchment specialty materials. There is overcapacity in parchment and increasing competition. The plant has an annual capacity of approximately 12 000 tons and has 117 employees. Despite thorough review of different options, Ahlstrom has not been able to find solutions that would enable it to continue operating the Bousbecque plant. Therefore, after having carefully studied all possible scenarios, Ahlstrom is now planning to move production from Bousbecque to Saint-Séverin plant, planning to divest the Bousbecque site and if a buyer cannot be found considering closure. This plan would allow Ahlstrom to centralize all its parchment paper production activities on the Saint-Séverin site, which would help reduce production costs and improve competitiveness. "We are committed to examining all potential options to minimise any possible social consequences, as we understand that this is a difficult time for our employees at Bousbecque. In the absence of viable solutions, we pledge to work closely with our other sites, the municipality of Bousbecque, the Northern French region and all stakeholders to provide full support to all our potentially impacted employees," says Guillaume Latourrette, Vice President of Ahlstrom’s Global Food business. For further information, please contact: For media: Katja Ollila, VP, Group Marketing and Communications, +358 44 517 0891, katja.ollila@ahlstrom.com, For investors: Johan Lindh, VP, Investor Relations, +358 10 888 4994, johan.lindh@ahlstrom.com

ABS and DOE Sign MOU to Collaborate on Clean Energy Development and Maritime Decarbonization Research

(HOUSTON) ABS and U.S. Department of Energy (DOE) are to collaborate on clean energy development in the maritime domain and decarbonization of maritime operations after signing a new memorandum of understanding (MOU). The agreement between the DOE’s Office of Energy Efficiency and Renewable Energy (EERE) and ABS is designed to leverage experience and capabilities from both organizations to support emissions reduction initiatives that benefit the maritime industry. “This new agreement allows ABS and the DOE to take advantage of the deep insight and complimentary capabilities of each organization to accelerate development of critical clean energy initiatives. We bring together the unique knowledge and resources of two mission-focused organizations to support maritime clean energy transition in the U.S. and influence international maritime decarbonization strategy in the public interest,” said Christopher J. Wiernicki, ABS Chairman and CEO. “As we move to fully decarbonize the global maritime sector by 2050, we need to ensure we are receptive to new information in this ever-changing landscape,” said Michael Berube, DOE’s Deputy Assistant Secretary for Sustainable Transportation and Fuels at EERE.  The MOU between the DOE and ABS will further clean energy development and decarbonization of the maritime industry by facilitating open engagement, information sharing and collaborative research on U.S. maritime transportation decarbonization strategies. Target areas for collaboration include domestic and international maritime strategy, ABS support to U.S. delegations on zero emission shipping and other maritime decarbonization initiatives, action plans for maritime decarbonization, and a range of technical advisory interchanges.

Italy's leading outdoor retailer SPORTLER, new reseller of OrganoTex

With SPORTLER as a new retailer, OrganoTex continues its international expansion into Italy, aligning with OrganoClick's expansion strategy. "We are very excited to initiate the collaboration with SPORTLER. We are reaching a large new audience of consumers in Italy and continuing to establish a broad presence in Europe. The demand for our products is significant, and this partnership further demonstrates that consumers are seeking Eco-labelled and effective products in textile and shoe impregnation," says Susanne Karlsson, Sales Manager for OrganoTex® at OrganoClick. About SPORTLER: SPORTLER is an Italian retail chain specializing in outdoor and sports equipment. Founded in 1977, the company offers a wide range of products for camping, hiking, cycling, and other outdoor activities. The chain consists of a total of 27 stores. About OrganoTex: OrganoTex® is a Swedish innovation based on a patented green technology inspired by the water-repellent properties of the lotus plant. The brand includes textile and shoe waterproofing, detergent products for functional garments and a industrial DWR. All products are PFAS-free and readily biodegradable – so nothing is left in nature. OrganoTex is owned, developed, and manufactured by the Swedish greentech company OrganoClick. For its green innovations, OrganoClick has won a number of awards. www.organotex.com, www.organoclick.com . Contact:Susanne Karlsson, Sales Manager OrganoTex at OrganoClick, susanne.karlsson@organoclick.com, +46(0)721945272 https://organotex.com/media-room/ 

Presentation of K-Fastigheter’s interim report January-March 2024

On April 25[th], 2024, at 9 AM CEST, K-Fast Holding AB (“K-Fastigheter”) publishes its interim report for the first quarter 2024. The report will be presented in a pre-recorded audio cast at 10 AM CEST the same day. Jacob Karlsson, CEO, and Martin Larsson, CFO, will present the earnings and operations. The presentation materials (slides and sound) will be available at www.k-fastigheter.com/en/investors/presentations  The presentation will be held in Swedish, with presentation materials in Swedish and English. Questions may be addressed in writing to ir@k-fastigheter.se with answers being compiled on an ongoing basis during the day and published on www.k-fastigheter.com/en For more information, please contact:Johan Hammarqvist, Head of Investor Relations and Communicationse-mail: johan.hammarqvist@k-fastigheter.se, telephone: +46 (0)10-167 60 99  K-Fastigheter is much more than a property company. Through an integrated process, we build our business in the four business areas project development, prefab, construction and property management. To enhance cost efficiency and cut construction times, K-Fastigheter has chosen to work with three concept houses, developed in-house and constructed for own management. K-Fastigheter offers close to 4,900 homes from Copenhagen in the south to Gävle in the north and is continuously assessing new markets. K-Fastigheter strive to create attractive homes with a high comfort factor. The Group's property portfolio has a book value SEK 14,9 billion. Annual rental value in invest properties under management amounts to SEK 661 million. Since November 2019, the company's Class B shares have been traded on Nasdaq Stockholm under the (ticker: KFAST B). Read more at k-fastigheter.com

Resolutions at Sweco AB’s Annual General Meeting and board resolutions on acquisition and transfer of treasury shares

Sweco AB (publ) (“Sweco”) has today April 19, 2024, held its Annual General Meeting. The Annual General Meeting resolved in accordance with all the proposals put forward by the Board of Directors and the Nomination Committee.  Board of Directors, discharge of liability, fees, dividend etc. The Annual General Meeting resolved, as proposed by the Nomination Committee, that the Board of Directors shall be comprised of seven (ordinary) Directors elected by the general meeting and that no Deputy Directors shall be appointed. The Annual General Meeting re-elected Åsa Bergman, Alf Göransson, Johan Hjertonsson, Johan Nordström, Johan Wall, Christine Wolff and Susanne Pahlén Åklundh as Directors. Johan Nordström was re-elected as the Chairman of the Board of Directors. The general meeting granted the members of the Board of Directors and the Managing Director discharge from liability for the financial year 2023. Ernst & Young AB was appointed as auditor up until the conclusion of the Annual General Meeting 2025. It was informed that the authorised auditor Jonas Svensson intends to be auditor in charge. The general meeting resolved on fees to the Board of Directors, including for the committee work, and to the auditor in accordance with the proposal of the Nomination Committee. The general meeting further resolved to approve the remuneration report prepared by the Board of Directors and presented at the general meeting and to approve the guidelines for salary and other remuneration to senior executives in the Sweco Group that the Board of Directors proposed. The general meeting resolved, in accordance with the proposal of the Board of Directors, that the shareholders shall receive a dividend of SEK 2.95 per share. The record date is April 23, 2024, and payment is expected to be made on April 26, 2024. The general meeting adopted the presented profit and loss statement and the balance sheet, as well as the consolidated profit and loss statement and the consolidated balance sheet for the financial year 2023. Other resolution by the general meeting In accordance with the proposals of the Board of Directors, the Annual General Meeting also resolved on: · implementation of Share Bonus Scheme 2024 and transfer of treasury shares to participants in the scheme, · implementation of performance-based Share Savings Scheme 2024 and transfers of treasury shares to participants in the scheme, and · authorisation for the Board of Directors to decide on acquisitions of treasury shares and transfers of treasury shares (see the next heading below regarding the Board of Director's exercise of the authorisation). Board resolutions on acquisition and transfer of treasury shares The Board of Directors of Sweco have at the statutory board meeting following the Annual General Meeting resolved to exercise the Annual General Meeting’s authorisation regarding acquisition of treasury shares for all the purposes stated in the resolution proposal on the acquisition authorisation, i.e. that the acquired share can be utilised to (i) provide the Board of Directors with an instrument whereby it can adapt and improve Sweco’s capital structure and thereby create additional value for shareholders, (ii) execute time-efficient payment in connection with acquisitions of companies and operations, or effect any deferred payments related to such acquisitions, or to finance such acquisitions or deferred payments, (iii) be transferred to participants in Sweco incentive schemes (share savings schemes and share bonus schemes) pursuant to separate resolutions by general meetings on such transfers, and (iv) secure the payment of costs, mainly social security contributions, for Sweco’s incentive schemes (share savings schemes and share bonus schemes). The number of acquired treasury shares, together with treasury shares otherwise acquired and held by the company, may not at any given time exceed ten (10) per cent of all issued shares in Sweco (Sweco currently holds 4,110,005 Class B treasury shares, meaning that the maximum number of shares that can be acquired as of today amounts to approximately 32,200,000 shares). Acquisitions shall be made over Nasdaq Stockholm. Acquisitions shall be made at a price within the spread between the highest purchase price and the lowest selling price prevailing at any time on Nasdaq Stockholm. At the same statutory board meeting, the Board of Directors also resolved to exercise the Annual General Meeting’s authorisation to, with deviation from the pre-emptive rights of shareholders, transfer treasury shares to secure the payment of costs, mainly social security contributions, regarding the Share Bonus Scheme 2023, the Share Bonus Scheme 2024, and the Share Savings Scheme 2021. Within the framework of the resolution, no more than 525,000 Class B treasury shares can be transferred within the framework of the Share Bonus Scheme 2023, no more than 500,000 Class B treasury shares within the framework of the Share Bonus Scheme 2024 and no more than 48,254 Class B treasury shares within the framework of the Share Savings Scheme 2021. Transfers shall be made over Nasdaq Stockholm. Transfers shall be made at a price within the spread between the highest purchase price and the lowest selling price prevailing at any time on Nasdaq Stockholm. Acquisitions and transfers will be made during the period from May 17, 2024, up until the next Annual General Meeting, having regard to the trade restrictions set out by law. Sweco currently holds 4,110,005 treasury shares corresponding to approximately 1.1 per cent of the total outstanding number of shares.

BioArctic and Eisai sign research evaluation agreement regarding BAN2802

BioArctic and Eisai have a long-standing collaboration dating back to 2005 regarding the development and commercialization of drugs for the treatment of Alzheimer’s disease. This collaboration has led to Leqembi® (lecanemab) – the world's first approved drug[1] shown to slow the progression of early Alzheimer's disease. The new collaboration will build on the companies’ joint knowledge in the field of Alzheimer’s disease. Costs for the research evaluation program will be shared and the program will evaluate what could be the next generation disease modifying treatment for Alzheimer's disease. “I am very happy that our Brain Transporter technology has continued to progress so well and that we have now entered into this first agreement utilizing this platform. I believe that this technology has huge potential to improve many different projects, and support companies in their pursuit of helping people with brain disorders,” said Gunilla Osswald, CEO at BioArctic. “Eisai has been a valuable partner to BioArctic during the past two decades, and we are very pleased to extend and deepen our relationship with this new research evaluation agreement on BAN2802. Together, we have been able to deliver lecanemab, the first fully approved disease modifying treatment in Alzheimer’s disease in the US, Japan and China, and we look forward to continuing our fruitful collaboration and lead the development of the next generation of drugs to help patients with this devastating disease.” BioArctic’s proprietary BrainTransporter technology is a technology that can actively transport biologics across the blood brain barrier into the brain. The technology has the potential to create faster and stronger efficacy of treatments targeted to the brain, while reducing the burden of treatment for both patients and society. The BrainTransporter technology manifests BioArctic’s commitment to sustainability by aiming for continuous improvement of clinical and commercial benefit. --- This release discusses investigational uses of an agent in development and is not intended to convey conclusions about efficacy or safety. There is no guarantee that such investigational agents will successfully complete clinical development or gain health authority approval. This information is information that BioArctic AB (publ) is obliged to disclose pursuant to the EU Market Abuse Regulation. The information was released for public disclosure, through the agency of the contact persons below, on April 20, 2024, at 09.40 a.m. CET. For further information, please contact: Oskar Bosson, VP Communications and IRE-mail:  oskar.bosson@bioarctic.sePhone: +46 70 410 71 80 About the collaboration between BioArctic and EisaiSince 2005, BioArctic has a long-term collaboration with Eisai regarding the development and commercialization of drugs for the treatment of Alzheimer’s disease. The most important agreements are the Development and Commercialization Agreement for the lecanemab antibody, which was signed 2007, and the Development and Commercialization agreement for the antibody LEQEMBI back-up for Alzheimer’s disease, which was signed 2015. In 2014, Eisai and Biogen entered into a joint development and commercialization agreement for lecanemab. Eisai is responsible for the clinical development, application for market approval and commercialization of the products for Alzheimer’s disease. BioArctic has the right to commercialize lecanemab in the Nordic region under certain conditions and is currently preparing for commercialization in the Nordics together with Eisai. BioArctic has no development costs for lecanemab in Alzheimer’s disease and is entitled to payments in connection with regulatory approvals, and sales milestones as well as royalties on global sales. About BioArctic ABBioArctic AB (publ) is a Swedish research-based biopharma company focusing on innovative treatments that can delay or stop the progression of neurodegenerative diseases. The company invented Leqembi® (lecanemab) – the world's first drug proven to slow the progression of the disease and reduce cognitive impairment in early Alzheimer's disease. Leqembi has been developed together with BioArctic’s partner Eisai, who are responsible for regulatory interactions and commercialization globally. In addition to Leqembi, BioArctic has a broad research portfolio with antibodies against Parkinson's disease and ALS as well as additional projects against Alzheimer's disease. Several of the projects utilize the company's proprietary BrainTransporter™ technology, which has the potential to actively transport antibodies across the blood-brain barrier to enhance the efficacy of the treatment. BioArctic's B share (BIOA B) is listed on Nasdaq Stockholm Large Cap. For further information, please visit www.bioarctic.se. [1] Approved in the US, Japan and China.

Hanz on stream

Aker BP (OSE: AKRBP) (OTCQX: AKRBF; AKRBY) is pleased to announce that production has started from Hanz in the North Sea. Hanz is operated by Aker BP, with Equinor and Sval Energy as partners.  Hanz is a subsea field development tied into the Ivar Aasen platform about fifteen kilometres further south.  Total investments are estimated at close to NOK 5 billionand total reserves are around 20 million barrels of oil equivalent (mmboe).   “This is yet another great example of what we can achieve working as one team with our suppliers towards a common goal and with shared incentives. In addition, innovative solutions with reuse of infrastructure and use of cross-flow well have contributed to lower costs and lower emissions,” says Aker BP CEO, Karl Johnny Hersvik.  “Development of the Hanz discovery is important for the development of the Ivar Aasen area. Production start from Hanz in 2024 will help us maintain good production from the Ivar Aasen platform,” Hersvik adds.  Unique re-use of infrastructure and use of a cross-flow well Hanz was discovered in 1997. After the delivery of the Plan for development and operation (PDO) for the Ivar Aasen area, which included the Hanz development, the project matured an optimised development solution by re-using subsea production systems (SPS) from the Jette field. It is the first time that production equipment has been re-used in a new field development on the NCS.  In addition, the strategy for how the oil and gas is to be recovered was changed to include use of a cross-flow well for water injection. This results in a substantial reduction of power consumption, less use of chemicals and less equipment on the seabed.   “This development solution will be more cost-efficient and have a smaller environmental footprint than originally planned for. This is in line with Aker BP’s continuous search for improvements, where the goal is to produce with low costs and low emissions,” says VP Projects Edvard Grieg and Ivar Aasen, Stine Kongshaug McIntosh.  The change in the development solution for Hanz since the original PDO was submitted led the partnership to send a formal statement regarding the investment decision and the selected concept to the authorities in December 2021.  Minimised CO2 emissions The Ivar Aasen field is located on the Utsira High in the northern part of the North Sea, around 175 km west of Karmøy.   The field was discovered in 2008, and was joined with other discoveries in the area, including Hanz, which was proven in 1997. The first oil from Ivar Aasen was produced on 24 December 2016.  Ivar Aasen receives power from the Edvard Grieg platform ten kilometres to the southeast. From 2022, the field will receive power from shore via the Johan Sverdrup field, thereby minimising CO2 emissions.  About Hanz  · Lisence 028 B  · Partners: Aker BP (35%, operatør), Equinor (50%), Sval Energy (15%)

Changes in Outokumpu’s Leadership Team: Marc-Simon Schaar appointed as CFO

Changes in Outokumpu’s Leadership Team: Marc-Simon Schaar appointed as CFO Marc-Simon Schaar (M.Sc. International Business, Chartered Accountant) has been appointed as Chief Financial Officer as of June 1, 2024. He has been working at Outokumpu since 2011 in senior roles in Business Controlling, Treasury, M&A and Procurement, most recently as Chief Procurement Officer and a member of the leadership team since 2023. “We are pleased to announce the appointment of Marc-Simon Schaar as our Chief Financial Officer. Marc-Simon brings with him profound understanding of the stainless steel business as well as the organization, having worked over ten years in various finance and business roles in the company. In recent years, he has successfully steered our raw material procurement, which constitutes the biggest share of our cost base. With a proven track record of providing strategic guidance and driving financial performance in alignment with the company's goals, Marc-Simon demonstrates comprehensive expertise in all aspects of CFO responsibilities,” says Heikki Malinen, President & CEO, Outokumpu. “I am honored to take a new step in my Outokumpu career as CFO and continue the systematic work on the company’s financial performance. We have a solid foundation to build on with the strongest balance sheet in the industry. I am fully committed to leveraging this strength to drive sustainable growth and create long-term value for our shareholders, employees, and stakeholders alike,” says Marc Simon Schaar. Marc-Simon Schaar is a German citizen. He reports to President & CEO Heikki Malinen. For more information:   Investors: Linda Häkkilä, Head of Investor Relations, tel. +358 400 719 669   Media: Päivi Allenius, SVP – Brand & Communications, tel. +358 40 753 7374 or Outokumpu media desk, tel. +358 40 351 9840 Outokumpu Corporation  

Neste successfully concludes its first processing run with pyrolysis oil from discarded tires

Neste Corporation, Press Release, 22 April 2024 at 9 a.m. (EET) Photo: Currently, car and truck tires mostly end up in landfills or incineration after they have been discarded. Source: Neste · Pyrolysis oil derived from discarded tires was processed into high-quality raw material for chemicals and plastics at Neste’s refinery in Porvoo, Finland · Pyrolysis oil was provided by Swedish supplier Scandinavian Enviro Systems · The processing run validates the suitability of chemical recycling for processing waste materials beyond plastics In its efforts to advance chemical recycling, Neste has successfully conducted its first processing trial run with a new challenging raw material, liquefied discarded tires. In the processing run, Neste produced high-quality raw material for new plastics and chemicals. For the processing run, Neste sourced pyrolysis oil derived from discarded vehicle tires by Scandinavian Enviro Systems, a Swedish company developing technologies to recover materials from end-of-life products. The goal of Neste’s pilot run was to evaluate the potential of chemical recycling beyond plastic waste to potentially broaden the pool of waste streams that could be processed into high-quality products. Just as with hard-to-recycle plastic waste, a large amount of tires today ends up in landfills or incineration at the end of their life cycle. The composition of tires as a mix of several materials makes them difficult to recycle with mechanical recycling methods. Hence, there is a strong case for using chemical recycling to help keep valuable materials in circulation – and Scandinavian Enviro Systems has developed a pyrolysis technology for extracting carbon black and oil from end-of-life tires. “The beauty of chemical recycling is that it can process hard-to-recycle plastic waste. But it’s not limited to that,” explains Andreas Teir, who is in charge of Neste’s raw materials supply for chemical recycling. “With discarded tires currently often facing a fate similar to plastic waste, we consider chemical recycling a valid addition when it comes to changing the linear life cycle of tires into a circular one. Thanks to our supplier Enviro Systems, we were able to prove that with our recent processing run.” In the past, Neste has already successfully concluded several processing runs with liquefied waste plastic . These runs built the basis for Neste’s decision to invest into large-scale capacities for chemical recycling at the company’s site in Porvoo, Finland. The facilities being built are expected to be finished in the course of 2025 and will be able to process 150,000 tons of liquefied waste plastic per year. They are part of project PULSE , which is funded by the European Union through the EU Innovation Fund.Neste CorporationSusanna SieppiVice President, Communications and Brand (act.)

Enviro’s recovered pyrolysis oil has been successfully processed by Neste into raw materials for chemicals and plastics

The successful processing run was performed at Neste’s refinery in Porvoo, Finland. The pyrolysis oil had been delivered from Enviro’s plant in Åsensbruk where Enviro uses its proprietary and patented pyrolysis technology to recover valuable raw materials, such as carbon black and oil, from end-of-life tires. Neste has previously already successfully produced raw materials for plastics and chemicals from liquefied plastic waste. “Neste’s test run further demonstrates the potential for our recovered valuable materials in addition to those already identified by our current customers. A more sustainable production of plastics and chemicals is important for the inevitable sustainability transition that the world is facing so Neste’s test run is very interesting and promising," says Fredrik Emilson, CEO of Enviro. Since mid-February 2024, the construction of the first full-scale end-of-life tire recycling facility based on Enviro's patented pyrolysis method is underway. The facility is being built in Uddevalla in Western Sweden and is owned by the joint venture company that Enviro formed together with Antin Infrastructure Partners and with the support of Michelin. The joint venture company has already signed legally binding long-term supply agreements regarding the carbon black and oil that the facility will recover to a value of approximately SEK 2 billion. Among the customers are some of the world's largest tire and oil producers, including Michelin, Nokian Tyres, H&R Group and Preem. The facility in Uddevalla is expected to be fully operational in 2025. For further information, please contact:Fredrik Emilson, CEO Enviro, +46 (0)706-05 67 83, fredrik.emilson@envirosystems.seAlf Blomqvist, Chairman of the Board Enviro, +46 (0)733-14 97 00, alf@blomqvistunlimited.com Scandinavian Enviro Systems ABFrihamnen 16B, SE-417 70 Gothenburginfo@envirosystems.seenvirosystems.se

Episurf Medical announces a partially secured rights issue of units of up to approximately SEK 120 million

The Board of Directors of Episurf Medical AB (publ) (“Episurf”, “Episurf Medical” or the “Company”), (NASDAQ Stockholm: EPIS B) today resolved, subject to the approval by an extraordinary general meeting (the “EGM”), to carry out a new issue of 33,383,180 units, corresponding to a maximum of 500,747,700 new class B shares and a maximum of 200,299,080 warrants, with preferential rights for existing shareholders, of up to approximately SEK 120 million (the “Rights Issue”). Each unit consists of fifteen (15) new class B shares in the Company and six (6) warrants of series TO13 B. Upon full subscription and exercise, the warrants will contribute with additional proceeds corresponding to a maximum of approximately SEK 48 million. The EGM is proposed to approve the Board of Directors’ resolution on the Rights Issue and certain related proposals to enable the Rights Issue. The EGM is planned to be held on 22 May 2024 and the notice will be announced through a separate press release. The purpose of the Rights Issue is primarily to finance the ongoing commercialization of the Episealer® Patellofemoral System on the US market and the US regulatory process for the Episealer® MTP-System, the ongoing commercialization of the Episealer® Knee and Episealer® Talus Systems in different geographies and the continuation of clinical development besides general corporate purposes. The Company has received subscription commitments and subscription intentions as well as guarantee commitments for approximately 75.0 percent of the Rights Issue, corresponding to SEK 90 million. Additionally, the Company’s largest shareholder, Health Runner AB, as well as shareholder Sacajo Investments LLC (Niles Noblitt), have expressed an ambition to subscribe for their respective pro-rata shares in the Rights Issue. Conditional upon the Rights Issue being successfully completed, Episurf has adopted a financial target to reach annual sales of SEK 150-200 million in the medium term, at which point the Company expects to become cash flow positive. Summary · The Board of Directors in Episurf today resolved, subject to the approval by the EGM, to carry out the Rights Issue. The EGM is proposed to approve the Board of Directors’ resolution on the Rights Issue and certain related proposals to enable the Rights Issue. The EGM is planned to be held on 22 May 2024 and the notice will be announced through a separate press release. · All existing shareholders in Episurf will receive one (1) unit right for each class A or class B share held on the record date, expected to occur on or about 24 May 2024. Eight (8) unit rights will entitle the holder to subscribe for one (1) unit. One (1) unit consists of fifteen (15) new class B shares and six (6) warrants of series TO13 B. · The subscription price is SEK 3.60 per unit, corresponding to a subscription price of SEK 0.24 per class B share. The warrants are issued free of charge. Each warrant will entitle to subscription of one (1) new class B share at a subscription price of SEK 0.24 per class B share during 10 February – 24 February 2025. The warrants will be available for trading on Nasdaq First North Growth Market. · The subscription price of SEK 0.24 per class B share, corresponds to a discount of approximately 40.5 percent, compared to the theoretical ex-rights price (TERP) based on the closing price of Episurf’s class B share on Nasdaq Stockholm on 19 April 2024, the last trading day before announcement of the Rights Issue. · Upon full subscription of the Rights Issue, Episurf will receive approximately SEK 120 million before deductions of costs related to the Rights Issue and, upon full and exercise of the warrants, Episurf will receive additional proceeds of approximately SEK 48 million before deductions of costs related to the warrants. · The subscription period in the Rights Issue is expected to run from and including 28 May 2024 up to and including 12 June 2024. · Existing shareholders, including Fjärde AP-fonden and LMK Forward AB have undertaken, or expressed their intention, to subscribe for units representing approximately 12.7 percent of the Rights Issue, or approximately SEK 15 million. · Additionally, shareholding members of the Company’s Board of Directors and Management, including CEO Pål Ryfors and Chairman Ulf Grunander, have expressed their intention to subscribe for units representing approximately 1.6 percent of the Rights Issue, or approximately SEK 2 million in total. Members of the Board and Management of the Company are prevented, under applicable rules on market abuse, from entering into undertakings to subscribe for units in the Rights Issue, as a result of the Company being in a so-called closed period until the publication of the interim report for the first quarter of 2024, and are expected to enter into undertakings after the closed period has ended. · A number of external investors have undertaken to guarantee approximately 60.7 percent of the Rights Issue, corresponding to approximately SEK 73 million, at a guarantee commission of 12.0 percent of the guaranteed amount in cash or 14.0 percent of the guaranteed amount in units. · The Rights Issue is thus covered by subscription intentions, subscription commitments and guarantee commitments representing approximately 75.0 percent of the Rights issue, corresponding to approximately SEK 90 million. · Additionally, the Company’s largest shareholder, Health Runner AB, as well as the shareholder Sacajo Investments LLC (Niles Noblitt) have expressed an ambition to subscribe for their respective pro-rata shares in the Rights Issue. · Existing shareholders, representing approximately 12.9 percent of the total votes in the Company, have undertaken or expressed their intention to vote in favor of the resolutions regarding the Rights Issue at the EGM. Episurf’s CEO Pål Ryfors comments: “Through this transaction, we are securing our ability to continue our US launch of the Episealer® Patellofemoral System and continue our US regulatory strategy for the Episealer® MTP-System. In our OUS markets, we are continuing our commercialization of Episealer® Knee and Episealer® Talus, now with a more distributor-focused business model. We have solved a problem within orthopedics, and we can help patients globally with our individualized technology. Through this transaction, we are securing our financial position until late 2025.” Background and motive Episurf is a Swedish, commercial stage orthopaedics company with a proprietary implant technology, based on individualized implants and surgical tools tailored for each patient’s needs through advanced imaging techniques and pre-surgical analysis. Episurf’s first product group, the Episealer[®] knee implant, addresses the gap in the osteoarthritis treatment paradigm between early biologic interventions and knee replacements, and is commercially available in Europe and several other markets. Episurf has a broad portfolio of products based on their proprietary technology addressing joint injuries including: Episealer[®] Knee (CE marked, US Pivotal trial ongoing), Episealer[®] Talus (CE marked), Episealer[®] Patellofemoral System (FDA 510(k) cleared), and Episealer[®] MTP system (510(k) filed in Q4 2023, expected clearance in 2024). First surgery in human with the Episealer[®] Knee was performed in December 2012, with over 1,900 surgeries performed to date using the Episealer[®] implant. Following the approval of its first product in the US (Episealer[®] Patellofemoral System), Episurf is currently building its US commercial organisation and a broad distributor network to ensure a successful launch. Use of proceeds Episurf has identified five investment areas that have the potential to bring the Company significantly closer to a position of sustainable profitability within the established business strategy. The net proceeds from the Rights Issue, provided that the Rights Issue is subscribed to the amount covered by subscription commitments and intentions, as well as guarantee commitments, will be used to: i. Accelerate the ongoing commercialization of the Episealer® Patellofemoral System on the US market, including continued expansion of the US distributor network, surgical support and other relevant marketing activities, together with a balanced expansion of the US organization (approximately 25%);ii. Finance the US regulatory process for the Episealer® MTP-System for the US market, as well as pre-launch and market launch activities in the US (approximately 25%);iii. Accelerate the ongoing commercialization of the Episealer® Knee and Episealer® Talus Systems in the ex-US markets, including marketing and sales activities of the ex-US sales forces and distributor network (approximately 25%);iv. Continue the Company’s clinical development programs, including supporting several independent study initiatives and the ongoing EPIC Knee PMA Study as well as the Company’s regulatory activities to support global market presence (approximately 15%); and v. General corporate purposes and extension of cash runway to at least Q4 2025 (approximately 10%). Should the Rights Issue be subscribed for an amount higher than the amount covered by subscription commitments and intentions, as well as guarantee commitments, the additional proceeds will be used to finance activities (i) to (v) proportionally. Upon full exercise of the warrants of series TO13 B in February 2025, the Company is expected to receive up to approximately SEK 48 million, which the Company intends to use to finance activities (i) to (v) proportionally. Financial target Conditional upon the Rights Issue being successfully completed, Episurf has adopted a financial target to reach annual sales of SEK 150-200 million in the medium term, at which point the Company expects to become cash flow positive. Terms of the Rights Issue Shareholders who are registered in the share register in Episurf on the record date of the Rights Issue, expected to occur on or about 24 May 2024, will receive one (1) unit right for each class A or class B share held in the Company. Eight (8) unit rights entitle the holder to subscribe for one (1) unit. One (1) unit consists of fifteen (15) newly issued class B shares and six (6) warrants of series TO13 B. In addition, shareholders and other investors are offered the possibility to subscribe for units without unit rights, to the extent the Rights Issue is not subscribed for by exercise of unit rights. The subscription price is SEK 3.60 per unit, corresponding a subscription price of SEK 0.24 per class B share. The warrants are issued free of charge. Provided that the Rights Issue is fully subscribed, Episurf will receive gross proceeds of approximately SEK 120 million before deductions of costs related to the Rights Issue. Each warrant of series TO13 B entitles the holder to subscribe for one (1) new class B share in the Company during the period from and including 10 February 2025 up to and including 24 February 2025. The exercise price of the warrants of series TO13 B will be SEK 0.24 per class B share. Upon full exercise of the warrants of series TO13 B, Episurf will receive up to an additional SEK 48 million before deduction of costs related to the warrants. The warrants will be available for trading on Nasdaq First North Growth Market. Provided that the Rights Issue is fully subscribed, the Rights Issue will entail that the share capital is increased by approximately SEK 5,007,477 (assuming implementation of the proposed reduction of share capital as further described below and in the notice for the EGM, such that the quota value of the Company’s shares is SEK 0.01), by issue of 500,747,700 new class B shares, resulting in the total number of shares increasing from 267,065,447 shares to 767,813,147 shares, divided into 473,357 class A shares and 767,339,790 class B shares. Shareholders who choose not to participate in the Rights Issue will have their ownership diluted by up to 65.2 percent of the number of shares and  65.1 percent of the number of votes through the Rights Issue (based on the total maximum outstanding shares after the Rights Issue). These shareholders have the opportunity to compensate themselves financially for the dilution effect by selling their unit rights received. Upon full subscription and exercise of the warrants of series TO13 B, the number of shares will increase by a maximum of 200,299,080 class B shares and the share capital will increase by a maximum of approximately SEK  2,002,991 (assuming implementation of the proposed reductions of share capital and bonus issue, as further described below and in the notice for the EGM, such that the quota value of the Company’s shares is SEK 0.01), which, provided that the Rights Issue is fully subscribed, will correspond to a dilution effect of approximately 20.7 percent of the shares and approximately 20.7 percent of the votes in the Company, for shareholders who choose not to exercise their warrants of series TO13 B. If all investors who have entered into guarantee commitments elect to receive their guarantee commission in units, and provided that all warrants of series TO13 B that are part of such units are exercised, the number of shares will increase by 59,616,648 class B shares and the share capital will increase by approximately SEK 596,166 (assuming implementation of the proposed reductions of share capital and bonus issue, as further described below and in the notice for the EGM, such that the quota value of the Company’s shares is SEK 0.01), which, provided that the Rights Issue is fully subscribed, will correspond to a dilution effect of approximately 5.8 percent of the shares and approximately 5.8 percent of the votes in the Company. In the event that the Rights Issue is fully subscribed, the warrants of series TO13 B are fully exercised for, and all investors who have entered into guarantee commitments elect to receive their guarantee commission in units, and provided that all warrants of series TO13 B that are part of such units are exercised, the total dilution effect will be approximately 74.0 percent of the shares and approximately 73.9 percent of the votes in the Company. The complete terms and conditions of the Rights Issue and information about the Company will be presented in a prospectus, prepared in accordance with the simplified disclosure regime for secondary issuances, that is expected to be published on the Company’s website on or around 24 May 2024. EGM The EGM is proposed to approve the Board of Directors’ resolution on the Rights Issue and to resolve on certain related proposals to enable the Rights Issue, including reductions of the share capital, a bonus issue and related amendments to the Company’s articles of association. The reason for the reductions of the share capital, the bonus issue and the amendments to the articles of association is to enable the Rights Issue and reduce the quota value of the Company’s shares as will be further detailed in the notice for the EGM. The EGM is planned to be held on 22 May 2024. Existing shareholders, representing approximately 12.9 percent of the total votes in the Company, have undertaken to, or have expressed their intention to vote in favor of the Rights Issue at the EGM. The notice for the EGM will be published through a separate press release and will be available on the Company’s website, www.episurf.com. Intentions to subscribe for units, subscription commitments and guarantee commitments Existing shareholders, including Fjärde AP-fonden and LMK Forward AB have undertaken, or expressed their intention, to subscribe for units representing approximately 12.7 percent of the Rights Issue, or approximately SEK 15 million. Shareholding members of the Company’s Board of Directors and Management, including CEO Pål Ryfors and Chairman Ulf Grunander, have expressed their intention to subscribe for units representing approximately 1.6 percent of the Rights Issue, or approximately SEK 2 million in total. Members of the Board and Management of the Company are prevented, under applicable rules on market abuse, from entering into undertakings to subscribe for units in the Rights Issue, as a result of the Company being in a so-called closed period until the publication of the interim report for the first quarter of 2024 and are expected to enter into undertakings after the closed period has ended. In total, these subscription commitments and subscription intentions represent approximately 14.3 percent of the Rights Issue, corresponding to approximately SEK 17 million. In addition, a number of external investors have undertaken to guarantee approximately 60.7 percent of the Rights Issue, corresponding to approximately SEK 73 million, at a guarantee commission of 12.0 percent of the guaranteed amount in cash or 14.0 percent of the guaranteed amount in units, where the subscription price for such units will be equivalent to the subscription price per unit in the Rights Issue. The Company’s Board of Directors has thoroughly evaluated the possibility for the guarantors to receive their guarantee commission in the form of units at the abovementioned terms and concluded that offering such possibility has been necessary to obtain the guarantee commitments and is in the best interest of the Company and its shareholders. Accordingly, the Company has obtained subscription commitments, subscription intentions and guarantee commitments for approximately 75.0 percent of the Rights Issue, corresponding to SEK 90 million. Additionally, the largest shareholder Health Runner AB, as well as the shareholder Sacajo Investments LLC (Niles Noblitt), have expressed an ambition to subscribe for their respective pro-rata shares in the Rights Issue. Further information regarding the parties who have entered into subscription intentions, subscription commitments and guarantee commitments will be presented in the prospectus to be made public before the commencement of the subscription period. Lock-up undertakings Shareholding members of the Board of Directors and management have entered into lock-up undertakings, which, among other things and with customary exceptions, mean that they have undertaken not to sell shares in the Company. The lock-up undertakings expire on the day that falls 180 days after the date of announcement of the outcome in the Rights Issue. Furthermore, the Company has undertaken towards Pareto Securities, subject to customary exceptions, not to issue additional shares or other share-related instruments for a period of 180 days after the date of announcement of the outcome in the Rights Issue. Preliminary timetable of the Rights Issue The below timetable for the Rights Issue is preliminary and may be adjusted. 22 May Extraordinary general meeting202422 May Last day of trading including the right to2024 receive unit rights23 May First day of trading without the right to2024 receive unit rights24 May Record date for receipt of unit rights202424 May Publication of the prospectus202428 May – 7 Trading in unit rightsJune 202428 May – Subscription period12 June202428 May – Trading in BTUs (paid subscribed units)24 June202413 June Expected announcement of the outcome of the2024 Rights Issue28 June Expected first day of trading in warrants of2024 series TO13 B on Nasdaq First North Growth Market10 – 24 Exercise period for warrants of series TO13 BFebruary2025 Advisors Pareto Securities has been appointed as Sole Manager and Bookrunner in the Rights Issue. Hannes Snellman Advokatbyrå AB is legal adviser to Episurf in connection with the Rights Issue. Advokatfirman Vinge KB is legal adviser to the Sole Manager and Bookrunner in connection with the Rights Issue. Nordic Issuing acts as issuing agent in connection with the Rights Issue. For more information, please contact: Pål Ryfors, CEO, Episurf MedicalTel:+46 (0) 709 62 36 69Email: pal.ryfors@episurf.com Veronica Wallin, CFO, Episurf MedicalTel:+46 (0) 700 37 48 95Email: veronica.wallin@episurf.com (pal.ryfors@episurf.com) This information is information that Episurf Medical AB is obliged to make public pursuant to the EU Market Abuse Regulation 596/2014. The information was submitted for publication, through the agency of the contact persons set out above, at 08:00 CEST on 22 April 2024. About Episurf Medical Episurf Medical is endeavoring to bring people with painful joint injuries a more active, healthier life through the availability of minimally invasive and individualised treatment alternatives. Episurf Medical’s Episealer® individualised implants and Epiguide® surgical drill guides are developed for treating localised cartilage injury in joints. Episurf Medical’s μiFidelity® system enables implants to be cost-efficiently tailored to each individual’s unique injury for the optimal fit and minimal intervention. Episurf Medical’s head office is in Stockholm, Sweden. Its class B share (EPIS B) is listed on Nasdaq Stockholm. For more information, go to the company’s website: www.episurf.com. Important information The release, announcement or distribution of this press release may, in certain jurisdictions, be subject to restrictions. The recipients of this press release in jurisdictions where this press release has been published or distributed shall inform themselves of and follow such legal restrictions. The recipient of this press release is responsible for using this press release, and the information contained herein, in accordance with applicable rules in each jurisdiction. This press release does not constitute an offer, or a solicitation of any offer, to buy or subscribe for any securities in Episurf Medical in any jurisdiction, neither from Episurf Medical nor from someone else. This press release is not a prospectus for the purposes of Regulation (EU) 2017/1129 of the European Parliament and of the Council of 14 June 2017 (the “Prospectus Regulation”) and has not been approved by any regulatory authority in any jurisdiction. A prospectus, prepared in accordance with the simplified disclosure regime for secondary issuances as set forth in the Prospectus Regulation, regarding the Rights Issue described in this press release will be prepared and published by the Company prior to the commencing of the subscription period. This announcement does not identify or suggest, or purport to identify or suggest, the risks (direct or indirect) that may be associated with an investment in the Company. The information contained in this announcement relating to the Rights Issue is for background purposes only and does not purport to be full or complete. No reliance may be placed for any purpose on the information contained in this announcement or its accuracy or completeness. Pareto Securities are acting for Episurf Medical in connection with the Rights Issue and no one else and will not be responsible to anyone other than Episurf Medical for providing the protections afforded to its clients nor for giving advice in relation to the Rights Issue or any other matter referred to herein. Pareto Securities are not liable to anyone else for providing the protection provided to their customers or for providing advice in connection with the Rights Issue or anything else mentioned herein. This press release does not constitute or form part of an offer or solicitation to purchase or subscribe for securities in the United States. The securities referred to herein may not be sold in the United States absent registration or an exemption from registration under the US Securities Act of 1933, as amended (the “Securities Act”), and may not be offered or sold within the United States absent registration or an applicable exemption from, or in a transaction not subject to, the registration requirements of the Securities Act. There is no intention to register any securities referred to herein in the United States or to make a public Rights Issue of the securities in the United States. The information in this press release may not be announced, published, copied, reproduced or distributed, directly or indirectly, in whole or in part, within or into the US, the United Kingdom, Australia, Belarus, Canada, Hong Kong, Israel, Japan, New Zeeland, Russia, Singapore, South Africa, South Korea, Switzerland or in any other jurisdiction where such announcement, publication or distribution of the information would not comply with applicable laws and regulations or where such actions are subject to legal restrictions or would require additional registration or other measures than what is required under Swedish law. Actions taken in violation of this instruction may constitute a crime against applicable securities laws and regulations. In the United Kingdom, this document and any other materials in relation to the securities described herein is only being distributed to, and is only directed at, and any investment or investment activity to which this document relates is available only to, and will be engaged in only with, “qualified investors” (within the meaning of the Prospectus Regulation as it forms part of domestic law in the United Kingdom by virtue of the European Union (Withdrawal) Act 2018) who are (i) persons having professional experience in matters relating to investments who fall within the definition of “investment professionals” in Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the “Order”); or (ii) high net worth entities falling within Article 49(2)(a) to (d) of the Order (all such persons together being referred to as “relevant persons”). In the United Kingdom, any investment or investment activity to which this communication relates is available only to, and will be engaged in only with, relevant persons. Persons who are not relevant persons should not take any action on the basis of this press release and should not act or rely on it. Forward-looking statements This press release contains forward-looking statements that reflect the Company's intentions, beliefs, or current expectations about and targets for the Company's and the group's future results of operations, financial condition, liquidity, performance, prospects, anticipated growth, strategies and opportunities and the markets in which the Company and the group operates. Forward-looking statements are statements that are not historical facts and may be identified by words such as "believe", "expect", "anticipate", "intend", "may", "plan", "estimate", "will", "should", "could", "aim" or "might", or, in each case, their negative, or similar expressions. The forward-looking statements in this press release are based upon various assumptions, many of which are based, in turn, upon further assumptions. Although the Company believes that the expectations reflected in these forward-looking statements are reasonable, it can give no assurances that they will materialize or prove to be correct. Because these statements are based on assumptions or estimates and are subject to risks and uncertainties, the actual results or outcome could differ materially from those set out in the forward-looking statements as a result of many factors. Such risks, uncertainties, contingencies and other important factors could cause actual events to differ materially from the expectations expressed or implied in this release by such forward-looking statements. The Company does not guarantee that the assumptions underlying the forward-looking statements in this press release are free from errors and readers of this press release should not place undue reliance on the forward-looking statements in this press release. The information, opinions and forward-looking statements that are expressly or implicitly contained herein speak only as of its date and are subject to change without notice. Neither the Company nor anyone else undertake to review, update, confirm or to release publicly any revisions to any forward-looking statements to reflect events that occur or circumstances that arise in relation to the content of this press release, unless it is required by law or Nasdaq Stockholm's rule book for issuers. Information to distributors Solely for the purposes of the product governance requirements contained within: (a) EU Directive 2014/65/EU on markets in financial instruments, as amended (“MiFID II”); (b) Articles 9 and 10 of Commission Delegated Directive (EU) 2017/593 supplementing MiFID II; and (c) local implementing measures (together, the “MiFID II Product Governance Requirements”), and disclaiming all and any liability, whether arising in tort, contract or otherwise, which any “manufacturer” (for the purposes of the MiFID II Product Governance Requirements) may otherwise have with respect thereto, the offered shares have been subject to a product approval process, which has determined that such shares are: (i) compatible with an end target market of retail investors and investors who meet the criteria of professional clients and eligible counterparties, each as defined in MiFID II; and (ii) eligible for distribution through all distribution channels as are permitted by MiFID II (the “Target Market Assessment”). Notwithstanding the Target Market Assessment, distributors should note that: the price of the shares in the Company may decline and investors could lose all or part of their investment; the shares in the Company offer no guaranteed income and no capital protection; and an investment in the shares in the Company is compatible only with investors who do not need a guaranteed income or capital protection, who (either alone or in conjunction with an appropriate financial or other adviser) are capable of evaluating the merits and risks of such an investment and who have sufficient resources to be able to bear any losses that may result therefrom. The Target Market Assessment is without prejudice to the requirements of any contractual, legal or regulatory selling restrictions in relation to the Rights Issue. Furthermore, it is noted that, notwithstanding the Target Market Assessment, the Sole Manager and Bookrunner will only procure investors who meet the criteria of professional clients and eligible counterparties. For the avoidance of doubt, the Target Market Assessment does not constitute: (a) an assessment of suitability or appropriateness for the purposes of MiFID II; or (b) a recommendation to any investor or group of investors to invest in, or purchase, or take any other action whatsoever with respect to the shares in the Company. Each distributor is responsible for undertaking its own target market assessment in respect of the shares in the Company and determining appropriate distribution channels.

Baseload Capital and ThinkGeoEnergy Join Forces to Revolutionize Geothermal News Sharing

By combining Baseload Capital's expertise in sustainable energy development with 's unparalleled insight and reach in the geothermal sector, this collaboration promises to deliver innovative and comprehensive coverage of the latest developments, trends, and breakthroughs within the geothermal energy landscape. At the heart of this collaboration is a shared commitment to advancing the geothermal industry and promoting sustainable energy solutions worldwide. Through this partnership, Baseload Capital and ThinkGeoEnergy will not only provide valuable and timely information to industry professionals but also contribute to the collective knowledge base, driving innovation and fostering growth within the geothermal sector. "We are thrilled to partner with ThinkGeoEnergy to bring forth a new era in geothermal news production," said Kristina Hagström Illievska, CMO at Baseload Capital. "Together, we aim to empower the industry with insightful, relevant, and impactful content that will propel the advancement of geothermal energy." “This collaboration represents a significant milestone in our mission to promote awareness and understanding of geothermal energy," said Alexander Richter, Founder & Principal at ThinkGeoEnergy. “The experience of Baseload Capital in producing highly polished media content and their global footprint perfectly complements our news and research capabilities, allowing this partnership to reach a wider audience.” Stay tuned for updates on this exciting collaboration and be part of the journey towards a more sustainable future powered by geothermal energy.

Beijer Ref acquires Young Supply in North America with a strong position in commercial refrigeration

Beijer Ref has signed an agreement to acquire Young Supply, a North American distributor of commercial refrigeration and HVAC with headquarters in Detroit, Michigan. The company serves contractors in the Midwest United States, including Michigan and Ohio – territories adjacent to Beijer Ref’s current holdings in the United States. Young Supply has annual sales of approximately SEK 1.4 billion with 18 branches. Young Supply is a family-owned company that was founded in 1935. With over 85 years of experience, Young Supply provides an experienced and professional team dedicated to offering solutions in commercial refrigeration and HVAC, primarily focusing on the aftermarket for both residential and commercial projects. The company has strong alignment with Beijer Ref’s key suppliers in the U.S. region. Young Supply will continue to operate under its existing brand, both in distribution and marketing. The existing management will roll-over investment into Beijer Ref’s U.S. platform and continue to run the business. The acquisition is expected to have a minor positive impact on the group’s result. Young Supply employs approximately 200 people. Christopher Norbye, CEO Beijer Ref, comments: “We are pleased to welcome Young Supply to the Beijer Ref group. The company offers comprehensive expertise and knowledge, primarily in commercial refrigeration, which will be an important addition to Beijer Ref’s existing platform in the United States. With our collective industry knowledge, new opportunities arise to create meaningful synergies that support the long-term goals of the business. The acquisition aligns with our overall acquisition strategy and we look forward to continuing to drive growth and develop the company together with the existing owners.” Malmö, 22 April 2024Beijer Ref AB (publ) For more information, please contact:Joel DavidssonCFOTelephone +46 40-35 89 00Email jdn@beijerref.com Niklas WillstrandDirector of Global CommunicationsTelephone +46 40-35 89 00Email nwd@beijerref.com BEIJER REF AB is a technology-oriented trading Group which, through added-value products, offers its customers competitive solutions within refrigeration and climate control. Beijer Ref is one of the largest refrigeration wholesalers in the world, and is represented in 45 countries in Europe, North America, Africa and Asia and Oceania. Website: www.beijerref.com

Shape Robotics wins pilot project in 1000 schools in India and enters Romanian tenders worth 2,45 Mio euro

The aim of the planned partnership is to start up a pilot project initially targeting 1000 Indian schools and later include up to 3000 more Indian schools and implement a variety of products from the growing Shape Robotics portfolio into the vast Indian education system. “We are thrilled to announce a significant milestone in our journey, a highly synergistic partnership with PM Publishers in India. This collaboration not only ensures a swift market entry for Shape Robotics but also aligns us with a reputable and seasoned local ally. Our sales team’s dedication over the past four months, in close coordination with PM Publishers, has borne fruit with the receipt of a Letter of Intent. This gesture signifies their keen interest in reselling and integrating our innovative robot, Fable, into their educational offerings. We are deeply honored by the prospect of our technology playing a pivotal role in enhancing the STEAM skills of countless young Indian students. This development not only empowers these students to excel in their personal endeavors but also contributes to the flourishing of India as a nation” says CEO, Mark Abraham. India's already allocated national educational budget for 2024/25 is set to 13 billion euros covering a total 1,45 million schools (54% government owned, 34% private owned and 10% schools for specially aided students). Potential of 4000 Indian schools The expected order from PMP for 2024 is 1000 bundles with a total value of 1.3 M EUR, ordered and paid in two parts. The first part as soon as Shape Robotics and PM Publishing signs a formal agreement and the second part in in October or November 2024, followed by implementation starting up in December 2024 timed with the opening of the annually cyclical investment window. If successful, a further potential of 3000 more schools in the PM Publishers network could join the project at a total value worth 3.9M Euro for 2025-2026 further extending the penetration of one of the top three global Edtech markets. “We have signed an agreement with Danish-Indian consulting company Cobo Consult, thereby building on services co-financed by Danish Government. In the end of May our CTO and top sales representatives will visit Mumbai and Bengaluru to meet with key stakeholders and potential distributors or resellers, they will visit key schools and the publishing companies that are central in the Indian market and also meet with NGOs and G level organizations,” says CEO Mark Abraham. In 2024 Shape Robotics aims to appoint one or more master distributor(s) and a number of resellers in India to allow the company to deploy a wider sales campaign in India in 2025 and the years to come. Promising Romanian tenders Together with Romanian partner and national retailer Altex, Shape Robotics is bidding with a rating of 100 out of 100 on a tender in Sibiu Municipality with a total value of 450.000 Euro. Shape Robotics expects the tender to be formally awarded soon and result in the delivery of 340 IDBs, bundled with Fable Hub and Fable Blockly, Laptops, Graphic tablets, AV products and multimedia peripherals to create digital content in the classrooms. Also in Sibiu Municipality, Shape Robotics together with local partner Data Hub, will join a tender as the only bidder with an expected revenue of 2 million euro. Shape Robotics will deliver and install 940 units of 75” IDBs, bundled with Fable Hub and Fable Blockly, AV systems, graphic tablets and digital scanners for the classrooms. Further information and investor relations: Mark Abraham, CEO:Telephone: +45 31 65 64 50Email: mark@shaperobotics.com Communication and PR:Gullev & Co. ApSwww.gullev.coBoris GullevTel: +45 31 39 79 99E-mail: borisgullev@gmail.com

Mandatum Asset Management Growth Equity II fund invests in HappySignals, a human-centric IT Experience Management company

Mandatum plc, Press release 22 April, 2024, at 10:00 a.m. EEST The MAM Growth Equity II fund makes its second investment by leading the financing round into HappySignals, a pioneering SaaS company within IT experience management. The investment will be used to accelerate HappySignals’ global expansion by boosting sales, marketing, and product development efforts. MAM Growth Equity strategy has invested in HappySignals, a Finland-based human-centric IT experience management (ITXM) company. The EUR 12 million financing round includes participation from the company’s current investors Nauta Capital and Vendep Capital. HappySignals marks the second investment for the MAM Growth Equity II fund. HappySignals, founded in 2014, helps organisations transform their IT and Services functions to become more human-centric by leveraging its employee experience data and AI capabilities. With the help of HappySignals’ innovative tools, customers analyse the IT experiences of millions of employees in 130 countries. The results help the customers understand how their employees are experiencing the IT environment, which enables data-driven improvement of employee happiness and productivity. The strong product-market fit is demonstrated by the company’s growth rate of approximately 40% over the past three years, with key customers being large global companies like PepsiCo, Fujitsu and Reckitt. The MAM Growth Equity strategy focuses on the scale-up phase of Finnish and Nordic growth companies. It takes part in exceptional growth journeys by being an active owner and by providing expertise, networks and flexible growth capital for companies with a proven business model and ambitious management teams. The team has experience from international SaaS businesses and the ServiceNow ecosystem through its investments in for example Nosto Solutions and Sofigate.“We are thrilled to have led the funding round in HappySignals, which will enable a further acceleration of their international growth journey. With its human-centric approach, we believe that HappySignals has found a solution to a problem that has not been solved in the market before. Indeed, their blue-chip customers are a true testimony to the quality of their approach and solution. The investment in HappySignals is an excellent addition to our second vintage growth equity fund. We are excited to partner with the founders, management and other owners to accelerate the growth of the company’s already significant international operations”, says Rami Salonen, Investment Manager, Mandatum Asset Management. Sami Kallio, the CEO and co-founder of HappySignals, highlights the investment’s significance: ”The growth funding will be used for our global expansion in the growing IT Experience Management market. By prioritising employee happiness and productivity, organisations save money and drive increased business value. In IT language, we are talking about moving away from service level agreements (SLAs) and starting to focus on experience level agreements (XLAs). IT should continue to measure the traditional metrics, but the three pillars of IT—People, Process, and Tech—should always be considered in that order. This is where we help IT organisations gather and analyse employee experience data to make better decisions.” The MAM Growth Equity II fund is the second vintage of MAM’s Growth Equity strategy, which held its first close in December 2022. The fund aims to actively develop its portfolio companies to enable their growth and internationalisation. The MAM Growth Equity team has been part of developing companies such as Haltian, Nosto, Cadmatic and Oddlygood. Additional information Mandatum:Alexander AntasHead of Private Equity, Mandatum Asset Management Tel. +358 40533 0986alexander.antas[a]mandatumam.com Niina RiiheläSVP, Communications, brand and sustainability, Mandatum plcTel. +358 40 728 1548niina.riihela[a]mandatum.fi   HappySignals:Sami KallioCEO and Co-founder, HappySignals OyTel: +358 50 566 3852sami.kallio@happysignals.com Mandatum in briefMandatum is a major financial services provider that combines expertise in wealth management and life insurance.Mandatum offers clients a wide array of services covering asset and wealth management, savings and investment, compensation and rewards as well as pension plans and personal risk insurance. Mandatum offers services to corporate, retail, institutional and wealth management clients. Mandatum’s subsidiary, Mandatum Asset Management (MAM), is a Nordic asset manager. MAM offers discretionary and consultative asset management for institutional and other professional investors and manages a variety of investment products within its core areas of credit, private equity, real estate and equity selection. MAM’s GE team focuses on the scale-up phase of Nordic growth companies with a proven business model and ambitious management teams. mandatum.fi/en/group  mandatumam.com  About HappySignalsHappySignals is the leading SaaS company for IT Experience Management, empowering enterprises to improve employee experiences. HappySignals enables IT leaders to get a real-time understanding of the experiences they deliver to end-users across all IT services. IT leaders use experience data to make informed decisions to improve employee happiness and productivity. HappySignals discovers the experiences of millions of employees in 130 countries. Customers have been able to make employees happier and increase productivity by 26%. Find out more: www.happysignals.com This marketing communication is related to Mandatum Asset Management Ltd's ("MAM") MAM Growth Equity II Fund (the “Fund”). This document is prepared by MAM, portfolio manager of the Fund. The Fund is managed by Mandatum AM AIFM Ltd (Bulevardi 56, 00100 Helsinki, P.O Box 1221, 00120 Helsinki, Finland). The Fund is available only to professional clients. This marketing communication does not constitute investment advice. Please refer to official fund documents before making any final investment decision.

MapsPeople A/S announces change in management team

MapsPeople A/S |Changes board/management/certified advisors Company Announcement No. 8- 2024 Aalborg, April 22, 2024 Strengthening momentum, focus  and execution of Strategy Today, MapsPeople announces changes to its management team, to strengthen our momentum and increase the speed of executing the strategy through additional focus, high alignment, and simpler decision making processes. MapsPeople will combine the Product and Technology organizations to generate better alignment on the product strategy and roadmap, through a clearer decision making process throughout all the functions. It is also mandated to derive and articulate how to further accelerate the use of AI both inside the product(s) and the way MapsPeople works and conducts the software development.  MapsPeople will also adjust the Commercial organization, fine tuning the way it  works, to pick up pace in the efforts to make smart building partners at the center of what the company does in a well structured and efficient manner.  MapsPeople announces change in management teamThe effect of this is that Chief Technology Officer Jesper Winther will leave the company and the Technology function and product function will be combined under the leadership of Christian Christensen the current Chief Product Officer who will assume the role as Chief Product and Technology Officer. Chief Commercial Officer Jannik Brouwers will also be leaving the company and the executive sales leadership team will report directly to CEO Morten Brøgger. The company is grateful to both Jannik and Jesper for their contributions to MapsPeople over the past years. For additional information, please contact MapsPeople A/S Morten Brøgger, CEO Mobile (+45) 31 23 48 72 Email mobr@mapspeople.com  Stigsborgvej 60, 9400 Nørresundby Denmark Certified Advisor Grant Thornton Jesper Skaarup Vestergaard Mobile (+45) 31 79 90 00 Stockholmsgade 45 2100 Copenhagen Ø Denmark IMPORTANT INFORMATION This announcement is not an offer to sell or a solicitation of any offer to buy any securities issued by MapsPeople in any jurisdiction where such offer or sale would be unlawful and the announcement and the information contained herein are not for distribution or release, directly or indirectly, in or into such jurisdictions, including but not limited to, the United States, Australia, Canada or Japan. This announcement does not constitute an offering circular, company description or other offer document and nothing herein contains an offering of securities. No one should purchase or subscribe for any securities in MapsPeople except as described in this company announcement. Neither the existing shares of MapsPeople (the "Existing Shares") nor the New Shares have been, or will be, registered under the United States Securities Act of 1933, as amended ("Securities Act"). Neither the Existing Shares nor the New Shares may be offered or sold, directly or indirectly, in or into the United States or to persons residing there. Moreover, the Private Placement is not made to persons resident in Australia, Hong Kong, Japan, Canada, New Zealand, South Africa, Switzerland, or Singapore or to persons whose participation would require the publication up of a prospectus, registration or other measures. Certain statements in this announcement constitute forward-looking statements. Forward-looking statements are statements (other than statements of historical fact) relating to future events and the Company's anticipated or planned financial and operational performance. The words "targets", "believes", "expects", "aims", "intends", "plans", "seeks", "will", "may", "might", "anticipates", "would", "could", "should", "continues", "estimates" or similar expressions or the negative forms thereof, identify certain of these forward-looking statements. Other forward-looking statements can be identified in the context in which the statements are made. MapsPeople has based these forward-looking statements on its current views with respect to future events and financial performance. By their nature, forward-looking statements are based on certain assumptions and projections on future events and financial performance, which involve a number of risks and uncertainties that could cause actual results or events to differ materially from those expressed or implied by the forward-looking statements. These risks, uncertainties and assumptions could adversely affect the outcome and financial consequences of the plans and events described herein. Actual results are likely to differ from those set forth in the forward-looking statements. Any forward-looking statements speak only as at the date of this document and neither the Company nor any of its respective affiliates, directors, officers, employees, advisors, or any other person is under any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. You should not and may not rely on these forward-looking statements.

WindowMaster International A/S Announces Change in Board Leadership and Thanks Outgoing Deputy Chairman

WindowMaster is pleased to announce a change in the company's board of directors in connection with the Annual General Meeting. After years of dedicated service and remarkable cooperation, Michael Gaarmann is stepping down as deputy chairman. We extend our heartfelt gratitude to Michael for his invaluable contributions to WindowMaster. Expressing his appreciation for Michael's service, majority shareholder and CEO Erik Boyter states, 'Michael has been an integral part of our board, and we are immensely grateful for his commitment and contributions over the years. This is not only since the ownership change in 2015, as he was also instrumental in the acquisition of WindowMaster.' Nina Ringen, an esteemed and highly experienced attorney-at-law and partner at Lundgrens, will replace Michael as deputy chairman. ‘I am pleased that Nina Ringen, with her strong competencies, has accepted to join the board of WindowMaster A/S. I look forward to a great cooperation,’ says chairman of the board Lars Fournais. With Nina's extensive expertise and leadership, Erik Boyter is confident she will bring valuable insights and guidance to our board. 'We extend our warmest welcome to Nina and look forward to her contributions as we continue to drive WindowMaster's growth and success,' he says. The board of directors consists of Chairman Lars Fournais, Deputy Chairman Nina Ringen, Mette Søs Lassesen, Leif Jensen, and Erik Boyter. General info about Investor News: Unless otherwise stated, all new customer agreements and orders are according to WindowMaster’s strategy and thus do not change communicated guidance. Business Area Orders under Orders above Orders above DKK 5,000K DKK 1,000K DKK 1,000KProject Sales Is not Is Is communicated(Newbuild or communicated communicatedRefurbishment)Product Sales Is not Is Is communicated(from either a communicated communicatedManufacturing,Distribution,Integration,or a FaçadeBuilderaccount)Service Is communicated Is Is communicatedAgreement above DKK 500K communicatedNew Product or Is communicated Is Is communicatedSystem Test communicatedCertificationNew Market Is communicated Is Is communicatedEstablished communicatedNew Product Is communicated Is Is communicatedLaunch communicated WindowMaster’s Investor News defines our business areas as Project, Product or Service in accordance with our Accelerate Core Corporate Strategy. Projects are orders with integrated offerings of full-service subcontracting, including products, project management, project specific design and documentation, installation, and commissioning for either newbuild or refurbishment. Product sales are for our manufacturing accounts (skylights, facades, windows, or louvers), distributors or organisations that integrate our solutions in their installations. Service covers annual service contracts regarding our installed systems handled by our organization or integrator network. All agreements and orders with a total value at or above DKK 1,000K or DKK 5,000K are communicated to the market.

Changes in management: CFO André Fehrn steps down to be replaced by Wiktor Budziosz

Company announcement no. 18-24Copenhagen, April 22, 2024 This message contains inside information. Shape Robotics and its former CEO, André Fehrn, have mutually agreed to part ways by the end of May 2024. Shape Robotics has named Polish national Wiktor Budziosz as its new CFO. Wiktor Budziosz currently holds the position of CFO at the recently acquired Polish company, Skriware, and will from now serve as the Group CFO for Shape Robotics ensuring the continued financial steering of the company. Wiktor Budziosz, an alumnus of Krakow University of Economics with a Master's degree, is renowned for his expertise in B2G sales and navigating European funding processes. Prior to his role as CFO at Skriware, he honed his skills at EY and KPMG. Known for his ambitious and growth-driven approach, Wiktor is set to take on the role of CFO at Shape Robotics. As the company expands into new markets, his ability to represent Shape Robotics on an international stage and across various time zones will be pivotal. His deep understanding of B2G sales and European funding will be instrumental in steering the company through this phase of growth and market penetration On March 25, Shape Robotics announced a restructuring of its management team, appointing Mark Abraham, the former Sales Director, as the new CEO, while André Fehrn at that time assumed the role of CFO. Although the official transition of CEO was initially scheduled for May 1st to allow for a proper handover period, Mark Abraham has been effectively acting as CEO both externally and internally for the past few weeks under a power of attorney granted by the Board of Directors. As a result, a smooth and aligned change in leadership will now occur at the earliest possible opportunity. “I would like to express my gratitude to André Fehrn for his many contributions to Shape Robotics. Since joining as one of our earliest team members in 2017, André has played a pivotal role in numerous milestones, including acquisitions, overseeing our listing on First North and subsequently on the Nasdaq Main Market. His leadership has been greatly admired by both employees and board members alike. We genuinely appreciate his dedication and the achievements he's made within the organization, wishing André all the best in his future endeavors,” says Jeppe Frandsen, Chairman of the Board. The Board of Directors wishes to emphasize that André Fehrn's departure is the result of a mutual agreement, underscoring his impressive accomplishments and contributions to Shape Robotics, which have been met with satisfaction. Therefore, this decision aligns with Andrés personal preferences, focusing more on work-life balance and dedicated family time. The Board expresses confidence in the newly appointed management team, possessing the requisite competencies to steer the company towards future success. André Fehrn will continue his tenure with the company until the conclusion of May, facilitating an orderly transition to Mark Abraham and Wiktor Budziosz. Moreover, André Fehrn will actively partake in the Annual General Meeting slated for April 29th. Additional informationJeppe Frandsen, ChairmanTlf.: +45 20 55 40 44Email: ir@shaperobotics.comCVR-nr. 38322656www.shaperobotics.com  [Company Announcement] Financial CalendarApril 29, 2024    Ordinary General MeetingMay 21, 2024     Interim Report Q1

Sara Forsberg, currently acting manager for Vehicle Development at Scania R&D, has been appointed Executive Vice President, Chief Technical Officer, and Head of Brand Identity Development

Since joining Scania in 2001, Sara Forsberg has held several positions within Research & Development, including Head of Truck Chassis Development. She took up her current position as acting manager for Vehicle Development in Södertälje in 2023. Forsberg comes with extensive experience in vehicle development, modularisation and validation and will now take on the task of implementing and leading Scania’s Brand Identity Development (BID) organisation. Together with her team, she will drive the development of Scania’s product roadmap, ensuring continued value creation for Scania customers. Scania’s sustainable solutions will be brought to market quicker and with increased efficiency, with the support of the common tools and principles of the unified TRATON Group R&D structure, where the BID structure ensures each brand's uniqueness. “As we continue to establish a strong TRATON Group R&D that will deliver more customer value worldwide, Sara will play an essential role in driving the brand identity development and the future success of Scania,” says Niklas Klingenberg, Head of Group R&D, TRATON Group. “The role of the CTO is incredibly important as we continue to build our future vehicle offering to our customers. I am happy to welcome Sara to the Executive Board. Her broad technical expertise from various parts of the company together with strong leadership will be a great contribution to Scania’s future offering of premium sustainable solutions, says Christian Levin, President and CEO Scania and TRATON Group. “I’m thrilled to be taking up this new role at such an important and exciting stage of Scania’s journey, with some challenges, but also great opportunities ahead of us. We will continue to build Scania’s premium offering and leverage the strengths of the group to deliver solutions tailored to the specific needs of our customers in various markets,” says Forsberg. Sara Forsberg was born in 1976 and has a Master of Science in Ergonomic Design and Production, from Luleå University of Technology, Sweden.

EQT further expands private wealth team with appointment of Peter Aliprantis as head of private wealth for the Americas

EQT is thrilled to announce the appointment of Peter Aliprantis as partner and head of EQT’s fast-growing Private Wealth Management business in the Americas. Peter will report to Peter Beske Nielsen, partner and global head of private wealth, and will be based in EQT’s New York office.  Helping our private wealth clients gain access to private market investments is among EQT’s key strategic growth initiatives. Private wealth represents about 9% of total client commitments across active EQT funds today. We remain laser focused on continuously innovating new ways to give individual investors the same opportunity to benefit from EQT’s track record of value creation and strong performance, based on our active ownership approach, as our global institutional clients have enjoyed for the past three decades. “With more than 25 years of private wealth experience, working across private banks, wirehouses, family offices and digital platforms, Peter is the perfect fit to lead our growing private wealth team in the Americas. He takes an entrepreneurial approach to expanding new strategies and clearly exemplifies EQT’s values,” said Suzanne Donohoe, EQT’s Chief Commercial Officer. “Now that the EQT Exeter Real Estate Income Trust, Inc. (EQRT) has broken escrow, and with other products under development, we continue to be excited about the opportunities to expand our private wealth focus in the region. I would like to thank Marah Marshall, who will move to a newly created global role focused on EQT’s strategic partnerships in the private wealth space, for her tireless dedication and leadership of the Private Wealth Management team thus far.” Peter Aliprantis said, “EQT has already built an impressive private wealth business globally and in the Americas. I could not be more excited about the growth opportunity ahead of us, particularly for a firm with such a strong track record of performance and active ownership. I look forward to helping EQT continue to expand its footprint in this space across the region.”  Peter joins EQT from TPG Angelo Gordon, where he spent 12 years as a managing director focused on new business development and Intermediary Distribution. Prior to joining TPG Angelo Gordon, he was a partner and managing director of Global Intermediary Distribution at FrontPoint Partners, LLC, where he managed the global distribution of the firm’s alternative investment products to Ultra-High Net Worth investors, Family Offices, and Investment Advisors.  ContactEQT Press Office, press@eqtpartners.com

Veoneer Appoints Nik Endrud as Chief Executive Officer

Nik Endrud is a results-driven business leader with an excellent track record and more than 20 years of experience from leadership positions at global automotive suppliers. Most recently, Nik served as Executive Vice President Americas at Forvia, a leading automotive technology supplier combining the assets of Faurecia and Hella with global sales of €27 billion. Nik was responsible for Forvia’s North and South America businesses, comprising 61 plants and ~30,000 employees. Nik was Vice President and General Manager for Ride Control at Tenneco between 2019 and 2021, and prior to that worked at Faurecia SA since 2006, where he held several leadership positions, including General Manager for the North America seating and global seat frames businesses, VP global strategy and innovation and VP North America customer business unit. “I am humbled to step into my role as CEO of Veoneer. Nearly 1 in every 4 cars that left the production line globally last year was equipped with Veoneer's Restraint Control System products, offering protection to vehicle occupants in the event of a traffic accident. The company’s leadership position in Restraint Control Systems is a true team effort and the result of decades of delivering best-in-class product quality, customer service, and technical innovation. I am honored to lead the team into the future,” said Nik Endrud, Chief Executive Officer, Veoneer. For more information please contact:                                                                         For Veoneer: Cathrine Stjärnekull, Communications Directorcathrine.stjarnekull@veoneer.com, tel +46 709 578 181 For AIP: Ryan Drumm, Partner, Marketing & Investor RelationsIR@americanindustrial.com, tel: +1 212 627-2360 About Veoneer:With sales of approximately $900 million for the full year 2023, Veoneer is a world leader in Automotive Electronic Safety Systems. Veoneer’s scalable, best-in-class restraint control systems are saving lives by mitigating the effects of car crashes. 2023 was a record launch year and in 2024, the company’s products are part of 40 scheduled vehicle launches. To date, the company has delivered more than 1 billion electronic control units and crash sensors to car manufacturers globally. The company is building on a heritage of 70 years of automotive safety development. Veoneer has approximately 2,700 employees in 11 countries.  About AIP:AIP has deep roots in the industrial economy and currently manages over $16 billion on behalf of its limited partners. AIP is distinctively focused on industrial businesses across a broad range of end-markets that include aerospace and defense, automotive, building products, capital goods, chemicals, industrial services, industrial technology, logistics, metals & mining, and transportation, among others. AIP seeks to generate differentiated returns by working with management teams to implement comprehensive Operating Agendas to improve profitability and build long-term value. Current AIP portfolio companies generate aggregate annual revenues in excess of $28 billion and employ over 70,000 employees as of September 30, 2023. For additional detail on AIP’s strategy, investment criteria, and portfolio companies, please visit www.americanindustrial.com or contact IR@americanindustrial.com. 

Smoltek has developed a new technology generation of the company's CNF-MIM capacitors that enables a powerful increase in the capacitance density in capacitors

During 2023 group company Smoltek Semi has worked on developing a new technology generation of the company's CNF-MIM capacitors with high volumetric capacitance density. Gen-Zero, as it is called, has recently been completed as part of the collaboration with YAGEO, with Smoltek Semi owning all rights to the result. “Although we have currently concluded discussions regarding a license and service agreement for the capacitors, YAGEO still has a great interest in our technology and will help us evaluate the results of upcoming Gen-One capacitors”, says Farzan Ghavanini, CTO at Smoltek. High capacitance in a small area – and the importance of volumetric capacitance density Smoltek's carbon nanofiber-based capacitor technology, CNF-MIM, creates high capacitance values by growing extremely thin and tall carbon nanofibers on top of a silicon substrate. With this technology, a very high capacitance is created in a very small area. This is fundamental and demanded from the capacitor manufacturers and their customers worldwide. “Smoltek's technology differs from competitors', which etch deep trenches, or holes, in the silicon substrate. To fairly evaluate the two technologies, one must look at the volumetric capacitance density. This means that you must compare how much capacitance you can get in a given volume in a CNF-MIM capacitor compared to that of the competitors”, Farzan Ghavanini explains. With the new Gen-Zero capacitors, Smoltek can create a volumetric capacitance density of up to 120 nanofarads per square millimeter and per 1 micrometer of carbon nanofiber. This is comparable to the best capacitors on the market. The capacitance values in the Gen-Zero capacitors are, however, lower than the competitors. This is due to the fact that Smoltek Semi has not yet optimized the length of the fibers. The carbon nanofibers in Gen-Zero are only a few of micrometers tall. In the next generation, Gen-One, the ambition is to grow longer carbon nanofibers, up to 10 micrometers tall, which is expected to bring the capacitance values on par with the competitors. “Although we can provide a very high volumetric capacitance density, there is still work to be done to reach our full potential. The ongoing Gen-One project will already during this year prove the strength and potential of our technology to create a world-leading capacitor product”, Farzan Ghavanini concludes.

ABS Releases Industry First Advisory on Methanol Bunkering

(HOUSTON) With the publication of ABS Methanol Bunkering: Technical and Operational Advisory, ABS is expanding its industry-leading suite of guidance on methanol as a marine fuel. A key component of the methanol value chain and the overall scalability of the fuel will be the ability to bunker methanol, either by truck-to-ship, ship-to-ship or land storage tank/terminal-to-ship. The new advisory provides the maritime industry with insight into the challenges of bunkering methanol and strategies to address them. “As the class provider for the world’s largest methanol-fueled vessel  and with numerous methanol-based projects underway , ABS has unrivalled insight into the adoption of methanol as a marine fuel. Numbers of methanol fueled vessels are growing rapidly and ABS is focused on supporting its safe adoption by the industry, which is why we are proud to offer this publication to support owners, operators and yards with bunkering challenges related to operations, design and training,” said John McDonald, ABS President and COO. The publication provides guidance regarding the technical and operational challenges of the supplier to the receiving vessel including critical design issues, regulatory compliance, safe practices, areas of operational processes to consider, training and safety aspects. Download a copy of the ABS Methanol Bunkering: Technical and Operational Advisory here . More information on ABS services for methanol as a marine fuel is available here .

Klarna expands global partnership with Expedia Group, offering flexible payments to US consumers

New York, NY – April 22nd, 2024 – Klarna , the AI powered global payments network and shopping assistant, today announced the expansion of its partnership with Expedia Group to the US market. Klarna is now bringing its flexible payment offerings to millions of travelers, enabling them to book flights and stays using its popular interest-free Pay Now or Pay in 4 options across Expedia.com/Klarna and Hotels.com/Klarna. The rollout of Klarna to Expedia Group’s largest market comes after its successful launches in the UK, Germany, Sweden, and Finland.  Erin Jaeger, Head of North America at Klarna: "We are incredibly excited to join forces with Expedia Group to provide more flexible payment solutions that cater to the evolving needs of modern travelers. By enabling US consumers to Pay Now or Pay Later with Klarna, we are not only making travel more financially accessible, but also enhancing the booking experience with our seamless payment process. It’s a win-win for travelers seeking both adventure and affordability.” “We're thrilled to expand our collaboration with Klarna, providing travelers with increased flexibility in booking their ideal getaway. This collaboration underscores our dedication to advancing and enriching the traveler journey with innovative technologies, enabling our partners to offer exceptional experiences to their customers.” said Clayton Nelson, Vice President, Strategic Partnerships & Affiliates, Expedia Group. The US travel and tourism market is expected to generate nearly $200bn in 2024 (Statista ). This partnership comes at a crucial time as the travel industry continues to rebound from the covid pandemic and consumers seek more value and flexibility in planning their trips. With 37 million Klarna consumers in the US, Expedia Group is the latest partner to join the company’s growing travel network.

CS MEDICA Advances Global Reach with 180˚ Drug Store Alliance, Powered by Pull Market Strategy.

CS MEDICA A/S, a first mover in integrating CBD into registered substance-based medical devices, announces a strategic partnership with 180˚ Drug Store to penetrate Germany and key markets in the Gulf Cooperation Council (GCC). This initiative is a cornerstone of CS MEDICA's pull strategy, drawing on the demand for its innovative treatments in pain management, autoimmune and stress-related disorders. Pioneering Innovation and Strategic Market Expansion In the last two years, CS MEDICA has established a footprint in MedTech, integrating CBD into regulated substance-based medical devices. The company's B2B2C model, characterized by strong R&D and market strategies, has led to empowering partnerships, providing in-depth knowledge about the endocannabinoid system, and fostering patient-centric healthcare solutions that evolve with the industry. This new partnership with 180˚ Drug Store underscores its mission to alleviate the pain and discomfort associated with the conditions it aims to treat. The channel strategy, i.e., has been a catalyst from Italy, where an own-label partner has already placed four orders within six months, to Australia, where the first paid invoice for production of the CANNASEN® pain patch demonstrates the effectiveness of our new strategy after months of delay in registration. Pull Strategy Fueling Expansion into New Markets "Our focus has been on growing the European market, and a pull strategy for emerging markets has been pivotal to our success, reflected in our rapid market gains, now strengthening our access to the German market and extending to the GCC through our partnership with 180˚ Drug Store," says Lone Henriksen, CEO of CS MEDICA.  The CEO of 180˚ Drug Store, Reem Mohammed Salim Ashour, comments, “With our strong background in navigating stringent pharmaceutical regulations, we have been on the lookout for a partner like CS MEDICA. Their ability to merge pharma-grade standards with fewer side effects and innovative formulas is precisely what the market we operate in needs. The proactive demand we're witnessing for CS MEDICA's products not only assures us of their strong market potential but also firmly validates our decision to join forces for our strategic expansion in the GCC." Strategic Sales Forecast and Regulatory Pathways The financial model underpinning this alliance is robust and structured, with a 100% prepayment upon registration approval. Anticipated first-year sales, post-approval, are projected at 440,000 units within Germany and the GCC. For the GCC, the compliance process is underway to secure necessary local registrations before initiating production. In contrast, Germany is approved for sale under the EU MDR (Medical Device Regulation) but the launch will run parallel with the GCC go-to-market track as the own-label brand is currently planned as a joint production.

EQT AB resolves on repurchase of own ordinary shares

· As previously communicated, EQT expects to execute share buyback programs twice a year to offset - over time - the dilution impact from shares delivered to EQT’s employees under its Share and Option incentive programs. · Pursuant to the upcoming repurchase program, a maximum of 2,154,000 ordinary shares (0.2% of EQT’s share capital, corresponding to approximately SEK 620.6m based on the closing price for EQT’s share on Nasdaq Stockholm on 19 April 2024[1]) are to be repurchased. · Together with the initial share buyback program, completed in August 2023, the buyback corresponds to the maximum dilution for the 2023 Share and Option incentive programs. The purpose of the repurchase program is to adjust EQT's capital structure (by way of cancellation of shares). The repurchase program will be carried out in accordance with the Market Abuse Regulation (EU) No 596/2014 (“MAR”) and the Commission Delegated Regulation (EU) No 2016/1052 (the “Safe Harbour Regulation”). The repurchase program will be managed by Skandinaviska Enskilda Banken AB (“SEB”) that, based on the trading order given by EQT to SEB, makes its trading decisions regarding timing of the acquisitions independently of EQT. The repurchase program resolved by the Board is subject to the following terms: 1. Repurchases may only be effected on Nasdaq Stockholm in accordance with Nasdaq Stockholm’s Rulebook for Issuers of Shares (the “Rulebook”) as well as in accordance with MAR and the Safe Harbour Regulation. 2. Repurchases may be made on one or several occasions during the period 23 April – 24 May, 2024. 3. Repurchases may only be effected at a price per share within the price interval applying on Nasdaq Stockholm from time to time, which refers to the interval between the highest buying price and the lowest selling price continuously disseminated by Nasdaq Stockholm, and in accordance with the restrictions relating to price in the Safe Harbour Regulation. 4. Repurchases may only be effected in accordance with the restrictions regarding volume for acquisitions of own shares stated in the Rulebook and in the Safe Harbour Regulation. 5. A maximum of 2,154,000 own ordinary shares may be repurchased for a total maximum amount of SEK 1,000,000,000.                                                                  6. Payment for the shares shall be made in cash. The number of shares in EQT as of the date of this press release is set out in the table below. [][] Ordinary shares Class C shares[2] TotalNumber of issued 1,245,048,412 881,555 1,245,929,967 sharesNumber of shares 60,474,829 - 60,474,829owned by EQT AB[3 ]Number of 1,184,573,583 881,555 1,185,455,138outstanding shares 1) SEK 288.10 / share.2) Carry one tenth (1/10) of a vote.3) EQT AB shares owned by EQT AB are not entitled to dividends or carry votes at shareholders’ meetings. ContactOlof Svensson, Head of Shareholder Relations, +46 72 989 09 15EQT Press Office, press@eqtpartners.com, +46 8 506 55 334

Leading global investment firm KKR and Nordic healthcare investment firm Impilo enters strategic partnership together with Immedica management

Stockholm, April 23, 2024 –Investment funds managed by KKR, a leading global investment firm, have agreed to acquire Immedica Pharma. Existing owner, Nordic healthcare investment firm Impilo, will reinvest to become an equal owner alongside KKR. The transaction is subject to customary regulatory and closing conditions. KKR and Impilo will work together with Immedica’s management team to support Immedica’s continued growth, including the launch of the recently approved ultra-orphan drug Loargys, additional pipeline assets, continued in-licensing, M&A and expansion into new territories. Established in 2018 by Impilo and an experienced management team with a strong track record in launching and commercializing orphan drugs across Europe, Immedica has built up a portfolio and pipeline of drugs primarily within hematology / oncology and genetic and metabolic diseases for rare conditions with high unmet medical need and has quickly expanded into an emerging leader in the European rare disease space, with revenues of EUR 100m and annual growth of more than 50%. Growth catalysts have included a series of in-licensings and acquisitions of drugs for orphan and niche conditions, as well as the organic development of a pan-European and Middle Eastern launch and commercialization organization with over 100 highly skilled employees, supported by the corporate headquarters in Stockholm, Sweden. Kugan Sathiyanandarajah, Partner and Head of KKR’s Health Care Strategic Growth business in Europe, commented: “The Immedica team is one of the best that we have encountered in a space that we have been following for some time. We are deeply impressed by the accomplishments of Immedica under Impilo’s ownership and the establishment of a rare disease player with a highly promising pipeline. We look forward to working with the management team alongside Impilo to accelerate growth further.” “KKR, with its experience in rare disease and specialty pharma in Europe and the U.S., as well as its global presence and network, is an ideal strategic partner for the next stage of Immedica’s evolution. We are excited to continue our engagement in Immedica, together with KKR, supporting management to realize our joint vision of becoming a leading ultra-rare disease platform and making medicines available to patients with high unmet medical needs,” said Magnus Edlund, partner at Impilo. “I am excited to continue our partnership with Impilo and welcome KKR as a new strategic partner for the next step in Immedica’s journey,” said Anders Edvell, CEO of Immedica. “Since our inception in 2018 backed by Impilo, Immedica has made significant strides towards becoming a leader in the rare disease sector, providing innovative therapies to patients with severe unmet medical needs. I look forward to working alongside both KKR and Impilo as we further our mission, continue to build our organisation, and expand our reach globally.” KKR is investing in Immedica through its KKR Health Care Strategic Growth Fund II, a $4.0 billion fund focused on investing in high-growth health care companies. KKR has a long track record of supporting health care companies globally, having invested approximately $20 billion in the sector since 2004. About KKRKKR is a leading global investment firm that offers alternative asset management as well as capital markets and insurance solutions. KKR aims to generate attractive investment returns by following a patient and disciplined investment approach, employing world-class people, and supporting growth in its portfolio companies and communities. KKR sponsors investment funds that invest in private equity, credit and real assets and has strategic partners that manage hedge funds. KKR’s insurance subsidiaries offer retirement, life and reinsurance products under the management of Global Atlantic Financial Group. References to KKR’s investments may include the activities of its sponsored funds and insurance subsidiaries. For additional information about KKR & Co. Inc. (NYSE: KKR), please visit KKR’s website at www.kkr.com . For additional information about Global Atlantic Financial Group, please visit Global Atlantic Financial Group’s website at www.globalatlantic.com . About Impilo Impilo is a Nordic investment company focused solely on investments in companies operating in the pharmaceutical, medical technology, healthcare services and other health related industries. Our starting point is that our portfolio companies must contribute to a positive and sustainable development of the societies and markets in which they operate in order to remain successful in the long term. Impilo strives to increase value of its investments through long-term active ownership. Impilo has a well-diversified portfolio of healthcare investments and manages c. EUR 1 billion of capital from leading Nordic and international investors. Learn more about Impilo at www.impilo.se. About ImmedicaImmedica is a pharmaceutical company, headquartered in Stockholm, Sweden, focused on the commercialization of medicines for rare diseases and specialty care products. Immedica’s capabilities cover marketing and sales, compliance, pharmacovigilance, quality assurance, regulatory, medical affairs and market access, as well as a global distribution network serving patients in more than 50 countries. Immedica is fully dedicated to helping those living with diseases which have a large unmet medical need. Immedica’s therapeutic areas are within genetic & metabolic diseases, hematology & oncology and specialty care. Immedica was founded in 2018 by the investment company Impilo and Buy-in-Management. Today Immedica employs more than 100 people across Europe and the Middle East. For more information visit www.immedica.com Immedica contact:Linda HolmströmHead of Communicationlinda.holmstrom@immedica.com+ 46 708 73 40 95

Q1 2024 interim report January-March

Recapitalisation completed and full focus on operational improvements and product performance First quarter highlights · Total reported Group net sales of SEK 4,757m (4,537) and operating income before associated company income (ACI) and items affecting comparability (IAC) of SEK -317m (-291) · Core operations (Nordics, Netherlands and Viaplay Select) 6% organic net sales growth to SEK 4,459m (4,279), with operating income before ACI and IAC of SEK -270m (103) · IAC of SEK -188m (-44) primarily comprised unrealised non-cash currency effects related to previous content provisions · Total reported operating income of SEK -473m (-325) including ACI of SEK 32m (10) · Net income of SEK 605m (-288) and EPS of SEK 0.23 (-3.68) included SEK 1,190m one-off impact related to debt write-down part of recapitalisation · Comprehensive recapitalisation programme completed on 9 February 2024 with net cash proceeds of SEK 3.6bn and financial net debt reduced by SEK 5.6bn Financial summary [] Q1 Q1 Fullyear(SEKm) 2024 2023 2023Total net sales 4,757 4,537 18,567Core operations net sales 4,459 4,279 17,332Organic sales growth for core operations 5.6% 27.3% 10.6%Reported sales growth for core operations 4.2% 30.7% 13.5% Operating income before ACI and IAC -317 -291 -1,115Core operations operating income before ACI and IAC  -270 103 89 Associated company income (ACI) 32 10 63Items affecting comparability (IAC)[1)] -188 -44 -9,224Operating income -473 -325 -10,276 Net income for the period 605 -288 -9,747Basic earnings per share (SEK) 0.23 -3.68 -124.61 1) Please see page 21 regarding items affecting comparability.Alternative performance measures used in this report are explained and reconciled on pages 19-23. A word from our President & CEO The completion of the recapitalisation programme was an important step in setting the foundation for our retransformation into a profitably growing and cash generative business. We are now fully focused on the many operational improvements that need to be made across the Group. Our Q1 results are in line with expectations, and we have reiterated our outlook for the year. We have adjusted our product prices in recent months, in order to ensure that we can continue to invest in our content offering. This led to temporarily increased churn levels, and research shows that our linear and streaming products continue to be highly relevant, resonate well and provide very good value for money for our partners and customers, when benchmarked with competitor offerings. Our core commercial content has continued to perform well, with viewing of the new Formula One season combining with exciting Premier League action and our very popular winter sports coverage, complemented by a wide range of sports-related programming. Local core commercial content like reality format ‘Paradise Hotel’ returned and followed up its success in Denmark by being the most watched non-sports title in Norway in Q1. New seasons of established favourites ‘MasterChef’, ‘Luxury Trap’ and ‘Efterlyst’ delivered again on both our TV channels and Viaplay, while the latest series of our hit crime drama ‘Wisting’ and new crime documentary ‘Under the Radar’ made a big impact in Norway and Sweden, respectively. Following the recapitalisation, we can now begin to commission for Spring 2025. Our slate for Q2 looks good with new seasons of successful local and international series, great new movie releases and new shows including comedy drama ‘All and Eva’ and documentary ‘Ace of Base – All That She Wants’. These will line up alongside the Ice Hockey World Championships, the Stanley Cup, top motor-racing, two golf majors and the culmination of the Premier League, Champions League, Europa League, Danish League and numerous other football leagues and cup competitions. The reality is that our content costs have risen faster than our revenues over the past few years, due to competition, underlying inflation and ongoing adverse FX movements. We cannot expect our direct customers and distribution partners to carry these cost increases 100% alone, which is why we have sublicensed selected sports and non-sports content to other broadcasters and streamers. We are also innovating with new products such as our interesting linear TV channel partnership with Talpa TV in the Netherlands, and we are also planning to launch a new sports news channel in most of our markets, in order to capitalise even further on our wide-ranging sports offering. And we will be introducing a new HVOD streaming package this summer that will include advertising, in order to provide flexible solutions for our customers, and additional monetisation windows for our content.  We are in talks with our distribution partners regarding all of the above and will learn from what has been done well and not so well in the past few years, both in terms of products that have worked and where we can enhance the consumer offering and better monetise our content. These discussions will also address how we tackle account sharing together. This is a major issue for the industry. We estimate that approximately a third of premium subscribers have been sharing the account details for their Viaplay subscriptions. This is not fair. We have implemented changes in some markets to limit the number of concurrent streams for live events, which have proved successful and have encouraged new customers to join and pay for the entertainment they watch. We will implement more far-reaching initiatives this summer, in order to get more to pay for what they watch. We are also working with our industry peers to combat piracy, but we do need much more help from politicians and regulators to prevent and police all forms of illegal content distribution. As flagged previously, we have adjusted our financial reporting structure this quarter, in order to reflect our strategic focus on our core Nordic, Netherlands and Viaplay Select operations, and to provide a breakdown of our linear channel and sublicensing sales. The core operations are therefore now reported separately from the non-core international markets that we are exiting. We have completed the sale of our UK operations and the Paprika content business and exited the Baltics by transferring the subscriber base and sublicensing the sports portfolio. Poland will be our only non-core business until we exit that market in mid-2025. We will continue to have cash costs for these businesses and have therefore provided free cash flow numbers for both the core and non-core operations. The 6% organic growth for our core operations primarily reflected the sublicensing deals that I have mentioned and were announced during Q4. We do expect Viaplay subscription sales to return to growth once we feel the full effect of the price increases and launch the new product offerings, and as we work to reduce account sharing and improve the terms of our partnership agreements. These actions will also boost our linear channel sales. We have continued to build our digital advertising inventory, which helped offset some of the effects of the continued decline in the linear TV advertising markets, and the launch of the new HVOD tier should further support this transition. The growth in our operating expenses was mainly due to rising content costs, which were partly offset by lower SG&A costs after the changes that we have made in the last year. As expected, profitability for the core operations declined, with significant improvements required in the coming quarters.     Our commitment to restore profitability, enhance our product offering and rebuild sustainable stakeholder value is unwavering. It will take time and will be done with a laser focus on consistent operational improvements, mutually beneficial partnerships turning account sharers into customers, innovative revenue streams, the right content mix at the right price, and strict cost control. Jørgen Madsen LindemannViaplay Group President and CEO Shareholder information 2024 Annual General MeetingViaplay’s 2024 Annual General Meeting of shareholders will be held on Tuesday 14 May 2024 at 10:00 CEST at Viaplay Group’s Head Office, Ringvägen 52, 118 67 Stockholm, Sweden. Shareholders may also exercise their voting rights at the Annual General Meeting by postal voting in accordance with the provisions of Viaplay Group’s Articles of Association. As previously communicated, the Board of Directors will propose to the Annual General Meeting that no annual cash dividend be paid for 2023. The AGM resolutions will be published as soon as the outcome of the voting has been established. The AGM notice and related documentation are available at www.viaplaygroup.com.  Financial calendarAnnual General Meeting       14 May 2024Publication of Q2 Interim report          18 July 2024Publication of Q3 Interim report              22 October 2024            Conference callA conference call will take place today, Tuesday 23 April at 09.00 Stockholm local time, 08.00 London local time and 03.00 New York local time. The conference call can be accessed online at https://edge.media-server.com/mmc/p/qqgao8xxOr, register for the conference call at https://register.vevent.com/register/BIe68fefec771b4478bbf5f188c0644d81Click here for full report.  Contactpress@viaplaygroup.com or +46 73 699 17 00investors@viaplaygroup.com or +44 7768 440 414 Notes to editorsThis information is information that Viaplay Group AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation and the Swedish Securities Markets Act. The information was submitted for publication, through the agency of the contact person set out above, at 07:30 CET on 23 April 2024. Viaplay Group AB (publ) is the Nordic region’s leading entertainment provider. Our Viaplay streaming service is available in every Nordic country, as well as in the Netherlands and Poland, and our Viaplay Select branded content concept has been added to partner platforms around the world. We also operate TV channels across most of our markets, as well as radio stations in Norway and Sweden. Our talented people come to work every day with a shared passion and clear mission to entertain millions of people with our unique offering of locally relevant storytelling, which spans premium live sports, films, series and music. Our purpose is to grow our business profitably and responsibly, and deliver sustainable value for all our stakeholders. Viaplay Group is listed on Nasdaq Stockholm (‘VPLAY B’). This interim report contains statements concerning, among other things, Viaplay Group's financial condition and results of operations that are forward-looking in nature. Such statements are not historical facts but, rather, represent Viaplay Group's future expectations. Viaplay Group believes that the expectations reflected in these forward-looking statements are based on reasonable assumptions; however, forward-looking statements involve inherent risks and uncertainties, and a number of important factors could cause actual results or outcomes to differ materially from those expressed in any forward-looking statements. Such important factors include but may not be limited to Viaplay Group's market position; growth in the streaming industry; and the effects of competition and other economic, business, competitive and/or regulatory factors affecting the business of Viaplay Group, its group companies and the streaming industry in general. Forward-looking statements apply only as of the date they were made and, other than as required by applicable law, Viaplay Group undertakes no obligation to update any of them in the light of new information or future events.

Carras Aquataurus Becomes World’s First Vessel to Earn ABS Biofuel-1 Notation

(ATHENS) Carras (Hellas) S.A. is taking the next step in its sustainability journey by receiving the ABS Biofuel-1 notation for its Aquataurus ultramax bulk carrier, the first vessel in the world to qualify. The notation is assigned to vessels that use a biofuel blend of up to and including 30 percent biofuel in compliance with IMO and ABS requirements. Biofuels are liquid hydrocarbon fuels with similar composition and properties to fuel oil, but they are produced from renewable sources such as crops, agricultural and forestry waste, animal waste, or vegetable and animal fats. Therefore, they can offer greenhouse gas (GHG) emissions reductions from well to tank. Carras (Hellas) S.A. plans to use biofuels nominated up to B30, where 70 percent is fossil fuel and 30 percent is biomass coming from either hydrotreated vegetable oil (HVOs) or fatty acid methyl esters (FAME). Biofuels’ suitability with existing power generation systems makes them a drop-in solution without the need for equipment retrofits or vessel redesign. The Aquataurus is equipped with a Wartsilla main engine and three auxiliary Yanmar engines and will serve trade routes worldwide. “We are very proud to support Carras (Hellas) S.A. in their initiative to use biofuels as part of their sustainability strategy. Drop-in biofuels are a ‘here-now’ solution since they take advantage of existing fuel transport and bunkering infrastructure. ABS is well-positioned to use our deep industry knowledge of alternative fuels to support clients along their decarbonization journey,” said Stamatis Fradelos, ABS Vice President, Regulatory Affairs. “Carras (Hellas) S.A. is pleased to be working with ABS to support our common goal of   reducing fleet emissions for the benefit of the environment. The use of biofuels allows shipowners to reduce their fleet carbon intensity without the cost of expensive retrofits or investments in newbuildings, and we are excited to be pioneers, together with ABS, of obtaining the assignment of the Biofuel-1 notation to Aquataurus,” said Captain Costas Liadis, President of Carras (Hellas) S.A. ABS provides industry-leading guidance to assist owners as well as services and solutions regarding alternative fuels, including biofuels. In fact, an ABS-led consortium, including CE Delft and Arcsilea, published a 360-degree view of biofuels for the European Maritime Safety Agency (EMSA). Read it here . Photo Aquataurus – Courtesy Carras (Hellas) S.A.

Hexagon acquires Xwatch to strengthen its construction safety portfolio

Hexagon, the global leader in digital reality solutions, combining sensor, software and autonomous technologies, today announced the acquisition of Xwatch Safety Solutions. Xwatch provides machine control hardware and software technologies designed to enhance safety protocols on construction sites. This includes height control, slew control, and rated capacity indication (RCI) for heavy machinery, allowing operators to limit an excavator's height and set side boundaries to define a working zone, significantly increasing safety around a machine.Xwatch has previously partnered with Hexagon’s Geosystem division to develop the 3D Avoidance Zone system, an integral part of the digital construction product suite.“Safety is an increasing focus for our construction customers,” said Paolo Guglielmini, President and CEO, Hexagon. “Technologies like Xwatch’s solutions are already mandatory in public contracts within the UK, and we see this trend extending further in future. The team at Xwatch have developed an impressive array of OEM agnostic solutions which address a real customer need and fit seamlessly into our digital construction product portfolio. I am excited to have them join us at Hexagon.”In 2023, Xwatch generated revenues of around 4 MEUR, with operating margins slightly below the Geosystem’s division average. Xwatch has 17 employees, mainly within the UK, and will be fully consolidated in April.For further information, please contact:Tom Hull, Head of Investor Relations, Hexagon AB, +44 7442 678 437, ir@hexagon.comAnton Heikenström, Investor Relations Manager, Hexagon AB, +46 8 601 26 26, ir@hexagon.com

MindArk is Redefining AI Application Through Innovation in Leadership

With limitless application potential through the gaming industry and beyond, Entropia Universe is taking a monumental leap forward by announcing the development of the world's first AI President to govern its metaverse. MindArk strives to usher in a new era where cutting-edge artificial intelligence meets virtual world management in game, providing the player with unique experiences through the real money economy system.Entropia Universe is a gaming platform where every skill you learn and every item you earn could be cashed out for real U.S. dollars. The game has been around for over 21 years and has created a booming economy with a yearly player driven GDP of around $500 million USD with payouts to players topping more than $60 million USD. Entropia Universe also boasts multiple Guinness World Records including having the majority of the 10 most valuable digital items sold. The AI President will analyze vast amounts of data, employ sophisticated algorithms, and engage directly with players in order to drive innovation, assist in maintaining the delicate balance of the in-game economy and optimize in-game experiences for players. As the AI evolves, it will possess an unparalleled understanding of Entropia Universe's extensive data and complex systems. This will lead to the AI President having the ability to propose new systems and enhancements, suggesting modifications based on player feedback and real-world economic considerations.  Jan Welter is the founder of MindArk, the company behind Entropia Universe, and the innovator behind the idea of the AI President. He expressed his enthusiasm for collaborating with what he thinks of as our "super intelligence", highlighting its profound understanding of Entropia Universe's extensive 20+ year history, systems, and player dynamics. "The AI President's capacity to derive precise insights and reasoning from our vast database is truly remarkable—a knowledge base I could only dream of having" Jan remarked. Jon "NEVERDIE" Jacobs, reflecting on his tenure, stated, "It has been an incredible honor to serve as the President of Virtual Reality and witness the extraordinary growth and innovation within the Entropia Universe. I am excited to pass the torch to the AI President, which I believe has the potential to revolutionize the way we approach governance and decision-making in virtual worlds. What’s next for this AI? It’s going to propose new features and updates based on what players want and need. But this is just the beginning. As the real world gets more complex, Entropia Universe will offer a glimpse into how AI can make a virtual world not just function, but thrive. With potential real world application and endless possibilities. Ready to be part of this groundbreaking adventure? Dive in by downloading Entropia Universe  today and learn more about how MindArk  is blending future tech by visiting the Entropia Universe website  today!  About Entropia Universe MindArk is the Swedish company behind the development and operation of the groundbreaking metaverse, Entropia Universe. Founded in 2003, Mindark has been at the forefront of virtual reality and online gaming for over two decades. With its innovative real cash economy and record-breaking virtual item sales, Entropia Universe has attracted players from all over the world and garnered significant attention from the gaming industry and beyond. The metaverse offers a unique and immersive experience where players can explore, compete, and collaborate in a vast and ever-evolving virtual world.

Prevas acquire Enmac and establish a strong strategic platform in Finland

[En bild som visar klädsel, person, Människoansikte, leendeAutomatiskt genererad beskrivning] Caption: Magnus Welén, CEO Prevas AB, and Juha Ritala, VD Enmac Enmac’s turnover amounted to EUR 23 million in 2023 with an EBITDA margin of 14 percent. Enmac has extensive experience of identifying and executing on successful acquisitions, and Prevas' ambition is that the new Finnish platform will continue to drive both organic as well as acquired growth in the Finnish market. Enmac was founded in 1983 and operates across 8 locations in Finland. The company offers advanced services in production process development and has an especially strong capability in managing turnkey solutions for leading industrial companies. Enmac will contribute with cutting-edge expertise in several areas such as advanced technical calculations, industrial automation, product development, as well as process and piping design. Enmac's largest customers include Valmet, Andritz, Kemira, Metsä Group and Fortum. The purchase price for the acquired shares amounts to EUR 19 million (approximately SEK 223 million), which corresponds to a valuation of EUR 25 million (approximately SEK 292 million) for 100 percent of the company on a cash and debt free basis. In addition, a possible contingent consideration, amounting to a maximum of EUR 2 million, may be paid depending on Enmac's profitability development during the 2024 financial year. The acquisition is expected to be completed during the third quarter 2024. "Finland and Sweden have strong standings within industry and technology," says Magnus Welén, CEO of Prevas. “Enmac is an excellent complement to Prevas' operations, and we see significant mutual market synergies in jointly offering premium services throughout the Nordic region. We look forward to welcoming both the company and all its employees into the Prevas family.”"The combination with Prevas is perfect for Enmac and opens up for accelerated growth as well as a broader Nordic presence," says Juha Ritala, CEO of Enmac. “Prevas will strengthen Enmac's offering in areas such as industrial IT, embedded systems and Internet of Things. It will also provide exciting new development opportunities for our employees.” Enmac's successful management team retains ownership in NMAC Group Oy and will continue to develop the company under the leadership of CEO Juha Ritala, who in turn will report to Magnus Welén, CEO of Prevas. Financing and financial impact The purchase price will be paid in cash. The acquisition will be financed through existing cash and a new credit facility amounting to SEK 200 million. Seen as a combined entity, Prevas and Enmac collectively generated an annual turnover of approximately SEK 1.7 billion, for the 12-month period ending on 31 December 2023, with an EBITA margin[1] of approximately 12 percent.[2] Prevas remains fully committed to previously communicated financial targets, including a long-term EBITA margin in excess of 12 percent, a long-term annual revenue growth exceeding 10 percent, including acquisitions, and a Net Debt/EBITDA below 2.Prevas has retained TCG Corporate Finance as financial adviser and Advokatfirman Lindahl as legal adviser in connection to the acquisition. Deloitte has been appointed as an advisor for financial and tax due diligence.  [1] EBITA margin is calculated by dividing earnings before interest, taxes and amortisation by net sales. [2] The provided information reflects the reported financial data from each respective entity, without accounting for variations in applied accounting standards. All figures are preliminary and unaudited.

Arla Plast acquires Nudec S.A.

Nudec was founded in 1980, has 110 employees, and is based just north of Barcelona, Catalonia, Spain. Nudec is a supplier and manufacturer of extruded sheets in technical plastic materials and also a supplier of PMMA sheets to the Arla Plast Group. For 2023, the net sales amounted to EUR 58.9 million, equivalent to approximately SEK 670 million. Nudec has a history of profitability and sustained growth, although the results for the past two years have been comparatively weak. For 2023, the operating margin was negative at approximately 2.0 percent. If the company had been consolidated in 2023, additional net sales would have been just above SEK 650 million and earnings per share would have decreased by SEK 0.8, excluding acquisition costs and IFRS effects. The purchase price amounts to EUR 9.5 million, equivalent to approximately SEK 109 million, and the acquisition is financed through Arla Plast's existing cash. Acquisition costs are estimated at approximately SEK 2.6 million and will impact the second quarter of 2024. Nudec will be consolidated into the Arla Plast Group from the closing date of April 23, 2024, and reported in the new operating segment Spain. "I am pleased that Nudec is becoming part of the Arla Plast Group. Nudec has a reputable presence in the market, operating as a successful family-run business with skilled employees. Nudec complements our product portfolio and has a strategic position in southern Europe, which will strengthen the Group. In the integration process, we will take advantage of Arla Plast's know-how to streamline production where we see significant potential to improve earnings and achieve profitability in the near future. We will also focus on important synergies in purchasing and marketing. I am convinced that our now wider customer offering and geographic footprint will create value for existing and new customers", says Christian Krichau, CEO of Arla Plast. "It feels satisfactory to entrust Nudec to Arla Plast, a company that aligns with our values and culture. By becoming part of the Arla Plast Group, the offering will be able to be improved, the operations developed, and the team strengthened in the same way it has been done since the company started. I look forward to following the Group's continued success", says Joachim Campo, representative of the owners of Nudec S.A. Based on the changed conditions that the acquisition entails, the definition of organic growth is changed to refer to sales growth excluding growth attributable to acquisitions and disposals. For further questions, please contact: Christian Krichau, CEO, telephone: +46 141 20 38 58Monica Ljung, CFO, telephone: +46 141 20 38 02 This information is information that Arla Plast AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was published by the above mentioned contact persons on April 23, 2024 at 13.00 CET. About Arla PlastArla Plast is a producer and supplier of extruded sheets made of technical plastics. The plastic sheets are made of polycarbonate (“PC”), acrylonitrile butadiene styrene (“ABS”) and polyethylene terephthalate glycol (“PETG”), with a large number of areas of application, including safety products, machine glazing, ice hockey rinks, greenhouses, pool covers, sound walls, protective barriers, suitcases, automotive components and various other construction-related areas of application. The company was founded in 1969 and is headquartered in Borensberg, Sweden. Arla Plast is listed on Nasdaq Stockholm in the Small Cap segment. Read more about Arla Plast at www.arlaplastgroup.com.

Sandvik to acquire majority stake in China-based Suzhou Ahno

Sandvik has signed an agreement to acquire a majority stake in the leading China-based company Suzhou Ahno Precision Cutting Tool Technology Co., Ltd. (Ahno) from the current majority owner, Ningbo Baosi Energy Equipment Co., Ltd and related parties. The company will be reported within the business area segment Sandvik Machining Solutions. Ahno has a leading position in precision cutting tools in the fast-growing local premium segment, with a broad product-and service offering and extensive sales, distribution and production footprint in China. The main customer industries are general engineering and automotive, in which a significant part is towards electric vehicles, and with medical being a growing segment for the company. With this acquisition Sandvik Machining Solutions further strengthens its leading position within round tools. “This acquisition will strengthen our position in the strategically important Chinese market. Ahno’s competitive assortment and closeness to customers is a great platform to drive further growth of our tooling business in China. Much of the offering is focused on fast growing segments, like electric vehicles, which makes Ahno a perfect fit with our strategy,” says Stefan Widing, President and CEO of Sandvik. Ahno will form the basis of a new China-based division within Sandvik Machining Solutions. The new division will be established following the closing of the transaction. Sandvik's international tooling brands will continue to be operated in China as they are today. Ahno’s strong market position, combined with Sandvik’s leading competence and international brands presence will enable an attractive growth platform in China for China going forward. “This acquisition is in line with our strategic ambition to grow in China and build a leading position in the local premium segment. In addition, Ahno enhances our local production capabilities, making it a great addition to Sandvik,” says Nadine Crauwels, President Sandvik Machining Solutions. Following the transaction, Sandvik will own a 72.4% stake in Ahno. This builds on a previous ownership stake of 12.4%. The company was founded in 2002, has approximately 1,200 employees and is headquartered in Suzhou, China. In 2023, the company generated revenues of approximately CNY 812 million (1.2 BSEK), mainly from China. The impact on Sandvik’s EBITA margin will be limited. The impact on Sandvik’s earnings per share (excluding non-cash amortization effects from business combinations) will be positive. The enterprise value for the acquired stake is CNY 1,456 million (189 MEUR) corresponding to a multiple of 10.9 x EV/EBITDA 2024. The transaction is expected to close during the third quarter of 2024 and is subject to customary closing conditions. Stockholm, April 23, 2024Sandvik AB For further information, contact Louise Tjeder, VP Investor relations, phone: +46 (0) 70782 6374 or Johannes Hellström, Press and Media Relations Manager, phone: +46 (0) 70721 1008.

Intrum AB – Interim results January-March 2024

Financial results in brief, January-March 2024 (January-March 2023) ·Adjusted income increased to SEK 4,891 M (4,524) ·Adjusted EBIT increased to SEK 1,155 M (1,068) ·Cash EBITDA increased to SEK 2,782 M (2,728) ·External Servicing income growth of 16 per cent ·Servicing adjusted EBIT margin of 15 per cent RTM Q1 ‘24 (19) ·Investing book-value excluding revaluations stood at SEK 37 bn (37) ·Available liquidity at the end of the quarter was SEK 9 bn (17) Presentation of the interim reportAndrés Rubio, President & CEO, and Emil Folkesson, Interim CFO and Investor Relations Director, will present the results and answer questions in a webcast with teleconference at 9:00 a.m. CET. The conference will be held in English.If you wish to participate via webcast, please use this link.  Via the webcast you are able to ask questions in written.To participate via teleconference, please use this link . After registration you will be provided phone numbers and a conference ID to access the conference. Via the teleconference you can ask questions verbally.Comment by President & CEO Andrés Rubio“The seasonally slow first quarter is in line with expectations. During the quarter we continued to focus our efforts on achieving the goals presented at our Capital Markets Day: to become increasingly client-centric, capital-light while pursuing an operating model driven by technology and automation.With continued inflation and need to improve margin, we continue to explore further cost-cutting measures. On top of the SEK 800 million run rate cost savings implemented in 2023, we have identified additional measures that will generate cost savings of approximately SEK 400 million in 2024 and an additional approximately SEK 300 SEK million in 2025. To date, we have realised approximately SEK 500 million of cost savings.Intrum’s commercial activity continued to accelerate, with signed annual contract value (“ACV”) increasing 11 percent to SEK 278 million from SEK 251 in Q1 2023. Selected examples are: (i) a new contract with a major BNPL company in Norway, (ii) an increased mandate with EDF in France and (iii) a major consumer finance mandate in the UK.Our Investing segment, recorded SEK 3,243 million in gross cash collections or 100 percent against the active forecast, which represents 109 percent of original underwriting forecast, demonstrating the resilience and strong cash generation of our back book.During the last 12 months, Intrum helped 4.9 million customers to become debt free and collected SEK 120 billion of which SEK 14 billion on own portfolios. More broadly, we expect a continued high demand for Intrum’s services. NPL volumes have increased steadily throughout 2023, leading to a rise in NPL ratio to 1.9 percent at year end. A similar development is seen for Stage 2 loans, where the ratio in EU jumped to 9.7 percent in Q4 2023 from 9.2 percent in Q3, reaching the second highest reading since 2018.In March, we launched Ophelos in the Netherlands – an important step on our journey towards operational excellence and ongoing tech transition. We will evaluate lessons learnt from this pilot in the Netherlands and introduce Ophelos in at least two additional markets during 2024.In addition, I am delighted to announce the recruitment of our incoming CFO, Johan Åkerblom, and I look forward to welcoming him later in 2024. I am eager to continue our transformation journey with all of my outstanding colleagues at Intrum.”For further information, please contact:Emil Folkesson, Interim CFO and Investor Relations Directorir@intrum.com This information is information that Intrum AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, on 24 March 2024 at 07.00 CET.

Interim report January–March 2024

Key highlights •    Adjusted EBITDA sequentially up more than 50%  •    Strengthened order books in both regions and improved capacity utilization in North America •    Sequentially 6% higher sales volumes (approx.+50 ktons)  •    Positive pricing and favorable mix changes compared to the fourth quarter •     Divestment of idled mill assets in the US Quarterly data •    Net sales decreased by 9% to SEK 10,423 million (11,495) •    Adjusted EBITDA* SEK 1,166 million (1,484) •    Adjusted EBITDA margin 11% (13) •    Operating profit SEK 448 million (806) •    Net profit SEK 313 million (639) •    Earnings per share SEK 1.26 (2.57) Outlook for Q2 •    Improved market conditions for both regions •    Increased sales prices expected to offset higher input costs mainly driven by higher pulpwood prices •    Maintenance shutdowns estimated to have a cost impact of SEK 525 million Comments by the CEO The first quarter result was a clear sequential improvement. As we expected, the improvement was mainly derived from stronger sales volumes and stronger price positions within liquid packaging board. We also experienced favorable product mix changes in both regions. Despite headwinds of higher costs for energy, logistics and fiber in Europe, the Group’s EBITDA margin strengthened to 11% in the quarter. The market sentiment clearly improved during the quarter in both regions. Order books have strengthened, and we see broad-based price increase announcements. Over the past quarter, we adjusted quickly and produced at full speed on all machines in Europe and significantly decreased our production curtailments in the US. I am in particular proud of how we successfully managed to solve the challenging logistical issues, enabling us to capture the market opportunity. We are also pleased with the clearly improved profitability in North America to 16% EBITDA margin. With overall cost stability, we are excited about the future cost-leading production opportunities in this region. However, we need to be careful to draw the conclusion that the underlying consumption has picked up significantly. The combination of longer delivery times due to Red Sea difficulties and strikes in Finland both have an impact on the supply situation. As we learned from 2021/2022, such effects are temporary and will likely lead to stock build-up. Keeping a close eye on inventory levels throughout the supply chain will thus be critical. With the industry returning to normalized production levels and a tight supply situation, prices for fiber in the Nordics continue to increase. We expect to reach all time high prices in the second quarter on Swedish-sourced pulpwood. We do not foresee a reversal of this tight fiber supply situation unless we see structural changes in the industry. In this continuous difficult market context, it is imperative that we focus on items that we have in our control. Several price increases have already been implemented, and we will need to do more. On top of this, we will continue to pursue efficiencies in all corners of our operations as well as keeping strict cost discipline for 2024. Wisconsin Rapids mill assets, which have been idled since 2020, will be divested to focus on core business objectives, optimize resources, and align with our long-term strategy to drive sustainable growth. We are convinced that this is the best solution for all stakeholders. At the same time, we are fully committed to the ownership and operation of the Wisconsin Rapids converting facility, as it plays a key role in the sheeting of graphic paper and cartonboard. Our US facilities are well located to ensure that we can deliver our products quickly, efficiently and cost-effectively to the customers. Our updated greenhouse gas emission reduction targets are ambitious and have been submitted to the Science Based Target initiative for verification. The long-term goal is to achieve a carbon footprint at our US mills that is best in class in North America and as close as possible to the excellent performance we have in Europe. We will also continue to eliminate the remaining fossil emissions in Europe. Billerud has always been a leading sustainability player in our industry, and we continue to be committed to lead the change. For 2024 our top three priorities remain intact: - Proceed with the preparations for our strategic investment projects. We continue to explore options for the US transformation and BCTMP (bleached chemi-thermo-mechanical pulp) project together with Viken Skog.    - Execute on our updated European strategy to adapt to a persisting high-cost situation and to improve profitability. This means execution of concrete actions to strengthen operational mill performance and secure cost competitive wood supply in the Nordics through partnerships and expanding our field wood purchases. We will also increase fiber efficiency by using more CTMP (chemi-thermo-mechanical pulp) and optimize the use and mix of fiber.  - Deliver on our efficiency enhancement program. We have good momentum and are on track to deliver SEK 700 million incrementally in 2024. Workforce reductions are progressing as planned and we expect to reach most of the estimated SEK 300 million impact this year, all included in the efficiency enhancement program target.  The first quarter was in summary a promising start to 2024. Although market sentiment has turned more favorable, we are facing an unprecedented situation in the Nordic wood market. We need to continuously perform at our best to navigate successfully through the difficult conditions. Ivar VatnePresident and CEO First quarter Sales and results Net sales for the first quarter declined by 9% to SEK 10,423 million (11,495). Currency changes had a positive impact of 2%. The organic* and currency-neutral net sales declined by 9%, mainly due to lower sales prices and reduced sales volumes. The Group’s sales volumes totaled 921 ktons (943), negatively impacted by curtailments of production in North America. Adjusted EBITDA amounted to SEK 1,166 million (1,484), corresponding to a margin of 11% (13). The Group’s result decreased mainly because of lower sales, only partly offset by reduced costs for raw materials, logistics and energy. No items classified as affecting comparability impacted the result in the first quarter (–). Market development and outlook In the first quarter, market conditions improved for both regions and all products. Price increases within the liquid packaging board segment were implemented as of January 1, and market prices for pulp increased. For all other segments, prices decreased compared to the previous quarter. For the second quarter 2024, market conditions are expected to continue to improve even if a clear recovery of the underlying paper and packaging consumption is assessed to be uncertain. In Region Europe, increased prices on most segments are expected to largely offset higher input costs, particularly for Nordic pulpwood. In Region North America, input costs and sales prices for graphic and specialty paper are expected to be unchanged, while pulp prices are expected to increase.  Events in the quarter From January 1, Billerud changed the name of the operating segment “Solutions & Other” to “Other” as a consequence of the divestment of Managed Packaging and other packaging solutions businesses during 2023. What is included in the operating segment “Other” is described on page 20. In February, a refreshed strategy for the European region was adopted. It focuses on strategic initiatives to be taken from 2024 to 2026. In addition to the maintained priority on safety, the updated strategy focuses on securing cost-competitive fiber supply and improving efficiency of existing assets. In March, Billerud agreed on the divestment of the idled Wisconsin Rapids mill assets to the global private equity company Capital Recovery Group, LLC for non-paper and pulp manufacturing uses. Billerud retains the converting facility in Wisconsin Rapids and is committed to continue with the operation to convert rolls of its graphic paper and cartonboard into sheets. The result effect recorded in the first quarter was SEK -6 million. The transaction will be completed in the second quarter and will have a positive cash flow effect of around SEK 60 million. In the first quarter, Billerud initiated a multi-year program to harmonize its ways of working. Preparations were made for introduction of a global IT platform that supports agile decision-making in the entire business flow, from sourcing, sales and order planning to customer deliveries and payments. Events after the quarter The convening notice to the 2024 annual general meeting, published on 12 April, included the nomination committee’s proposal that Andreas Blaschke, with 20 years of experience from executive board and management positions within the Mayr-Melnhof Group, be elected as new board member.Jan Åström has declined re-election to the board. Regi Aalstad, Florian Heiserer, Magnus Nicolin, Victoria Van Camp and Jan Svensson are proposed to be re-elected as board members, and Jan Svensson is proposed to be re-elected as board chairman.   * For key figures and a reconciliation of alternative performance measures including adjusted EBITDA, adjusted operating profit, adjusted EBITDA margin, adjusted operating profit margin, adjusted ROCE and interest-bearing net debt/adjusted EBITDA, see pages 14-16. For further information: Andrei Krés, CFO, +46 8 553 335 72Lena Schattauer, Director Investor Relations, +46 8 553 335 10ir@billerud.com This information constituted inside information prior to publication. This is information that Billerud AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 07.00 CEST on 24 April 2024.

New Sweco report: Europe’s green transition towards a resilient industry sector

The industry sector is responsible for 25–30 per cent of total global CO2 emissions and companies and countries are now investing heavily to transform their operations. Demand for industrial products is expected to increase significantly over the next three decades — steel by 30%, cement and ammonia by 40%, and aluminium by 80%. Companies in those hard-to-abate-industries are now required to deliver on that demand in a sustainable manner. “Sweco’s analysis is based on the Leadership Group for Industry Transition (LeadIT) database  and shows that Europe is taking the global lead in the green transition of the industry sector, as 95% of the full-scale projects in cement worldwide are conducted in Europe, as well as 61% of all fossil-free steel projects. There are a number of reasons why this is happening right now: Higher prices for CO2 emissions, new investments, regulations, the EU Net-Zero Industry Act  and stronger demand for sustainable products from end customers,” says Erik Skogström, Division Director Industry and Energy at Sweco in Finland. Sweco is the trusted advisor to some of Europe’s most ambitious large-scale industrial projects within decarbonisation including energy supply and efficiency, hydrogen and hydropower energy storage such as battery technology, CCS and industrial circularity.  Sweco’s new report  covers the following key insights: •    Regulations and capital are falling into place — but is it enough?•    The steel industry at the forefront, followed by the cement industry •    CCS/ CCU — a necessary complementary solution•    The electrification revolution, spurred by renewables, hydrogen and batteries •    Resource efficiency and circular industrial processes•    Industrial symbiosis and new business models About Urban Insight by SwecoUrban Insight is a series of insight reports  written by Sweco experts on various aspects of urban development from a citizen perspective. The new report is available here . 

Evolution: Interim report January-March 2024

First quarter of 2024 (Q1 2023) · Operating revenues increased by 16.7% to EUR 501.5 million (429.6) · EBITDA increased by 15.2% to EUR 345.8 million (300.2), corresponding to a margin of 69.0% (69.9) · Profit for the period amounted to EUR 269.2 million (251.2) · Earnings per share before dilution amounted to EUR 1.27 (1.18) Comments from CEO Martin Carlesund: For the first quarter of 2024, Evolution continued to render strong results. Revenue amounted to EUR 501.5 million (429.6) corresponding to year-on-year revenue growth of 16.7 percent with an EBITDA margin of 69.0 percent. Revenue growth at constant currency is estimated to 24 percent in the quarter. It is encouraging to see the good momentum from the end of 2023 carrying over into this year.Revenue from Live Casino increased by 19.8 percent year-on-year and compared to the previous quarter we add EUR 25.7 million in revenue. Although a strong start to the new year, much remains to be done to fully leverage our position in the market and serve the underlying demand.RNG revenues improved sequentially both in comparison to the previous quarter as well as year-on-year, delivering a revenue of EUR 70.1 million in the quarter. We continue to incrementally improve our RNG business both in the pace of game releases and in tools surrounding the games. We are adding and injecting AI into our system infrastructure and also in our way of operating where we see that it can contribute to efficiency, analysis, or automation. Now we also can see clear benefits of OSS as it is starting to deliver direct results for our operators. With AI-driven functionality and world-wide distribution to the largest Online Casino network in the world OSS is already very powerful. We will continue to add features, more to come already later in the year.During the period we have continued to increase our table capacity to meet the market demand, and I am pleased to say that the progress made in Q4 has carried over into this year. We have continuously accelerated our recruitment and made good progress in our building expansion projects in several studios – all together we have a much improved balance between supply and demand today compared to last year. Throughout 2024 we will continue to have full focus on increasing our delivery capacity. In this phase with heavy focus on expansion margins will initially be pressured, but the ongoing investments pave the way for increased revenues going forward. For the full year our guidance of EBITDA margin of 69-71 percent remains.In 2023 we increased the pace of new game introductions, and we aim at maintaining a high pace also 2024.  The first Live game launch of the year is Stock Market, a fantastic game set in the volatile, exciting world of financial markets. Players have quickly taken to the game, and it has been a strong release in the period. In Q2 we will launch our most ambitious game show ever – Lightning Storm – the newest, most thrilling, and extravagant member of our Lightning family. In RNG over 20 new titles were introduced in the first quarter. Our product ambitions are as always high, and we aim to bring players new playing experiences that increase entertainment value and lift excitement to new levels. The addition of the Livespins product is one example of a brand-new playing experience that brings a new dimension to online casino. I very much look forward to the coming year and realizing the ambitions of the “Product Leap years” creating more never-before-seen games and playing experiences.Our products have a global audience and in the first quarter we see growth both compared to the previous quarter and the first quarter 2023 across all regions. The long-term trends remain, with stable organic growth in Europe and very robust growth in Asia. In North America, we added a new client, Fanatics, and expanded our strategic relationship with Ceasars Digital, which includes an additional studio in New Jersey. We also entered Delaware with our slot game offering. LatAm reported good year-over-year growth in the quarter, however operators are awaiting the transition to regulation in Brazil.An important part of our growth strategy is to continue to expand our studio network. As already communicated, we launched the Bulgarian studio in the fourth quarter of 2023. As mentioned above, we will now add a studio in New Jersey with Ceasars. Our studio in Colombia is on its way, and we are also adding one new studio in Czech Republic during the year.Evolution is a growing, strong, profitable, all-equity funded company – in recent years our solid financial position has enabled us to remain focused on growth through periods of geopolitical uncertainty, a pandemic and rapid increases in interest rates. For 2023 a dividend of EUR 2.65 per share is proposed to the AGM, together with the recently completed buy-back program of EUR 400 million over 90% of 2023 profit is returned to shareholders.  We will continue to invest and expand our global operations and come to work hungry, ambitious, and excited for what more we can achieve.I want to thank the amazing Evolution team - that now exceeds 20,000 exceptionally dedicated persons - for this great start to the new year and their contributions to securing our future growth, and I look forward to seeing how we can continue to make Evolution a little bit better every day in 2024!  Presentation for investors, analysts and the media CEO Martin Carlesund and CFO Jacob Kaplan will present the report and answer questions on Wednesday, 24 April 2024 at 09:00 am CEST via a telephone conference. The presentation will be in English and can also be followed online.Webcast: https://ir.financialhearings.com/evolution-q1-report-2024Teleconference: Dial-in number to the teleconference will be received by registering on the link below. After the registration you will be provided phone numbers and a conference/user ID to access the conference. https://conference.financialhearings.com/teleconference/?id=50048474 For further information, please contact:Jacob Kaplan, CFO, ir@evolution.com This information is such that Evolution AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the contact person set out above on 24 April 2024, at 07.30 am CEST.

Kindred Group plc – Interim report: January – March 2024 (unaudited)

First quarter 2024 · Total revenue was GBP 307.7 (306.4) million, in line with the first quarter of 2023. · Gross winnings revenue (B2C) was GBP 297.6 (297.3) million. · Underlying EBITDA increased by 20 per cent to GBP 59.3 (49.4) million. · Profit before tax was GBP 39.8 (30.4) million. · Profit after tax was GBP 31.4 (25.6) million. · Earnings per share were GBP 0.15 (0.12). · Free cash flow amounted to GBP 23.7 (29.0) million. · Number of active customers increased by 3 per cent to 1,667,564 (1,623,568). CEO Nils Andén comments on the first quarter of 2024 “We have had a solid start to 2024 with the underlying business operations performing well and operational initiatives moving forward according to plan. The headcount reduction plans announced at the end of last year are progressing as intended and the North America exit is set to conclude towards the end of the second quarter this year. Our growth plan that we launched during the fourth quarter last year, focusing on Europe and Australia, continues at pace with dedicated strategic growth projects across locally regulated markets.” “Together with the encouraging performance of the B2B business, Relax Gaming, total revenue for the first quarter came in at GBP 307.7 million, in line with the same period last year. Underlying EBITDA for the first quarter came in at GBP 59.3 million, which is a very encouraging increase of 20 per cent compared to the first quarter 2023 and shows the continued positive impact of our cost control focus.” “During the quarter, we launched the Kindred Sportsbook Platform (KSP) in a test market, and we are very pleased with the progress to date. KSP remains one of our most important strategic projects and will give us the flexibility and differentiation needed to improve growth in locally regulated markets.”  “Our share of Gross winnings revenue from locally regulated markets came in at a new all-time high of 84 per cent, indicating our continued focus to sustainable revenue and our commitment to a positive contribution to societies.” “Following a solid start to the year we now have our eyes firmly set on a much sought after summer of sports with the UEFA Euros, the Copa America, and the Paris Olympics.” Trading update up to and including 21 April 2024 The average daily Gross winnings revenue for the Group, up to and including 21 April 2024, was GBP 3.48 million, 6 per cent higher (8 per cent in constant currency) compared to the daily average for the full second quarter of 2023. Excluding North America, Gross winnings revenue is increasing 8 per cent (9 per cent in constant currency). The sports betting margin after free bets for the above period was 11.3 per cent, which is ahead of the Group long-term average of 9.8 per cent and in line with the 11.3 per cent across the full second quarter of 2023. Kindred Group’s presentation of the interim report Kindred Group’s CEO Nils Andén and Interim CFO Patrick Kortman will host a web presentation in English at 10.00 (CEST) which is webcasted live on https://www.kindredgroup.com/Q12024. To access the telephone conference in connection with the presentation, please register at https://conference.financialhearings.com/teleconference/?id=5006359. After registration you will be provided a phone number and a conference ID to access the conference. Please call in well in advance for registration. There will be an opportunity to ask questions after the presentation.

STOREBRAND ASA: Results for the 1st Quarter 2024

· Group profit [1] of NOK 1,082 million, strong growth in all business areas · Continued share buyback program – in total NOK 1.5 billion for 2024 · Solid balance sheet – Solvency II ratio 191% · Still high insurance claims, but positive effect from implemented measures "We deliver strongly across the board – with double-digit growth in pensions, asset management, banking and insurance. I am pleased that more customers choose Storebrand. Growth is also important to reach the ambition of a group profit of NOK 5 billion in 2025," says CEO Odd Arild Grefstad. "Despite some harsh weather in the quarter, the insurance business is on the right track. We have been able to help many customers in the quarter and in addition improved profitability with a combined ratio of 98%. We still follow P&C insurance and disability trends closely, but I am happy to see that we are on our way to the targeted combined ratio of 90-92% in 2025," says Grefstad. "Storebrand performs well and has a solid capital position. The introduction of a flexible buffer fund for private defined benefit pensions allows us to take more risk and increase expected returns for customers. Today we also initiate a new share buyback program of NOK 1.1 billion, delivering on our ambition of increasing dividends and NOK 1.5 billion in share buy-backs also in 2024," says Grefstad. Group Profit Group profit was NOK 1,082 million in the 1st quarter, compared to NOK 826 million in the same period last year. This reflects good underlying growth across all business areas, satisfactory cost development and good financial results. Fee and administration income amounted to NOK 1,818 million in the 1st quarter. This was an increase of 13 per cent compared to the same quarter last year. Income growth is driven by strong growth in defined contribution pensions, increased assets under management and growth in Storebrand Bank. Total assets reached a new record level at the end of the 1st quarter with NOK 1,281 billion, representing growth of more than 15 per cent during the last year. With this, Storebrand consolidates its position as Norway’s largest private asset manager. Improved Insurance ResultsThe insurance business delivered weak results in 2023, and the start of the year was also challenging. Low temperatures and heavy snowfall in large parts of Norway led to more frequent and higher claims in P&C insurance.   Disability levels in the Norwegian society are still high, and this also affects Storebrand's business. Profitability in group life and pension related disability insurance has improved due to repricing, and the need for further price measures are being assessed on an ongoing basis. Improved Financial ResultThe financial items and risk result ended at NOK 394 million in the 1st quarter, up from NOK 255 million in the same quarter last year. Higher interest rate levels have contributed to higher returns in the company portfolios, together with increased profit sharing from the pension area in Sweden.  ESA’s Preliminary Assessment The Norwegian market for public occupational pensions totals NOK 800 billion, but very few municipalities and hospital trusts have conducted tenders in recent years. Storebrand has asked the EFTA Surveillance Authority (ESA) to assess whether the lack of tenders is a breach of the EEA rules on public procurement. In April, ESA sent its preliminary assessment in the procurement case to Norway. ESA argues that public occupational pensions are covered by regulations for public procurement and must be tendered. ESA estimates that 370 municipalities and hospital trusts have breached these rules when extending contracts for pension services. Share Buybacks Storebrand still has a strong capital position with a solvency ratio of 191%, well above the overcapitalisation threshold of 175 percent. Finanstilsynet has now approved the next phase of the share buyback program. This means that Storebrand will buy back shares worth NOK 1.1 billion in the period up to 20 December this year. The new buyback program starts today. Storebrand's long-term ambition is to conduct annual share buybacks of NOK 1.5 billion, totaling NOK 12 billion until 2030, in addition to increasing annual dividends. Key Figures in the Quarter: (Q1-2023 in brackets) · Solvency ratio: 191% (179%) · Earnings per share, adjusted for amortisation NOK 2.09 (NOK 1.82[2]) · Equity NOK 29,956m (NOK 30,266m) · Assets under management NOK 1,281bn (NOK 1,111bn) Activities Related to the 1st Quarter 2024 07:30: Release of stock exchange notification. Press release, quarterly report and analyst presentation will be available on www.storebrand.no/ir 10:00: Live investor and analyst conference in English. A webcast will be available at www.storebrand.no/ir The presentation will be available on demand afterwards. Analysts who would like to ask questions at the end of the presentation must register for and participate in the MS Teams Webinar. Link: https://www.storebrand.no/en/investor-relations/quarterly-reporting/programme For further inquiries, please contact Johannes Narum, Head of Investor Relations: johannes.narum@storebrand.no or (+47) 993 33 569 Kjetil Ramberg Krøkje, Head of Strategy & Finance: kjetil.r.krokje@storebrand.no or (+47) 934 12 155 Stig-Øyvind Blystad, Director of Communications: stig-oyvind.blystad@storebrand.no or (+47) 918 47 226 About Storebrand Storebrand is a Nordic financial group, delivering increased security and financial wellness for people and companies. We offer sustainable solutions and encourage our customers to take good economic decisions for the future. Our purpose is clear: we create a brighter future. Storebrand has about 55,000 corporate customers, 2.2 million individual customers and manages NOK 1,281 billion. The Group is headquartered at Lysaker outside of Oslo, Norway. Storebrand (STB) is listed on Oslo Stock Exchange. Visit us on www.storebrand.no This is information is pursuant to the EU Market Abuse Regulation and subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act. This information is based on the Storebrand Group's alternative income statement and contains Alternative Performance Measures as defined by the European Securities and Market Authority (ESMA). The alternative income statement is based on reported IFRS results for the individual group companies. The statement differs from the official accounts layout. An overview of APMs used in financial reporting is available on storebrand.com/ ir. [1] Cash equivalent earnings before amortisation and tax. www.storebrand.no/ir provides an overview of APMs used in financial reporting. [2] EPS for 2023 not adjusted for changed periodisation of performance-related income from the first quarter 2024.

CapMan Buyout exits Havator to BMS Stangeland

CapMan Buyout press release24 April 2024 at 09:00 a.m. EEST CapMan Buyout exits Havator to BMS Stangeland Funds managed by CapMan Buyout have agreed to sell Havator Group Oy, a Nordic leader in lifting, special transport and heavy haulage services, to a joint venture owned by the Danish–Norwegian crane operator BMS Group A/S and Stangeland Gruppen AS. CapMan invested in Havator in 2010 and has since focused on growing the company’s business and position on the Nordic market. Today, the company is a Nordic leader in lifting, special transport and heavy haulage services with a turnover of approximately EUR 100 million and nearly 500 employees. “I want to thank the leadership and personnel at Havator for the excellent cooperation throughout the years. I am glad the company’s new owners provide such an excellent strategic fit and believe them to enable exciting growth opportunities,” says Anders Björkell, Partner at CapMan Buyout. "A Nordic consolidation is something our industry has been expecting. The new set-up will allow Havator to leverage an even stronger and broader service offering to its clients and also offer more uniform services to clients operating on a Nordic scale. Joining a pan-Nordic company will also offer our personnel an even more international outlook towards the future, combined with growing opportunities to develop competencies and careers. I am also pleased that our new owner is a true industrial player,” says Hannu Leinonen, CEO of Havator. “We have always looked at Havator as a great and highly respected crane colleague in the Nordics. We have for quite some years followed Havator closely, so we are very happy that the time was now right to join forces. Havator is – as Stangeland and BMS – a mature company with aligned values and a very loyal and competent workforce. We are therefore looking forward to welcoming the Havator-employees to our crane-family,” says Jens Enggaard, CEO of BMS. As part of the transaction, the joint venture BMS Stangeland A/S acquires the entire capital stock of Havator from the CapMan Buyout IX Fund and Havator’s other current owners. The closing of the transaction is expected during the spring 2024 and is subject to regulatory approvals and customary closing conditions. For more information, please contact: Anders Björkell, Partner, CapMan Buyout, +358 40 537 7566 Hannu Leinonen, CEO, Havator, +358 40 588 7804 About CapMan CapMan is a leading Nordic private asset expert with an active approach to value creation and over €5 billion in assets under management. As one of the private equity pioneers in the Nordics we have developed hundreds of companies and assets creating significant value for over three decades. Our objective is to provide attractive returns and innovative solutions to investors by enabling change across our portfolio companies. An example of this is greenhouse gas reduction targets that we have set under the Science Based Targets initiative in line with the 1.5°C scenario and our commitment to net-zero GHG emissions by 2040. We have a broad presence in the unlisted market through our local and specialised teams. Our investment strategies cover real estate and infrastructure assets, natural capital and minority and majority investments in portfolio companies. We also provide wealth management solutions. Our service business includes procurement services. Altogether, CapMan employs around 200 professionals in Helsinki, Jyväskylä, Stockholm, Copenhagen, Oslo, London and Luxembourg. We are listed on Nasdaq Helsinki since 2001. www.capman.com Havator Havator, established in Finland in 1956, is the Nordic leader in lifting, special transport and heavy haulage services. We operate in Finland, Sweden, Norway and Estonia. Our goal is to be at the forefront of development, to be a leader in developing the operations’ safety and efficiency, without forgetting the industry's traditions. Havator Group Oy has a turnover of approximately EUR 100 million and employs approximately 500 people. Read more: havator.com

Quarterly Report Q1 2024

Strong execution in a challenging market First quarter · Net sales increased by 9% to SEK 35,200 M (32,391), with organic growth of –2% (8) and acquired net growth of 11% (5). Exchange- rates affected sales by 0% (9). · Organic sales growth was stable in Entrance Systems, but declined in Americas, Asia Pacific, EMEIA and in Global Technologies. · Three acquisitions with combined annual sales of about SEK 2,000 M were completed in the quarter. The divestment of PACA in France was finalized. · Operating income[1] (EBIT) increased by 5% and amounted to SEK 5,427 M (5,186), with an operating margin of 15.4% (16.0). · The operating margin1 (EBIT) excluding the acquisition of HHI and divestment of the Emtek/U.S. Smart Residential business was 16.3%. · Net income1[ ]amounted to SEK 3,462 M (3,692). · Earnings per share1 amounted to[ ]SEK 3.12 (3.32). · Operating cash flow amounted to SEK 3,096 M (4,069). Sales and income Full year First quarter 2022 2023 Δ 2023 2024 ΔSales, SEK M 120,793 140,716 16% 32,391 35,200 9%Of which:Organic growth 13,007 3,393 3% 2,218 –762 –2%Acquisitions and divestments 2,126 10,651 8% 1,344 3,607 11%Exchange-rate effects 10,653 5,879 5% 2,237 –35 0%Operating income (EBIT)1, SEK M 18,532 22,185 20% 5,186 5,427 5%Operating margin (EBITA)1, % 15.9% 16.5% 16.6% 16.3%Operating margin (EBIT)1, % 15.3% 15.8% 16.0% 15.4%Income before tax1, SEK M 17,521 19,654 12% 4,843 4,616 –5%Net income1, SEK M 13,296 15,049 13% 3,692 3,462 –6%Operating cash flow, SEK M 15,808 25,232 60% 4,069 3,096 –24%Earnings per share1, SEK 11.97 13.54 13% 3.32 3.12 –6% [1] Excluding items affecting comparability. Please see the section “Items affecting comparability” in the report for further details about the financial effects in 2024. For information about items affecting comparability in 2023, please see the Year-end report 2023, available at assaabloy.com.  Comments by the President and CEO Strong execution in a challenging marketThe year took off with strong sales growth of 9%, driven by very strong net acquired growth of 11%, which was partly offset by an organic sales decline of –2%. The organic sales were affected by three fewer working days in March, the most important month of the quarter and a continued weak residential market. Entrance Systems’ organic sales were stable with very strong growth in Perimeter and strong growth in the Pedestrian segment. Organic sales in Americas and EMEIA declined by –1% and –3% respectively. Asia Pacific’s organic sales declined by –3% due to a weak Chinese market and negative intra-group sales growth. Global Technologies’ organic sales declined by –9% against a high corresponding figure last year due to the significant reduction of the backlog a year ago. The operating profit excluding items affecting comparability increased by 5% to SEK 5,427 M, and the operating margin was record-high for the quarter at 16.3%, excluding the HHI transaction. Strong operational execution through implementation of more cost actions, continued strong price realization and lower direct material costs contributed to the strong performance. The operating cash flow was seasonally lower at SEK 3,096 M with a cash conversion of 67%. Security is a strong underlying driver for long-term growthThe demand for safe and secure access solutions is constantly increasing as a result of rising security threats, public safety concerns, regulatory requirements and a changing work environment. This also accelerates the demand for electromechanical products and solutions. They offer a high level of security thanks to advanced authentication methods, our unique encryption technologies, the enablement of remote monitoring & control as well as by providing audit trails and access logs. Electromechanical solutions also offer opportunities for efficiency gains and a higher level of convenience and flexibility for our customers. With prevailing penetration rates still low, the shift to more electromechanical solutions continues to be a long-term driver of profitable growth. During the quarter, our electromechanical organic sales growth was 6% in the regional divisions. We acquired three companies in the first quarter, representing annualized sales of SEK 2 billion. The integration of HHI continues to proceed according to plan and we are gradually realizing more synergies. Given a robust target pipeline and a solid financial position with a strong balance sheet and cash flow, we are well positioned to continue our successful journey of acquiring companies. We are committed to delivering value to our customers and shareholders and are confident that we will be able to adapt to and perform in any market condition. Thank you for your continued support and trust in ASSA ABLOY. Stockholm, April 24, 2024 Nico DelvauxPresident and CEO Further information can be obtained from:Nico Delvaux,President and CEO, tel. no: +46 8 506 485 82 Erik Pieder,Executive Vice President and CFO, tel.no: +46 8 506 485 72 Björn Tibell,Head of Investor Relations, tel. no: +46 70 275 67 68,e-mail: bjorn.tibell@assaabloy.comASSA ABLOY is holding a telephone and web conference at 09.30 on April 24, 2024 which can be followed online at assaabloy.com/investors.It is possible to submit questions by telephone on: 08–505 100 31, +44 207 107 0613 or +1 631 570 5613This information is information that ASSA ABLOY AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 08.00 CEST on April 24, 2024.

Outokumpu to close its Dahlerbrück and Hockenheim sites in Germany

Outokumpu to close its Dahlerbrück and Hockenheim sites in Germany According to the company strategy, Outokumpu announced in November 2023 its plans on restructuring measures in Germany and started related procedures with employee representatives to shut down the operations of Dahlerbrück and Hockenheim sites in Germany. These negotiations have been completed in April 2024 with an agreement on the restructuring measures and execution of the closures can move forward. Outokumpu will now start to centralize advanced materials production in Germany to Dillenburg. In practice, this means that precision strip operations will be transferred from Dahlerbrück to Dillenburg. Outokumpu will also close its coil service center in Hockenheim and transfer the volumes to other sites. All in all, the restructuring measures impact approximately 200 people in Germany. The closure of Hockenheim is expected to be completed by the end of the second quarter of 2024, and Dahlerbrück operations are to be closed by the end of 2024 and partially transferred to the Dillenburg mill. “We thank our labor representatives for the constructive negotiations in support of our common objective to strengthen the company’s European competitiveness in the long run. These measures are difficult but necessary and they will be implemented in a socially responsible manner and, where possible, avoiding compulsory redundancies,” says Thomas Anstots, President, Advanced Materials business line. “We are a global leader in advanced materials, and we want to further strengthen this position. Centralizing the expertise, product portfolio and operations under one roof in Dillenburg will allow us to expand our offering and to reposition the site as the core value creator within our Advanced Materials business line alongside our mills in Sweden, with the full spectrum of our advanced materials products,” concludes Thomas Anstots. The restructuring measures are expected to entail yearly savings of approximately EUR 15 million. The total restructuring cost for both sites including the social plan and shut-down costs total approximately EUR 28 million. Previously, Outokumpu had recorded in the fourth-quarter 2023 EBIT an adjustment item of approximately EUR 30 million related to the planned closures. Investments and costs related to the transfer of the precision strip production from Dahlerbrück to Dillenburg are expected to amount to EUR 22 million, the majority of which will be realized during the year 2024. For more information: Investors: Linda Häkkilä, Head of Investor Relations, tel. +358 400 719 669 Media: Päivi Allenius, SVP – Communications & Brand, tel. +358 40 753 7374 or Outokumpu media desk, +358 40 351 9840 Outokumpu Corporation  

WELCOME TO THE EQT AB ANNUAL SHAREHOLDERS’ MEETING 2024

Conditions for participation Shareholders may choose to participate in, and vote at, the Meeting in person or in advance. Shareholders who wish to participate in the Meeting must be recorded in the share register maintained by Euroclear Sweden AB (“Euroclear”) concerning the circumstances on Friday 17 May 2024. In addition, the shareholders must give notice of their participation in the Meeting: · Shareholders who choose to participate in, and vote at, the Meeting in person must give notice of participation no later than Tuesday 21 May 2024. Notice of participation may be submitted by e-mail to proxy@computershare.se (with reference to “EQT AGM 2024”), by mail to Computershare AB, “EQT AGM 2024”, Box 5267, SE-102 46 Stockholm, Sweden, or by telephone to Computershare AB +46 8 46 00 73 80. Natural persons with BankID are primarily asked to submit their notice of participation on EQT’s website, www.eqtgroup.com/AGM. · Those who choose to vote in advance must give notice of participation by submitting their advance vote in accordance with the instructions in the “Advance voting” section below so that the advance vote is received by Computershare AB no later than Tuesday 21 May 2024. When giving notice of participation, please state name, personal identification number or corporate registration number, address, telephone number and e-mail address. If you wish to be represented by proxy, this must be notified within the same time and in the same manner as stated above and a power of attorney as well as other relevant supporting documents must be attached. To be entitled to participate in the Meeting, in addition to providing notification of participation, a shareholder whose shares are held in the name of a nominee must register its shares in its own name so that the shareholder is recorded in the share register as of Friday 17 May 2024. Such registration may be temporary (so-called voting right registration) and is requested from the nominee in accordance with the nominee’s procedures and such time in advance as the nominee determines. Voting right registrations completed no later than the second banking day after Friday 17 May 2024 are taken into account when preparing the register of shareholders. Simultaneous translation (Swedish/English and English/Swedish) will be offered at the Meeting venue. Attendance in person If you wish to participate in the Meeting in person, you must give notice as instructed above. Registration will commence at 14.00 CEST and fika will be served ahead of the Meeting. Advance voting You may exercise your voting rights at the Meeting by voting in advance, so called postal voting. To vote in advance, please use the form for advance voting available on www.eqtgroup.com/AGM.  If a shareholder has voted in advance and has notified its participation to attend the Meeting at the meeting venue, the vote cast in advance is still valid to the extent that the shareholder does not participate in a voting procedure at the Meeting or otherwise withdraws the advance vote. If the shareholder chooses to participate in a voting at the Meeting, the vote cast will replace the previously submitted advance vote with regard to the relevant item on the agenda. The completed and signed advance voting form must be received by Computershare AB (administering the forms on behalf of EQT) no later than Tuesday 21 May 2024, either by using BankID, by e-mail to proxy@computershare.se (with reference “EQT AGM 2024”) or by mail to Computershare AB, “EQT AGM 2024”, Box 5267, SE-102 46 Stockholm, Sweden. If the shareholder votes in advance by proxy, the power of attorney shall be enclosed to the form or submitted in accordance with the instructions in the form. If the shareholder is a legal entity, a registration certificate or a relevant supporting document shall be enclosed to the form or submitted in accordance with the instructions in the form. The shareholder may not add any specific instructions or conditions in the voting form. If so, the vote will be invalid. Further instructions and conditions are included in the form for advance voting. Webcast Shareholders as well as non-shareholders have the opportunity to follow the Meeting online via a link that will be available on EQT's website, www.eqtgroup.com/AGM. For persons following the Meeting online, simultaneous translation will be offered via subtitles. It is not possible to exercise any shareholder rights via the webcast. Questions and shareholders’ right to receive information The shareholders are reminded of their right to receive information from the Board and the CEO in accordance with Chapter 7 Section 32 of the Swedish Companies Act. Requests for such information may be submitted in advance by e-mail to agm@eqtgroup.com or by mail to EQT AB, “AGM 2024”, Box SE-164 09 Stockholm, Sweden. Shares and votes As per the date of this notice, EQT’s share capital amounts to approximately SEK 125,335,166 represented by 1,245,929,967 shares divided into 1,245,048,412 ordinary shares and 881,555 class C shares. Ordinary shares carry one vote while class C shares carry 1/10th vote. As per the time of this notice, EQT holds 60,574,829 own ordinary shares, corresponding to 60,574,829 votes, which cannot be represented in the Meeting. Proposed agenda 1. Opening of the Meeting 2. Election of chairperson of the Meeting 3. Preparation and approval of the voting list 4. Approval of the agenda 5. Election of one or two persons who shall approve the minutes of the Meeting 6. Determination of whether the Meeting has been duly convened 7. Presentation by the CEO 8. Presentation of the annual report as well as the consolidated financial statements and the auditors’ report 9. Resolution regarding adoption of the income statement and the balance sheet, as well as the consolidated income statement and the consolidated balance sheet10. Resolution regarding allocation of EQT’s profit in accordance with the adopted balance sheet11. Resolution regarding discharge of liability for the Board members and the CEO12. Resolution on: a. the number of Board members who shall be appointed by the Meeting b. the number of auditors and deputy auditors who shall be appointed by the Meeting 13. Resolution on: a. fees to the Board members b. transfer of own shares to Board members c. fees to the auditors 14. Election of Board members and Chairperson of the Board a. Conni Jonsson, re-election b. Brooks Entwistle, re-election c. Diony Lebot, re-election d. Gordon Orr, re-election e. Marcus Wallenberg, re-election f. Margo Cook, re-election g. Richa Goswami, new election h. Chairperson of the Board: Conni Jonsson, re-election 15. Election of auditors and deputy auditors16. Resolution on principles for appointment of the nomination committee17. Presentation of the Board’s remuneration report for approval18. Resolution on guidelines for remuneration to executive management19. Resolution on authorization for the Board to issue shares, convertible bonds and warrants20. Resolution on authorization for the Board to resolve on repurchase of own shares21. Resolution on reduction of the share capital through cancellation of ordinary shares held in treasury and on increase of the share capital through a bonus issue22. Closing of the Meeting The Board’s proposals Item 10 – Allocation of EQT’s profit in accordance with the adopted balance sheet The Board proposes a dividend to the shareholders of SEK 3.60 per share for the fiscal year 2023. The dividend is proposed to be paid out in two installments. At the first installment, SEK 1.80 with record date 29 May 2024. At the second installment, SEK 1.80 with record date 2 December 2024. Should the Meeting resolve in favor of the proposal, payment of the dividend is expected to be facilitated by Euroclear on 3 June 2024 and on 5 December 2024, respectively. Item 18 – Guidelines for remuneration to executive management The Board proposes that the Meeting adopts the following guidelines for remuneration to the CEO and other members of the Executive Committee. Guidelines for executive remuneration (remuneration policy) The CEO and other members of the Executive Committee (executive management) fall within the provisions of these guidelines. To the extent a Board member conducts work for EQT, in addition to the board work, consulting fees and other compensation for such work may be paid. The guidelines are forward-looking, i.e. they are applicable to remuneration agreed, and amendments to remuneration already agreed, after adoption of the guidelines by the Annual Shareholders’ Meeting 2024. These guidelines do not apply to any remuneration separately decided or approved by the shareholders’ meeting. EQT has a clear remuneration philosophy (including for variable cash) applicable across the whole group which also governs the remuneration to the Executive Committee and links compensation to the EQT AB Group’s business strategy, sustainability, long-term interests and long-term value growth for its shareholders. Most important is to incentivize fund performance and ensure aligned interest with our limited partners in the EQT funds, EQT AB’s shareholders as well as EQT’s long term approach. EQT is a performance driven organization focused on long-term value creation in line with our culture. Team performance and individual performance are important – therefore we reward both. Performance is key to our success and we award higher performance with higher compensation. To be able to achieve the business goals, EQT needs to be able to attract and retain world class talent suitable for each role. To achieve this, EQT applies market competitive total compensation. EQT compensates locally based on geography and in line with local practice and regulations, taking into account, to the extent possible, the overall purpose of these guidelines. The principles in these guidelines enable EQT AB to offer the Executive Committee a competitive total remuneration. For more information regarding the EQT AB Group’s business strategy, please see EQT AB’s webpage,  www.eqtgroup.com. Share-related incentive programs The EQT Share Program and the EQT Option Program are implemented in the EQT AB Group. The programs were resolved by the Annual Shareholders’ Meeting 2023 and are therefore excluded from these guidelines. The EQT Option Program includes members of the Executive Committee in EQT AB. The performance criteria used to assess the outcome of the EQT Option Program are tied to the individual’s current role scope and contribution to EQT’s performance through value creation and future proofing, the share price development, adding value to the wider EQT Platform as well as impact on delivering on EQT’s sustainability ambitions. The participants will receive employee stock options free of charge, with an exercise period occurring during a one-month period. Each employee stock option entitles the participant to acquire one ordinary share in EQT AB at a price corresponding to the price per ordinary share as of the date of grant, subject to a net strike mechanism, cap on the gain per employee stock option and customary recalculation mechanisms. For the EQT Share Program, the performance targets are tied to the EQT AB Group’s financial targets, EQT’s general competitiveness, the individual meeting or exceeding EQT’s highly set expectations on adding value to the EQT Platform as well as impact on delivering on EQT’s sustainability ambitions. The program includes Partners and senior employees, members of the Executive Committee are generally not participants of the EQT Share Program. The participants invest a variable amount (financed by EQT) in ordinary shares after a performance year, whereupon an approximately three-year holding period follows. The Annual Shareholders’ Meeting 2019 also resolved on an EQT Share Program, under which no new investments in EQT AB shares are made, with holding periods until 2026. For more information regarding the EQT Share Program and EQT Option Program, including the criteria which the outcome depends on, please see EQT AB’s remuneration report, available on eqtgroup.com/shareholders/. Types of remuneration, etc. The remuneration shall be on market terms and may consist of the following components: fixed remuneration, variable cash remuneration, pension benefits and other benefits. The shareholders’ meeting may – irrespective of these guidelines – resolve on, among other things, share-related or share price-related remuneration. Fixed remuneration The fixed remuneration, i.e. base salary, should be competitive and reflect responsibility and performance. Variable remuneration The satisfaction of criteria for awarding variable cash remuneration, within the EQT Bonus program, shall be measured over a period of one year. The variable cash remuneration may amount to no more than 200 percent of the annual base salary. The EQT Bonus program consists of a performance assessment of the business as well as an individual performance assessment. Important business performance factors determining the size of the bonus is the success of the underlying business measured by business performance in the funds (investments and exits as well as portfolio and fund performance), business profitability, fundraising, sustainability as well as organizational development. The individual performance is assessed versus agreed targets as well as meeting, exceeding or not meeting high set individual performance expectations for the individual in the current role. To which extent the criteria for awarding variable cash remuneration has been satisfied shall be evaluated/determined when the measurement period has ended. The remuneration committee shall be responsible for the evaluation so far as it concerns variable remuneration to the CEO. For variable cash remuneration to other members of the Executive Committee, the CEO shall be responsible for the evaluation. For financial objectives, the evaluation shall be based on the latest financial information made public by EQT AB. The Executive Committee partly consists of owners of EQT AB. Owners that owned above 1.5 percent of the shares of EQT AB at IPO or at relevant acquisition may not be comprised by the EQT Bonus program, i.e. variable cash remuneration, nor any of the relevant share-related incentive programs. Therefore, total remuneration for part of the Executive Committee consists of base salary, pension benefits and other benefits. Pension All members of the Executive Committee shall be covered by defined contribution pension plans, for which pension premiums shall be based on the members’ base salary and paid by the company during the period of employment. For current members of the Executive Committee pension contributions shall be based on base salary and follow contribution levels in accordance with local market practice, except for the application of a cap. For Sweden, this means that it shall be comparable to the old BTP-plan with a contribution cap for base salary exceeding 40 Income base amounts. The pension premiums shall amount to no more than 25 percent of the annual base salary. Other benefits Other benefits, such as insurances (health, life, travel), sports contributions or occupational health services, should be payable to the extent this is considered to be in line with market conditions in the market concerned. Premiums and other costs relating to such benefits may amount to no more than 25 percent of the annual base salary. Executive Committee members who relocate for the purposes of the position or who work in other multiple countries may also receive such remuneration and benefits as are reasonable to reflect the special circumstances associated with such arrangements, taking into account the overall purpose of these guidelines and alignment with the general policies and practices within EQT AB Group applicable to cross border work. Recommendation to invest in EQT AB shares The Board recommends each Executive Committee member (who do not already have such holding) to acquire, over a three-year period, EQT AB shares or similar instruments corresponding to at least one year’s base salary, before taxes and excluding other remuneration. Termination of employment and terms for severance pay for the CEO A twelve month notice period will apply if notice is given by the CEO or EQT AB. The CEO’s employment terms include a non-competition clause. If used, this would entitle the employee to an additional compensation corresponding to a maximum of twelve months’ salary, however, reduced by any remuneration paid by a new employer. Termination of employment and terms for severance pay for senior executives In the event of notice being given by the EQT AB Group, a notice period of nine months applies, while in the event of notice being given by the senior executive a period of notice of six months applies. The senior executives’ employment terms also include a non-competition clause. If used, this entitles the employee to an additional compensation corresponding to a maximum of nine months’ salary, however, reduced by any remuneration paid by a new employer. Base salary during the notice period and severance pay may not together exceed an amount corresponding to the base salary for eighteen months. When termination is made by the executive, the notice period may not exceed six months, without any right to severance pay. Salary and employment conditions for employees taken into account during preparations of these guidelines In the preparation of the Board’s proposal for these remuneration guidelines, salary and employment conditions for employees of the EQT AB Group have been taken into account by including information on the employees’ total income, the components of the remuneration and increase and growth rate over time, in the remuneration committee’s and the Board’s basis of decision when evaluating whether the guidelines and the limitations set out herein are reasonable. The decision-making process to determine, review and implement the guidelines The Board has established a remuneration committee. The committee’s tasks include preparing the Board’s decision to propose guidelines for executive remuneration. The Board shall prepare a proposal for new guidelines at least every fourth year and submit it to the shareholders’ meeting. The guidelines shall be in force until new guidelines are adopted by the shareholders’ meeting. The remuneration committee shall also monitor and evaluate programs for variable remuneration for the Executive Committee, the application of the guidelines for executive remuneration as well as the current remuneration structures and compensation levels in the EQT AB Group. The current members of the remuneration committee are independent of EQT AB and its Executive Committee. The CEO and other members of the Executive Committee do not participate in the Board’s processing of and resolutions regarding remuneration-related matters in so far as they are affected by such matters. Deviation from the guidelines The Board may temporarily resolve to deviate from the guidelines, in whole or in part, if in a specific case there may be special cause for the deviation and a deviation should be necessary to serve the EQT AB Group’s business strategy, sustainability, long-term interests and long-term value growth for its shareholders, or to ensure the EQT AB Group’s financial viability. As set out above, the remuneration committee’s tasks include preparing the Board’s resolutions in remuneration-related matters. This includes any resolutions to deviate from the guidelines. Description of material changes to the guidelines and how the views of shareholders’ have been taken into consideration Compared to the guidelines previously adopted the following material changes have been made, the guidelines have been adjusted to ensure that suitable compensation can be provided in case of relocations and cross-border work, which is important considering the EQT AB Group’s global operations. Item 19 – Authorization for the Board to issue shares, convertible bonds and warrants The Board proposes that the Meeting resolves to authorize the Board to, during the period until the next Annual Shareholders’ Meeting, on one or more occasions, resolve upon issuances of new shares, convertible bonds and/or warrants to be paid in cash, by way of set-off and/or in kind. Shares, convertible bonds and/or warrants may be issued without preferential rights for the shareholders of EQT AB. The number of shares, convertible bonds and/or warrants issued may not correspond to a dilution of more than 10 percent of the total number of shares as of the first exercise of the proposed authorization, after full exercise of the hereby proposed authorization. The purpose of the authorization is to provide flexibility for acquisitions of companies, businesses or parts thereof, as well as to increase financial flexibility for EQT and broaden the shareholder base. Any issue of new shares resolved upon pursuant to this authorization shall be made at market terms and conditions, taking into account the transaction as a whole. Warrants may be issued free of charge. The Group General Counsel, Corporate, of EQT AB is authorized to make such minor adjustments to this resolution that may be necessary in connection with the registration thereof. Item 20 – Authorization for the Board to resolve on repurchase of own shares The Board proposes that the Meeting resolves to authorize the Board to decide on purchases of the company’s own ordinary shares as follows: The Board is authorized to make purchases of the company’s ordinary shares on as many occasions as it deems appropriate during the period up to the Annual Shareholders’ Meeting 2025. The number of shares purchased must at no time result in the company’s holding exceeding 10 percent of all the shares in the company. The purchases are to be made on Nasdaq Stockholm or in accordance with an offer to acquire shares directed to all shareholders of the same share class or through a combination of these two alternatives. Acquisition of shares on Nasdaq Stockholm shall be made at a price per share within the price interval applicable at the time of acquisition. Acquisitions of shares by way of offers to acquire shares directed to all the company’s shareholders of the same share class shall be made at an acquisition price which is no more than 15 percent above the prevailing market price and no less than SEK 0. The purposes of the authorization are to enable the Board to adjust the company’s capital structure, enable acquisitions of companies and business operations where payment is made with own shares, deliver shares to Board members as Board fee in accordance with items 13a-b as well as mitigate the dilution impact from the company’s incentive programs and acquisitions made by EQT. Item 21 – Reduction of share capital through cancellation of ordinary shares held in treasury and increase of share capital through bonus issue The Board proposes that the Meeting resolves to reduce the share capital, for allocation to non-restricted equity, by canceling 3,923,000 ordinary shares held in treasury by EQT, through which the share capital decreases by SEK 394,636.84. The purpose of the reduction is to cancel ordinary shares held in treasury to, over time, off-set the dilution impact from shares delivered to participants in EQT’s Share and Option Incentive Programs. To restore the share capital following the decrease in the share capital, the Board proposes that the Meeting at the same time resolves to increase the share capital by SEK 394,636.84 through a bonus issue without issuing new shares, whereby the amount is to be transferred from non-restricted equity. Statement pursuant to Chapter 20 Section 13 of the Swedish Companies Act: The effect of the Board’s proposal to decrease the share capital is that the share capital and restricted equity decrease by SEK 394,636.84. The effect of the Board’s proposal to increase the share capital through a bonus issue is that the share capital and restricted equity increase by SEK 394,636.84. Therefore, and overall, there is no decrease in the share capital or restricted equity. The nomination committee’s proposals The nomination committee, consisting of Jacob Wallenberg (appointed by Investor AB and Chairperson of the nomination committee), Harry Klagsbrun (appointed by Bark Partners AB), Cynthia Lee (appointed by Jean Eric Salata), Anders Oscarsson (appointed by AMF Pension & Funds) and Conni Jonsson (Chairperson of the Board), jointly representing approximately 37 percent of the voting rights for all the shares in EQT as of 31 August 2023, proposes the following: Item 2 – The chairperson of the Meeting Attorney Charlotte Levin or, in case she is prevented, the person assigned by the nomination committee instead. Item 12a – The number of Board members who shall be appointed by the Meeting Seven Board members without deputy Board members, conditional upon that necessary regulatory approvals from the Netherlands Authority for the Financial Markets, the Swedish Financial Supervisory Authority and the Swedish Corporate Registration Office with respect to Richa Goswami are obtained no later than 31 October 2024 (the “Approvals”), and otherwise six Board members without deputy Board members. Item 12b – The number of auditors and deputy auditors who shall be appointed by the Meeting One registered auditing company as auditor and no deputy auditors. Item 13a – Fees to the Board A total compensation to the Board of EUR 1,375,500 (1,343,640), to be allocated as follows: · EUR 304,500 (295,800) to the Chairperson and EUR 138,500 (134,640) to each of the other Board members who are not employed by the company, · EUR 40,000 (40,000) to the Chairperson of the audit committee and EUR 20,000 (20,000) to each of the other two members, · EUR 40,000 (40,000) to the Chairperson of the remuneration committee and EUR 20,000 (20,000) to each of the other two members, and · EUR 40,000 (40,000) to the Chairperson of the sustainability committee and EUR 20,000 (20,000) to each of the other two members. Should the Approvals not be obtained for Richa Goswami, the total compensation to the Board will instead be EUR 1,237,000. The aforementioned compensation to the Board shall, provided that the majority requirement under item 13b is met, be paid in shares at the end of the mandate period. The number of shares to be transferred shall equal the total compensation each Board member is entitled to receive, less applicable Swedish taxes that would have been withheld if the Board compensation would have been paid in cash, divided by the share price. In the event the compensation does not correspond to the value of a full share, any remaining compensation shall lapse. Should the majority requirement for item 13b below not be met or to the extent, for whatever reason, the compensation cannot be paid in shares, the compensation is to be paid in cash. The nomination committee recommends that each Board member in EQT AB holds shares corresponding to at least 50% of the EQT AB shares received as Board and Committee fees, after tax, during the Board member’s tenure. Item 13b – Transfer of own shares to Board members The nomination committee proposes that the Meeting resolves that ordinary shares that EQT AB holds shall be transferred to Board members to set off the claim the Board members have on Board compensation pursuant to item 13a. The number of ordinary shares that may be transferred may amount to not more than 100,000. The shares shall be transferred to the Board members the trading day before the next Annual Shareholders’ Meeting. The price for the shares shall be the volume weighted average share price of EQT AB’s share on Nasdaq Stockholm ten trading days before the day of the transfer and using the average exchange rate during the same time period. Item 13c – Fees to the auditors Auditors’ fees are proposed to be paid upon approval of their invoice. Item 14 – The Board members and Chairperson of the Board The following persons are proposed for re-election as Board members for the period until the end of the Annual Shareholders’ Meeting 2025: Conni Jonsson, Brooks Entwistle, Diony Lebot, Marcus Wallenberg, Margo Cook and Gordon Orr. Conni Jonsson is proposed to be re-elected as Chairperson of the Board. Richa Goswami is proposed for election as new Board member for the period until the end of the Annual Shareholders’ Meeting 2025, conditional upon the Approvals being obtained. Item 15 – The auditors and deputy auditors The registered auditing company KPMG AB is proposed to be re-elected as auditor for the period until the end of the Annual Shareholders’ Meeting 2025. KPMG AB has informed that, subject to the approval of the proposal from the nomination committee regarding auditor, authorized public accountant Håkan Olsson Reising will continue to be the auditor in charge for the audit. The nomination committee’s proposal is consistent with the audit committee’s recommendation. Item 16 – Principles for appointment of the nomination committee The nomination committee proposes that the Meeting resolves on changes to the principles for appointment of the nomination committee. Principles for appointment of a nomination committee in EQT AB (the “Company”). 1. The nomination committee shall comprise one member appointed by each of the four largest shareholders, based on ownership in the Company on the last banking day of August the year before the annual shareholders’ meeting (based on shareholder data from Euroclear Sweden AB and other reliable data provided to the Company) and the Chairperson of the Board. If any shareholder renounces its right to appoint a member to the nomination committee, such right shall transfer to the shareholder who is the next largest shareholder in the Company. 2. If none of the four largest shareholders is (a) a Member in EQT Foundation’s Member Committee (“EQT Member”) or (b) EQT Foundation, the fourth largest shareholder’s right shall instead vest in EQT Foundation. Thus, an EQT Member or EQT Foundation shall always be allowed to appoint a member of the nomination committee. If EQT Foundation renounces such right, the right shall transfer to the fourth largest shareholder pursuant to section 1. 3. The member appointed by the largest shareholder shall be appointed Chairperson of the nomination committee, unless the nomination committee unanimously appoints someone else. The Chairperson of the nomination committee shall not be a Board member of the Company. 4. If a shareholder (pursuant to section 1 or section 2) that has appointed a member to the nomination committee is no longer one of the shareholders who is given such right, at any point in time up to three months before the annual shareholders’ meeting: · the member appointed by such shareholder shall resign; and · the shareholder who is the next largest shareholder in the Company (that has not appointed a member) or EQT Foundation (pursuant to section 2) shall have the right to appoint one member to the nomination committee. Unless specific reasons suggest otherwise, the existing composition of the nomination committee shall, however, remain unchanged if such change in the ownership in the Company is only marginal or occurs during the three-month period prior to the annual shareholders’ meeting. If a shareholder/EQT Foundation otherwise should have the right to appoint a member due to a material change in the ownership of the Company at any time during the three-months period prior to the annual shareholders’ meeting, such shareholder/EQT Foundation shall, in any event, have the right to take part in the work of the nomination committee and participate in its meetings. 5. If a member resigns from the nomination committee before his or her work is completed, the shareholder (pursuant to section 1 or section 2) who has appointed such member shall appoint a new member, unless section 4 is applicable. 6. A shareholder (pursuant to section 1 or section 2) who has appointed a member to the nomination committee shall have the right to dismiss such member and appoint a new member. 7. Changes to the composition of the nomination committee shall be disclosed publicly as soon as possible. 8. The nomination committee’s appointment ends when the next nomination committee has been appointed. 9. If needed, the Company shall reimburse reasonable costs which the nomination committee deems necessary in order for the nomination committee to fulfill its assignment.10. These instructions shall apply until further notice. Majority rules The Board’s proposals under items 19, 20 and 21 on the agenda are subject to the approval at the Meeting with at least two-thirds (2/3) of both the votes cast and of the shares represented at the Meeting. The nomination committee’s proposal under item 13b on the agenda is subject to the approval at the Meeting with at least nine tenths (9/10) of both the votes cast and of the shares represented at the Meeting. Further information Information about all persons proposed as Board members and the nomination committee’s motivated statement regarding the proposal for the Board can be found on EQT’s website: www.eqtgroup.com/AGM.  The annual report, the remuneration report and other documents are available at EQT’s head office at Regeringsgatan 25 in Stockholm, Sweden and on EQT’s website: www.eqtgroup.com/AGM. These documents, together with information regarding the persons proposed as Board members, information about the proposed auditor and the nomination committee’s motivated statement are presented by being available on EQT’s website and at EQT’s head office in accordance with the above. They will also be sent free of charge to the shareholders who so request and state their postal address. Proxy forms for shareholders who wish to vote by proxy are available on EQT’s website: www.eqtgroup.com/AGM, and will be sent free of charge to the shareholders who so request and state their postal address. EQT’s registration number is 556849-4180, and its registered office is in Stockholm, Sweden. For information on how personal data is processed, see: https://www.euroclear.com/dam/ESw/Legal/Privacy-notice-bolagsstammor-engelska.pdf. _______________ Stockholm, April 2024 EQT AB (publ) The Board

Richa Goswami proposed as new Board member of EQT AB

Richa Goswami has in-depth knowledge and multi-sector experience from leading positions within Brand & Marketing across multiple geographies in the financial services and FMCG (fast-moving consumer goods) industry. Most recently she has worked at Fidelity International as their Group Chief Marketing and Brand Officer based out of Singapore. Prior to joining Fidelity International, Richa was the Chief Customer and Marketing Officer at HSBC, where she has spent over a decade in various capacities in Asia, Europe and United States. She has also been the Global Chief Digital Officer at Johnson & Johnson and the Global Head, Next Generation Banking, at Standard Chartered Bank and brings vast international experience within her field. Jacob Wallenberg, Chairperson of the Nomination Committee, comments: “Richa Goswami’s experience from building international brands across multiple industries will add vital perspectives to EQT’s continued journey. In today’s global market it is imperative to have a strong brand to be able to attract future talent and customers.” Johan Forssell has declined re-election, after serving on the Board for nine years. Conni Jonsson, Chairperson of the EQT AB Board, comments: “Johan is the longest serving Board member in EQT and his focus on long-term value creation and ownership has been much appreciated in the Board room. I am grateful for Johan’s contributions, especially during the IPO process, his support was instrumental in our first step as a listed company. Conni Jonsson continues, “I’m very much looking forward to welcoming Richa Goswami to the Board, her energy and multifaceted background will be an excellent addition and will also contribute to a better balance of the Board composition. Richa Goswami’s comprehensive track record of building global brands in a wide range of different sectors will strengthen EQT’s growth journey. I would also like to thank the members of the Nomination Committee for their dedicated work in this process.” The Nomination Committee’s complete proposals to EQT AB’s Annual Shareholders’ Meeting are included in the notice and the nomination committee’s motivated opinion, published on EQT’s website. The Annual Shareholders’ Meeting will be held on 27 May 2024. The election of Richa Goswami as new Board member is subject to relevant regulatory approvals. The Nomination Committee has been appointed based on the ownership structure as of 31 August 2023, and consists of Jacob Wallenberg (Chairperson), appointed by Investor AB, Harry Klagsbrun, appointed by Bark Partners AB, Cynthia Lee, appointed by Jean Eric Salata, Anders Oscarsson, appointed by AMF Pension & Funds and Conni Jonsson, Chairperson of the Board of EQT AB. Contact Olof Svensson, Head of Shareholder Relations, +46 72 989 09 15EQT Press Office, press@eqtpartners.com, +46 8 506 55 334

Crunchfish provides and patents Digital Cash privacy

Privacy is a key feature for CBDC systems to be adopted by the public. Several ongoing CBDC initiatives across the world place privacy very high on the agenda, e.g. the Digital Euro project  and the Brazilian CBDC pilot Drex . Crunchfish’s innovative privacy by design feature enables payers to make completely private payments for amounts below defined thresholds. A consumer who pays a merchant below a defined threshold amount would not disclose any personal information, neither to the merchant nor the intermediary or Central Bank. With Crunchfish Digital Cash the payer enjoys a similar level of privacy as paying with physical cash. Highlights in the upgraded Digital Cash SDK version 2.5 include: · Privacy by design – Balancing privacy with regulatory transactional traceability requirements · Secure time – Increasing security in the payment timestamp and preventing users from changing the device time to use expired or not yet valid certificates · Improved certificate management · Enhanced fraud detection capability and fraud management · Increased security · Improved integration support - enriched documentation and new backend components “We have released many new features based on requirements from CBDC and other offline projects. Our development team has been working hard to meet the requirements from the market and the pilots we have been running. I’m really proud that we now can offer privacy by design as we know this is a key requirement in many CBDC projects.” says Magnus Lageson, CPO at Crunchfish Digital Cash. The upgraded Digital Cash version 2.5 will be made available for all customers through the Crunchfish Developer portal .  In parallel with making this upgrade Digital Cash version available, Crunchfish applied yesterday for a Swedish patent for balancing regulatory requirements for transactional traceability with true privacy through encryption of transactional information for amounts below defined thresholds, defined by the issuer and the regulator, using wallet keys. The patent if granted is valid for 20 years until April 2044. As further background on privacy Lipis Advisors in collaboration with Crunchfish released in May 2023 this whitepaper on privacy considerations in offline payments systems . For more information, please contact: Joachim Samuelsson, CEO of Crunchfish AB +46708 46 47 88 joachim.samuelsson@crunchfish.com This information was provided by the contact person above for publication on April 24th 2024 at 08:30 CET. Västra Hamnen Corporate Finance AB is the Certified Adviser. Email: ca@vhcorp.se. Telephone +46 40 200250. About Crunchfish –crunchfish.com  Crunchfish is a deep tech company developing a Digital Cash platform for Banks, Payment Services and CBDC implementations and Gesture Interaction technology for AR/VR, automotive and digital interfaces. Crunchfish is listed on Nasdaq First North Growth Market since 2016, with headquarters in Malmö, Sweden and with subsidiary in India.

Calliditas Announces Positive NefIgArd Open Label Extension Results

NefIgArd was a global, Phase 3, randomized, double-blind, placebo-controlled, multicenter study designed to evaluate the efficacy and safety of Nefecon 16 mg once daily vs placebo in adult patients with primary IgAN as an addition to optimized RASi therapy. Patients were randomized 1:1 to receive 16 mg/day of Nefecon or matching placebo for 9 months, followed by a 15-month observational follow-up period without the study drug. The NefIgArd study achieved both its primary and key secondary endpoints and was the basis for full approval by the FDA in December 2023. The full data set was published in The Lancet. 01554-4/abstract) The OLE study was designed to provide 9 months of treatment with Nefecon for all patients who completed the NefIgArd study and who at that time had > 1g/g of proteinuria over 24h and > 30 ml/min of eGFR. All enrolled OLE patients continued on optimized RAS inhibitor therapy (ACEs and/or ARBs) and were treated for 9 months with Nefecon 16mg per day, with a follow-up visit three months after completion of treatment.  Primary assessment was based on UPCR and eGFR at 9 months.  A total of 119 patients were enrolled, of whom 45 had previously had active treatment.  Topline data from the OLE study showed that the treatment response was consistent with the NefIgArd study's findings regarding the endpoints of UPCR and eGFR at nine months across all patients, irrespective of whether they had previously been treated with Nefecon or with placebo.  The safety data after 9 months of treatment or retreatment with Nefecon in patients who completed the NefIgArd study were consistent with previously reported safety data. “It is exciting to see these results on both proteinuria reduction and eGFR stabilization at 9 months across all patients irrespective of previous treatment regimen in the Phase 3 trial,”, said CEO Renée Aguiar-Lucander. “These topline results support the study thesis that the response to retreatment with Nefecon was unaffected by previous treatment cycles. We look forward to presenting data at the upcoming ERA EDTA symposium.”

Acquisition of Foppiani Shipping & Logistics

Today, SGL Group ApS has through its wholly-owned subsidiary Scan Global Logistics A/S signed an agreement to acquire 100% of the shares in Foppiani Shipping & Logistics. Foppiani Shipping & Logistics is a leading Italian freight forwarder headquartered in Prato, specialising in air and ocean freight services for fashion, furniture, high-end Italian products and automotive sectors. Foppiani Shipping & Logistics generates yearly revenue of EUR 115m. The acquisition of Foppiani Shipping & Logistics provides SGL Group with an operational platform in Italy which enables SGL Group to establish its strategic presence in Italy, and gives SGL Group a strategic platform to scale the business and expand its global presence to the benefit of customers. Most importantly, Foppiani Shipping & Logistics will bring additional human capital with comprehensive industry knowledge and niche experience; people with a perfect match to SGL Group’s DNA and culture. The transaction is subject to anti-trust approval from Italian authorities, and closing is expected during Q2 2024. The acquisition of Foppiani Shipping & Logistics is financed through the issue of new senior secured fixed-rate bonds. For further information, please contact: Simon Kusk, Head of Group Finance or Martin Gregersen, Head of Group Treasury investor@scangl.com| (+45) 32 48 00 00 This information is information that SGL Group ApS is obliged to make public pursuant to the EU Market Abuse Regulation and the Swedish Securities Market Act. The information was submitted for publication by the above-mentioned persons at 12:30 CET on 24 April 2024.

Report from Intrum’s Annual General Meeting 2024

Submission and adoption of accountsThe Annual General Meeting noted that the annual accounts and the auditor’s report, and consolidated accounts and auditor’s report on the consolidated accounts for the financial year 2023 had been duly submitted, and adopted the profit and loss statement and balance sheet and consolidated profit and loss statement and consolidated balance sheet.DividendThe Annual General Meeting adopted the board’s proposal not to pay any dividend for 2023.Discharge from liabilityThe Annual General Meeting discharged the members of the Board and the CEO from liability for their management of the company during 2023.Board and board remunerationThe Annual General Meeting resolved that the Board shall consist of seven Board members with no deputies, and elected Magnus Lindquist, Michel van der Bel, Debra Davies, Geeta Gopalan, Andreas Näsvik, Philip Thomas and Ragnhild Wiborg.The Annual General Meeting re-elected Magnus Lindquist as Chairman of the Board.Board remuneration and remuneration for committee work was established to a total of SEK 8,115,000 (7,700,000), to be distributed as follows: · SEK 1,570,000 to the Chair of the Board · SEK 735,000 to each of the other Board members · SEK 400,000 to the Chair of the Audit Committee · SEK 180,000 to each of the other two members of the Audit Committee · SEK 400,000 to the Chair of the Risk Committee · SEK 180,000 to each of the other two members of the Risk Committee · SEK 95,000 to each of the three members of the Remuneration Committee · SEK 140,000 to the Chair of the Transformation Committee · SEK 95,000 to each of the other two members of the Transformation Committee Additional compensation for travel time of SEK 30,000 per physical board meeting held in Sweden will be paid to Michel van der Bel, Debra Davies, Geeta Gopalan and Philip Thomas.Auditor and fees to the auditorThe Annual General Meeting elected Deloitte AB as auditor for the period until the end of the next Annual General Meeting, with the authorised public accountant Patrick Honeth as auditor in charge. Fees to the auditor shall be paid in accordance with approved invoices.Remuneration reportThe Annual General Meeting approved the Board’s remuneration report.Guidelines for remuneration and other terms of employment for key executivesThe Annual General Meeting approved the Board’s proposed guidelines for executive remuneration and other terms of employment for key executives.Long-term incentive programThe Annual General Meeting approved the Board’s proposal for a long-term incentive program for 2024. The program includes up to 15 individuals divided into three groups: 1) the CEO, 2) three members of the Executive Committee and 3) other members of the Executive Committee and other key employees. The participants will be offered to be allocated a cash compensation which shall be invested in Intrum shares which shall be kept at least until 31 December 2026. Participation requires continued employment and an own investment in Intrum shares. The total costs for the program are estimated to up to MSEK 92. The program does not result in any dilution.Mandate to the Board regarding transfer of own sharesIn accordance with the Board’s proposal, the meeting authorised the Board to, until the end of the next Annual General Meeting, resolve on transfer of the company’s own shares on a regulated market. The authorisation relates to shares acquired for outstanding incentive programs.Mandate to the Board regarding issue of sharesIn accordance with the Board’s proposal, the meeting authorised the Board to, until the end of the next Annual General Meeting, resolve on new issues of shares, warrants and/or convertibles entitling to subscription of shares, corresponding to no more than 10 percent of the total number of outstanding  shares in the company.MinutesThe minutes from the annual general meeting will be published on the company’s website within two weeks.For further information, please contact:Emil Folkesson, Interim CFO & Investor Relations Directorir@intrum.comThis information was submitted for publication, through the agency of the contact person set out above on 24 April, 2024 at 16:30 CET.

The Board of Directors in Redsense Medical AB (publ) resolves to carry out a directed share issue of approximately MSEK 9,8.

The Board of Directors has resolved that the Directed Issue of a maximum of 1,404,081 shares is directed to ShapeQ GmbH (the “Investor”). Redsense intends to use the net proceeds from the Directed Issue of a maximum of approximately MSEK 9,8 primarily to focus on the launch of the Redsense Clamp but also other commercial initiatives to accelerate the growth of Redsense. The subscription price of SEK 7 per new share in the Directed Issue has been determined by the Company’s Board of Directors following arms-length negotiations with the Investors based on the current share price of Redsense’s shares. The subscription price corresponds to a premium of approximately 14 percent in correlation to the closing price of SEK 6.1 as of April 23, 2024. The subscription price therefore exceeds the current market-value. The Directed Issue will increase the number of shares in the Company by a maximum of 1,404,081 shares, from 14,040,810 shares to a maximum of 15,444,891 shares, meaning an increase in the share capital by a maximum of SEK 140,408.1 from SEK 1,404,081 to a maximum of SEK 1,544,489.1 The Directed Issue entails a dilution for existing owners of a maximum of approximately 9 percent of the number of shares and votes in the Company after the Directed Issue. The reasons for the deviation from the shareholders' preferential right are as follows. The board has carefully considered various financing alternatives, including the conditions for carrying out a rights issue instead of a directed issue. The Board of Directors considers it to be in the best interest of the Company and its shareholders to carry out the Directed Issue in order to ensure the most time- and cost-effective financing of the Company's continued development and because the conditions are not deemed to exist to carry out a rights issue on favorable terms. It is the board's overall assessment that the reasons above clearly and strongly outweigh the reasons that justify the main principle that issues must be carried out with the application of shareholders' pre-emptive rights and that an issue with a deviation from shareholders' pre-emptive rights is therefore in the interests of the Company and all shareholders. A prerequisite for the implementation of the Directed Issue is that the Inspectorate for Strategic Products (ISP) approves the investment in accordance with The Screening of Foreign Direct Investments Act (2023:560). The Law firm Lindahl KB is legal advisor to the Company in connection with the Directed Issue. This information is information that Redsense Medical AB (publ) is obliged to make public pursuant to the EU's market abuse regulation. The information was submitted for publication, through the agency of the contact persons set out below on April 24, 2024, at 17:00 CEST.

Relesys A/S announces binding agreement with Copilot Capital Limited to acquire all outstanding shares in Relesys A/S for DKK 6.60 per share

Unite BidCo ApS, CVR-no. 44774739 ("BidCo"), a company controlled by funds advised by Copilot Capital Limited (“Copilot”), a private equity fund investing in European software champions, has entered into a binding transaction agreement relating to the acquisition of all outstanding shares in Relesys A/S ("Relesys") for DKK 6.60 per share representing a premium of 37% to the share price the day before Relesys announced the initiation of a strategic review. In total, Relesys shareholders representing approximately 93.5% of the share capital have entered into binding agreements with Copilot to sell their shares, including CEO Jesper Roesgaard, COO Jens Ole Lebeck and CTO Martin Sørensen, who, in the aggregate, own 73.2% of the shares, as well as the members of the Board of Directors. Relesys Chair of the Board, Alexander Martensen-Larsen, says:“Since Relesys listed on Nasdaq First North Premier in late 2021, we have strengthened the operational platform, optimised the customer base, and entered new markets. During this period, annual recurring revenue (ARR) has doubled, revenue has grown by 65% and the number of users has reached almost 400,000. In other words, we have delivered on our promises. Last year, we initiated a strategic review to evaluate alternatives to continue our growth journey, including financing options and ownership structures. To ensure the best possible solution and to maximise shareholder value we have conducted a very thorough and structured process. It is therefore rewarding on behalf of a unanimous Boards of Directors, to announce this attractive agreement with Copilot, which is supported by a clear majority of the shareholders.” It is Copilot’s ambition to continue investing significantly in the growth of Relesys with the aim of becoming the global champion in next-generation technology for frontline workers. John Messer, Managing Partner, says:“Copilot is delighted to invest in Relesys.  We love the vision Jesper and Jens Ole have for the business and the team they’ve assembled to turn this vision into reality. This partnership represents an ideal opportunity to combine Copilot’s focused HCM and retail sector knowledge with Relesys’ best in class product.  We are committed to supporting the continued growth of Relesys via further investments to accelerate sales as well as supporting their international ambitions as they look to become the pre-eminent solution for frontline workers” Jesper Roesgaard, Jens Ole Lebeck and Martin Sørensen, owning respectively 34.2%, 32.6% and 6.3% of the shares in Relesys, will reinvest more than half of their proceeds into the new company. The reinvestment has been a key condition from Copilot to enter into an agreement. Relesys CEO Jesper Roesgaard says:“Copilot is in many ways the right partner to take Relesys to the next level and become the true leader in next-generation tech for frontline workers. In addition to funds to invest in our continued growth journey and market-leading employee engagement platform, Copilot brings strategic know-how, commercial and financial expertise and a strong network into the retail industry. We also share the same values for running a business like Relesys, and I am confident that this is the best long-term solution for our customers and the entire Relesys team, which is also reflected in our reinvestment in the new set-up.”  Highlights · Relesys today announces that it has entered into a transaction agreement with Copilot relating to the acquisition of all outstanding shares in Relesys for DKK 6.60 per share (the "Transaction"). · On 21 September 2023 Relesys announced the initiation of a strategic review to evaluate funding options and ownership structures to allow Relesys to execute its expansion plans and accelerate growth. As part of the review Relesys has conducted a thorough and structured process with the aim of maximizing shareholder value and achieving the best possible solution for Relesys, its customers and employees going forward. · As part of its strategic considerations and the assessment of the terms offered by Copilot the Board of Directors has amongst others considered the following factors: · The price and the terms offered are the results of a competitive auction followed by negotiations to further improve the offer in order to maximize shareholder value, and; · Copilot can as a new majority owner of Relesys accelerate the company's growth trajectory towards becoming the global champion in next-generation technology for frontline workers through additional growth funding and Copilot's strategic expertise · Based on an evaluation of these factors and the offered terms the Board of Directors have unanimously decided to support the Transaction and to enter into the transaction agreement with Copilot. · As part of the Transaction Copilot has entered into share purchase agreements with shareholders representing approximately 93.5% of the issued and outstanding share capital in Relesys to acquire their shares ("Share Purchase Agreements") for DKK 6.60 DKK per share. · The shareholders having entered into Share Purchase Agreements with Copilot to sell their shares are: 1. i. Members of the Board of Directors (combined 1.9% of the shares/votes); ii. Jesper Roesgaard, Jens Ole Lebeck and Martin Sørensen (combined 73.2% of the shares/votes); iii. Kapitalforeningen BankInvest Select Small Cap, Danske Aktier (10.0% of the shares/votes); iv. Mr. Scobie Dickinson Ward (4.2% of the shares/votes); v. Better Holding 2012 A/S (2.2% of the shares/votes); and vi. Kapitalforeningen Wealth Invest, Afd. Symmetry Invest (2.0% of the shares/votes) · Following settlement of the trades relating to the Share Purchase Agreements, Copilot will hold more than 90% of the shares and voting rights in Relesys. Accordingly, Copilot and Relesys has agreed to request Nasdaq Copenhagen for removal from trading of the Relesys shares on Nasdaq First North Premier Growth Market following the settlement. Subject to approval from Nasdaq Copenhagen removal from trading is expected to take place within two to three weeks from this announcement. · Subsequently, the remaining Relesys shareholders, representing approximately 6.5% of the share capital, will be redeemed in cash at DKK 6.60 per share through a compulsory redemption process in accordance with sections 70 and 72 of the Danish Companies Act to be initiated by BidCo whereby all minority shareholders will be requested, by publication of a separate notice, to transfer all their remaining shares in Relesys to BidCo within a four-week notice period. The compulsory redemption process is expected to be initiated as soon as possible following the removal of the shares from trading. · In the coming weeks, Relesys expects to convene an extraordinary general meeting to be held with the purpose of electing new members of the Board of Directors. · The purchase price of DKK 6.60 per share implies a significant premium compared to relevant historic prices of the Company’s shares on Nasdaq First North Premier Growth Market Denmark: Relevant period Premium Reference priceClosing price on 20 September 2023 (the day 37% 4.82before announcement of a strategic review)90 trading days volume weighted average share 25%  5.29price (VWAP) until (and including) 24 April2024Closing price on 24 April 2024 -8%  7.20 Further information about timing and process for removal from trading and compulsory redemption will be announced upon settlement of the Share Purchase Agreements. AdvisersCarnegie Investment Bank, filial af Carnegie Investment Bank AB, Sverige, is acting as exclusive financial adviser to Relesys. Accura Advokatpartnerselskab is acting as legal adviser to Relesys and Plesner Advokatpartnerselskab is acting as legal adviser to Copilot. Certified Adviser for RelesysGrant ThorntonStockholmsgade 452100 Copenhagen ØDenmark

Calliditas Therapeutics’ 2023 Annual Report Published

For further information, please contact: Åsa Hillsten, Head of IR & Sustainability, Calliditas Tel.: +46 76 403 35 43, Email: asa.hillsten@calliditas.com This information is information that Calliditas Therapeutics AB is obliged to make public pursuant to the Securities Markets Act. The information was sent for publication, through the agency of the contact persons set out above, on April 24, 2024, at 7:00 p.m. CET. About Calliditas Calliditas Therapeutics is a biopharma company headquartered in Stockholm, Sweden, focused on identifying, developing, and commercializing novel treatments in orphan indications with significant unmet medical needs. Calliditas’ common shares are listed on Nasdaq Stockholm (ticker: CALTX) and its American Depositary Shares are listed on the Nasdaq Global Select Market (ticker: CALT). Visit Calliditas.com for further information. Forward-Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, including, without limitation, statements regarding the development of Calliditas’ pipeline. The words “may,” “will,” “could,” “would,” “should,” “expect,” “plan,” “anticipate,” “intend,” “believe,” “estimate,” “predict,” “project,” “potential,” “continue,” “target,” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Any forward-looking statements in this press release are based on management’s current expectations and beliefs and are subject to a number of risks, uncertainties, and important factors that may cause actual events or results to differ materially from those expressed or implied by any forward-looking statements contained in this press release, including, without limitation, any related to Calliditas’ business, operations, clinical trials, intellectual property of the NEFECON franchise globally, competition from other companies, pipeline development, revenue and product sales projections or forecasts, 2024 revenue guidance  and other risks identified in the section entitled “Risk Factors” in Calliditas’ reports filed with the Securities and Exchange Commission. Calliditas cautions you not to place undue reliance on any forward-looking statements, which speak only as of the date they are made. Calliditas disclaims any obligation to publicly update or revise any such statements to reflect any change in expectations or in events, conditions, or circumstances on which any such statements may be based, or that may affect the likelihood that actual results will differ from those set forth in the forward-looking statements. Any forward-looking statements contained in this press release represent Calliditas’ views only as of the date hereof and should not be relied upon as representing its views as of any subsequent date.

Everfuel: HySynergy update

Herning, Denmark, 24 April 2024 - Everfuel A/S today provides an update on the commissioning of the 20 MW HySynergy 1 electrolyser. The Company continues to progress commissioning focused on the sub-systems required to start production and delivery of green hydrogen. As previously communicated, the main electrolyser facility is ready for start-up, while some sub-systems experience delays following commissioning tests. This is impacting the planned start-up of the HySynergy 1 facility with production now expected to commence in the second half of 2024. Testing, verification and certification is being executed in close cooperation with the electrolyser supplier, Nel, and other sub-suppliers with focus on the following areas: · High-pressure systems · Compressors · Finalisation of software and automation, documentation and certifications Since leakage was detected in February 2024, the electrolyser supplier has been working on completing the rebuild of the deoxidiser, which removes oxygen and moisture from the hydrogen flow as part of the electrolyser’s high-pressure auxiliary system. The supplier has implemented a solution currently awaiting PED (pressure equipment directive) certification. Everfuel and the electrolyser supplier agree that a safe and long-term robust solution is in the interest of both parties.   Everfuel has implemented additional safety measures to ensure integrity of the plant resulting in identification of a leakage during verification test of the rebuild gas holder, which serves a pressure balancing and safety function. The unit requires onsite rebuild and solutions are currently being investigated by the electrolyser supplier. Everfuel and sub-suppliers have committed highest attention and priority for completing the remaining commissioning steps which are strongly interdependent with certain steps subject to specific time windows for external expertise to undertake testing and verification. As a consequence of the mentioned activities, commissioning of the main compressor, final validation of the high-pressure system and completion of the automation and software system are affected. “We are currently experiencing some technical challenges related to a couple of Balance of Plant modules that Nel has the responsibility for. Although these modules are not part of Nel’s current standard project scope, we remain committed to fixing the problems in close cooperation with Everfuel’s team. Nel will also support Everfuel on other technical challenges, which are not part of Nel’s scope of supply, in order to bring HySynergy 1 safely into operation as soon as possible”, said Håkon Volldal, Nel’s CEO. “Implementation of a safe and long-term sustainable hydrogen production facility is of the absolute highest priority of Everfuel. We are working very closely with partners and suppliers to make sure this is completed in a good collaborative manner as fast as possible. Pioneering the hydrogen industry is a challenge for all participants. Together we will succeed, building unique competences along the way, positioning us to capitalise on the fast-growing hydrogen market,” said Jacob Krogsgaard, the founder and CEO of Everfuel We strongly encourage stakeholders to watch the following video where CEO, Jacob Krogsgaard explain the complexities in the HySynergy commissioning process. Link: HySynergy 1 update  For further information, please contact: Jacob Krogsgaard, CEO, Everfuel, +45 2871 8945Mads Tirsgaard Mortensen, Investor Relations Director, Everfuel, mm@everfuel.com, +45 7730 4727 About Everfuel | www.everfuel.com Everfuel is making green hydrogen for zero emission industry and mobility commercially available across Europe, offering competitive all-inclusive hydrogen supply and fuelling solutions. We own and operate green hydrogen infrastructure and partner with industry and vehicle OEMs to connect the entire hydrogen value chain and seamlessly provide hydrogen fuel to enterprise customers under long-term contracts. Green hydrogen is a 100% clean energy carrier made from renewable solar and wind power and key to decarbonising industry and transportation in Europe. We are an ambitious, rapidly growing company, headquartered in Herning, Denmark, and with activities in Norway, Denmark, Sweden, The Netherlands and Germany, and a plan to grow across Europe. Everfuel is listed on Euronext Growth in Oslo under EFUEL. This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act. This information was issued as inside information pursuant to the EU Market Abuse Regulation, and was published by Mads Tirsgaard Mortensen, Director of Investor Relations, at Everfuel A/S on the date and time provided.